id	sid	tid	token	lemma	pos
easat-4163	1	1	edelweiss	edelweiss	PROPN
easat-4163	1	2	applied	apply	VERB
easat-4163	1	3	science	science	NOUN
easat-4163	1	4	and	and	CCONJ
easat-4163	1	5	technology	technology	NOUN
easat-4163	1	6	issn	issn	PROPN
easat-4163	1	7	:	:	PUNCT
easat-4163	1	8	2576	2576	NUM
easat-4163	1	9	-	-	SYM
easat-4163	1	10	8484	8484	NUM
easat-4163	1	11	vol	vol	NOUN
easat-4163	1	12	.	.	PROPN
easat-4163	2	1	9	9	NUM
easat-4163	2	2	,	,	PUNCT
easat-4163	2	3	no	no	INTJ
easat-4163	2	4	.	.	NOUN
easat-4163	2	5	1	1	NUM
easat-4163	2	6	,	,	PUNCT
easat-4163	2	7	505	505	NUM
easat-4163	2	8	-	-	SYM
easat-4163	2	9	514	514	NUM
easat-4163	2	10	2025	2025	NUM
easat-4163	2	11	publisher	publisher	NOUN
easat-4163	2	12	:	:	PUNCT
easat-4163	2	13	learning	learn	VERB
easat-4163	2	14	gate	gate	NOUN
easat-4163	2	15	doi	doi	PROPN
easat-4163	2	16	:	:	PUNCT
easat-4163	2	17	10.55214/25768484.v9i1.4163	10.55214/25768484.v9i1.4163	NUM
easat-4163	2	18	©	©	PROPN
easat-4163	2	19	2025	2025	NUM
easat-4163	2	20	by	by	ADP
easat-4163	2	21	the	the	DET
easat-4163	2	22	authors	author	NOUN
easat-4163	2	23	;	;	PUNCT
easat-4163	3	1	licensee	licensee	PROPN
easat-4163	3	2	learning	learning	NOUN
easat-4163	3	3	gate	gate	NOUN
easat-4163	3	4	©	©	PROPN
easat-4163	3	5	2025	2025	NUM
easat-4163	3	6	by	by	ADP
easat-4163	3	7	the	the	DET
easat-4163	3	8	authors	author	NOUN
easat-4163	3	9	;	;	PUNCT
easat-4163	3	10	licensee	licensee	PROPN
easat-4163	3	11	learning	learning	NOUN
easat-4163	3	12	gate	gate	NOUN
easat-4163	3	13	history	history	NOUN
easat-4163	3	14	:	:	PUNCT
easat-4163	3	15	received	receive	VERB
easat-4163	3	16	:	:	PUNCT
easat-4163	3	17	4	4	NUM
easat-4163	3	18	december	december	PROPN
easat-4163	3	19	2024	2024	NUM
easat-4163	3	20	;	;	PUNCT
easat-4163	3	21	revised	revise	VERB
easat-4163	3	22	:	:	PUNCT
easat-4163	3	23	31	31	NUM
easat-4163	3	24	december	december	PROPN
easat-4163	3	25	2024	2024	NUM
easat-4163	3	26	;	;	PUNCT
easat-4163	3	27	accepted	accept	VERB
easat-4163	3	28	:	:	PUNCT
easat-4163	3	29	6	6	NUM
easat-4163	3	30	january	january	NOUN
easat-4163	3	31	2025	2025	NUM
easat-4163	3	32	;	;	PUNCT
easat-4163	3	33	published	publish	VERB
easat-4163	3	34	:	:	PUNCT
easat-4163	4	1	9	9	NUM
easat-4163	4	2	january	january	NOUN
easat-4163	4	3	2025	2025	NUM
easat-4163	4	4	*	*	PUNCT
easat-4163	4	5	correspondence	correspondence	NOUN
easat-4163	4	6	:	:	PUNCT
easat-4163	4	7	abdullahi.aliyu@asu.edu.om	abdullahi.aliyu@asu.edu.om	PROPN
easat-4163	4	8	pathophysiology	pathophysiology	NOUN
easat-4163	4	9	,	,	PUNCT
easat-4163	4	10	management	management	NOUN
easat-4163	4	11	and	and	CCONJ
easat-4163	4	12	therapeutic	therapeutic	ADJ
easat-4163	4	13	challenges	challenge	NOUN
easat-4163	4	14	of	of	ADP
easat-4163	4	15	coagulopathy	coagulopathy	ADJ
easat-4163	4	16	in	in	ADP
easat-4163	4	17	covid-19	covid-19	PROPN
easat-4163	4	18	patients	patient	NOUN
easat-4163	4	19	abdullahi	abdullahi	PROPN
easat-4163	4	20	aliyu1,2	aliyu1,2	PROPN
easat-4163	4	21	*	*	PROPN
easat-4163	4	22	,	,	PUNCT
easat-4163	4	23	ibrahim	ibrahim	PROPN
easat-4163	4	24	kalle	kalle	PROPN
easat-4163	4	25	kwaifa3	kwaifa3	PROPN
easat-4163	4	26	,	,	PUNCT
easat-4163	4	27	bashir	bashir	PROPN
easat-4163	4	28	abdulhamid	abdulhamid	PROPN
easat-4163	4	29	danjuma3	danjuma3	PROPN
easat-4163	4	30	,	,	PUNCT
easat-4163	4	31	aliyu	aliyu	NOUN
easat-4163	4	32	ibrahim	ibrahim	PROPN
easat-4163	4	33	bagudo3	bagudo3	PROPN
easat-4163	4	34	,	,	PUNCT
easat-4163	4	35	isah	isah	PROPN
easat-4163	4	36	isaac	isaac	PROPN
easat-4163	4	37	zama3	zama3	PROPN
easat-4163	4	38	,	,	PUNCT
easat-4163	4	39	qais	qais	PROPN
easat-4163	4	40	al	al	PROPN
easat-4163	4	41	rawahi1	rawahi1	PROPN
easat-4163	4	42	,	,	PUNCT
easat-4163	4	43	mahmoud	mahmoud	PROPN
easat-4163	4	44	elnagger1	elnagger1	PROPN
easat-4163	4	45	,	,	PUNCT
easat-4163	4	46	adamu	adamu	PROPN
easat-4163	4	47	abdul	abdul	PROPN
easat-4163	4	48	abubakar1	abubakar1	PROPN
easat-4163	5	1	1department	1department	NUM
easat-4163	5	2	of	of	ADP
easat-4163	5	3	veterinary	veterinary	ADJ
easat-4163	5	4	medicine	medicine	NOUN
easat-4163	5	5	,	,	PUNCT
easat-4163	5	6	college	college	NOUN
easat-4163	5	7	of	of	ADP
easat-4163	5	8	applied	apply	VERB
easat-4163	5	9	and	and	CCONJ
easat-4163	5	10	health	health	NOUN
easat-4163	5	11	science	science	NOUN
easat-4163	5	12	,	,	PUNCT
easat-4163	5	13	a’sharqiyah	a’sharqiyah	PROPN
easat-4163	5	14	university	university	NOUN
easat-4163	5	15	,	,	PUNCT
easat-4163	5	16	oman	oman	NOUN
easat-4163	5	17	;	;	PUNCT
easat-4163	5	18	abdullahi.aliyu@asu.edu.om	abdullahi.aliyu@asu.edu.om	PROPN
easat-4163	5	19	(	(	PUNCT
easat-4163	5	20	a.a	a.a	PROPN
easat-4163	5	21	.	.	PROPN
easat-4163	5	22	)	)	PUNCT
easat-4163	6	1	qais.alrawahi@asu.edu.om	qais.alrawahi@asu.edu.om	PROPN
easat-4163	6	2	(	(	PUNCT
easat-4163	6	3	q.a.r	q.a.r	NOUN
easat-4163	6	4	.	.	PUNCT
easat-4163	6	5	)	)	PUNCT
easat-4163	7	1	mahmoud.elnagger@asu.edu.om	mahmoud.elnagger@asu.edu.om	NOUN
easat-4163	7	2	(	(	PUNCT
easat-4163	7	3	m.e	m.e	PROPN
easat-4163	7	4	.	.	PROPN
easat-4163	7	5	)	)	PUNCT
easat-4163	8	1	adamu.abubakar@asu.edu.om	adamu.abubakar@asu.edu.om	PROPN
easat-4163	8	2	(	(	PUNCT
easat-4163	8	3	a.a.a	a.a.a	PROPN
easat-4163	8	4	.	.	PUNCT
easat-4163	8	5	)	)	PUNCT
easat-4163	9	1	2faculty	2faculty	NUM
easat-4163	9	2	of	of	ADP
easat-4163	9	3	veterinary	veterinary	ADJ
easat-4163	9	4	medicine	medicine	NOUN
easat-4163	9	5	,	,	PUNCT
easat-4163	9	6	usmanu	usmanu	PROPN
easat-4163	9	7	danfodiyo	danfodiyo	PROPN
easat-4163	9	8	university	university	PROPN
easat-4163	9	9	(	(	PUNCT
easat-4163	9	10	udu	udu	PROPN
easat-4163	9	11	)	)	PUNCT
easat-4163	9	12	,	,	PUNCT
easat-4163	9	13	sokoto	sokoto	PROPN
easat-4163	9	14	,	,	PUNCT
easat-4163	9	15	nigeria	nigeria	PROPN
easat-4163	9	16	.	.	PUNCT
easat-4163	10	1	3department	3department	NUM
easat-4163	10	2	of	of	ADP
easat-4163	10	3	haematology	haematology	NOUN
easat-4163	10	4	,	,	PUNCT
easat-4163	10	5	school	school	NOUN
easat-4163	10	6	of	of	ADP
easat-4163	10	7	medical	medical	ADJ
easat-4163	10	8	laboratory	laboratory	NOUN
easat-4163	10	9	sciences	sciences	PROPN
easat-4163	10	10	,	,	PUNCT
easat-4163	10	11	college	college	NOUN
easat-4163	10	12	of	of	ADP
easat-4163	10	13	health	health	PROPN
easat-4163	10	14	sciences	sciences	PROPN
easat-4163	10	15	,	,	PUNCT
easat-4163	10	16	usmanu	usmanu	PROPN
easat-4163	10	17	danfodiyo	danfodiyo	PROPN
easat-4163	10	18	university	university	PROPN
easat-4163	10	19	(	(	PUNCT
easat-4163	10	20	udu	udu	PROPN
easat-4163	10	21	)	)	PUNCT
easat-4163	10	22	,	,	PUNCT
easat-4163	10	23	sokoto	sokoto	PROPN
easat-4163	10	24	,	,	PUNCT
easat-4163	10	25	nigeria	nigeria	PROPN
easat-4163	10	26	;	;	PUNCT
easat-4163	10	27	ibrahim.kwaifa@udusok.edu.ng	ibrahim.kwaifa@udusok.edu.ng	ADJ
easat-4163	10	28	(	(	PUNCT
easat-4163	10	29	i.k.k	i.k.k	ADJ
easat-4163	10	30	.	.	PUNCT
easat-4163	10	31	)	)	PUNCT
easat-4163	11	1	bashirabdulhamid.bad@gmail.com	bashirabdulhamid.bad@gmail.com	NOUN
easat-4163	11	2	(	(	PUNCT
easat-4163	11	3	b.a.d	b.a.d	PROPN
easat-4163	11	4	.	.	PUNCT
easat-4163	11	5	)	)	PUNCT
easat-4163	12	1	aliyubagudo1@gmail.com	aliyubagudo1@gmail.com	X
easat-4163	13	1	(	(	PUNCT
easat-4163	13	2	a.i.b	a.i.b	X
easat-4163	13	3	.	.	PUNCT
easat-4163	13	4	)	)	PUNCT
easat-4163	14	1	isah.isaac@udusok.edu.ng	isah.isaac@udusok.edu.ng	ADV
easat-4163	14	2	(	(	PUNCT
easat-4163	14	3	i.i.z	i.i.z	NOUN
easat-4163	14	4	.	.	PUNCT
easat-4163	14	5	)	)	PUNCT
easat-4163	15	1	abstract	abstract	NOUN
easat-4163	15	2	:	:	PUNCT
easat-4163	15	3	the	the	DET
easat-4163	15	4	pathophysiology	pathophysiology	NOUN
easat-4163	15	5	of	of	ADP
easat-4163	15	6	covid-19	covid-19	PROPN
easat-4163	15	7	-	-	PUNCT
easat-4163	15	8	associated	associate	VERB
easat-4163	15	9	coagulopathy	coagulopathy	ADJ
easat-4163	15	10	is	be	AUX
easat-4163	15	11	characterized	characterize	VERB
easat-4163	15	12	by	by	ADP
easat-4163	15	13	a	a	DET
easat-4163	15	14	complex	complex	NOUN
easat-4163	15	15	of	of	ADP
easat-4163	15	16	interactions	interaction	NOUN
easat-4163	15	17	within	within	ADP
easat-4163	15	18	viral	viral	ADJ
easat-4163	15	19	factors	factor	NOUN
easat-4163	15	20	,	,	PUNCT
easat-4163	15	21	abnormal	abnormal	ADJ
easat-4163	15	22	haemostasis	haemostasis	NOUN
easat-4163	15	23	,	,	PUNCT
easat-4163	15	24	dysfunction	dysfunction	NOUN
easat-4163	15	25	of	of	ADP
easat-4163	15	26	endothelial	endothelial	ADJ
easat-4163	15	27	cells	cell	NOUN
easat-4163	15	28	,	,	PUNCT
easat-4163	15	29	and	and	CCONJ
easat-4163	15	30	inflammatory	inflammatory	ADJ
easat-4163	15	31	reactions	reaction	NOUN
easat-4163	15	32	,	,	PUNCT
easat-4163	15	33	necessitating	necessitate	VERB
easat-4163	15	34	the	the	DET
easat-4163	15	35	research	research	NOUN
easat-4163	15	36	to	to	PART
easat-4163	15	37	elucidate	elucidate	VERB
easat-4163	15	38	underlying	underlying	ADJ
easat-4163	15	39	mechanisms	mechanism	NOUN
easat-4163	15	40	and	and	CCONJ
easat-4163	15	41	identify	identify	VERB
easat-4163	15	42	novel	novel	ADJ
easat-4163	15	43	therapeutic	therapeutic	ADJ
easat-4163	15	44	targets	target	NOUN
easat-4163	15	45	.	.	PUNCT
easat-4163	16	1	severe	severe	ADJ
easat-4163	16	2	covid-19	covid-19	PROPN
easat-4163	16	3	conditions	condition	NOUN
easat-4163	16	4	are	be	AUX
easat-4163	16	5	frequently	frequently	ADV
easat-4163	16	6	coupled	couple	VERB
easat-4163	16	7	with	with	ADP
easat-4163	16	8	an	an	DET
easat-4163	16	9	increased	increase	VERB
easat-4163	16	10	immunological	immunological	ADJ
easat-4163	16	11	response	response	NOUN
easat-4163	16	12	,	,	PUNCT
easat-4163	16	13	dubbed	dub	VERB
easat-4163	16	14	a	a	DET
easat-4163	16	15	cytokine	cytokine	NOUN
easat-4163	16	16	storm	storm	NOUN
easat-4163	16	17	,	,	PUNCT
easat-4163	16	18	which	which	PRON
easat-4163	16	19	facilitates	facilitate	VERB
easat-4163	16	20	the	the	DET
easat-4163	16	21	release	release	NOUN
easat-4163	16	22	of	of	ADP
easat-4163	16	23	pro	pro	ADJ
easat-4163	16	24	-	-	ADJ
easat-4163	16	25	inflammatory	inflammatory	ADJ
easat-4163	16	26	cytokines	cytokine	NOUN
easat-4163	16	27	(	(	PUNCT
easat-4163	16	28	e.g.	e.g.	ADV
easat-4163	16	29	,	,	PUNCT
easat-4163	16	30	interleukin-6	interleukin-6	NUM
easat-4163	16	31	,	,	PUNCT
easat-4163	16	32	tumour	tumour	NOUN
easat-4163	16	33	necrosis	necrosis	NOUN
easat-4163	16	34	factor	factor	NOUN
easat-4163	16	35	-	-	PUNCT
easat-4163	16	36	alpha	alpha	NOUN
easat-4163	16	37	)	)	PUNCT
easat-4163	16	38	.	.	PUNCT
easat-4163	17	1	the	the	DET
easat-4163	17	2	cytokine	cytokine	NOUN
easat-4163	17	3	storm	storm	NOUN
easat-4163	17	4	contributes	contribute	VERB
easat-4163	17	5	to	to	ADP
easat-4163	17	6	widespread	widespread	ADJ
easat-4163	17	7	inflammation	inflammation	NOUN
easat-4163	17	8	and	and	CCONJ
easat-4163	17	9	endothelial	endothelial	ADJ
easat-4163	17	10	activation	activation	NOUN
easat-4163	17	11	,	,	PUNCT
easat-4163	17	12	disrupting	disrupt	VERB
easat-4163	17	13	the	the	DET
easat-4163	17	14	balance	balance	NOUN
easat-4163	17	15	between	between	ADP
easat-4163	17	16	pro	pro	ADJ
easat-4163	17	17	-	-	ADJ
easat-4163	17	18	coagulant	coagulant	ADJ
easat-4163	17	19	and	and	CCONJ
easat-4163	17	20	anticoagulant	anticoagulant	ADJ
easat-4163	17	21	factors	factor	NOUN
easat-4163	17	22	.	.	PUNCT
easat-4163	18	1	additionally	additionally	ADV
easat-4163	18	2	,	,	PUNCT
easat-4163	18	3	it	it	PRON
easat-4163	18	4	is	be	AUX
easat-4163	18	5	capable	capable	ADJ
easat-4163	18	6	of	of	ADP
easat-4163	18	7	being	be	AUX
easat-4163	18	8	transmitted	transmit	VERB
easat-4163	18	9	by	by	ADP
easat-4163	18	10	contacting	contact	VERB
easat-4163	18	11	surfaces	surface	NOUN
easat-4163	18	12	that	that	PRON
easat-4163	18	13	are	be	AUX
easat-4163	18	14	contaminated	contaminate	VERB
easat-4163	18	15	and	and	CCONJ
easat-4163	18	16	then	then	ADV
easat-4163	18	17	rubbing	rub	VERB
easat-4163	18	18	the	the	DET
easat-4163	18	19	face	face	NOUN
easat-4163	18	20	.	.	PUNCT
easat-4163	19	1	biomarkers	biomarker	NOUN
easat-4163	19	2	such	such	ADJ
easat-4163	19	3	as	as	ADP
easat-4163	19	4	d	d	NOUN
easat-4163	19	5	-	-	PUNCT
easat-4163	19	6	dimer	dimer	ADJ
easat-4163	19	7	levels	level	NOUN
easat-4163	19	8	serve	serve	VERB
easat-4163	19	9	as	as	ADP
easat-4163	19	10	valuable	valuable	ADJ
easat-4163	19	11	tools	tool	NOUN
easat-4163	19	12	in	in	ADP
easat-4163	19	13	risk	risk	NOUN
easat-4163	19	14	assessment	assessment	NOUN
easat-4163	19	15	and	and	CCONJ
easat-4163	19	16	monitoring	monitoring	NOUN
easat-4163	19	17	,	,	PUNCT
easat-4163	19	18	yet	yet	CCONJ
easat-4163	19	19	their	their	PRON
easat-4163	19	20	interpretation	interpretation	NOUN
easat-4163	19	21	requires	require	VERB
easat-4163	19	22	careful	careful	ADJ
easat-4163	19	23	consideration	consideration	NOUN
easat-4163	19	24	within	within	ADP
easat-4163	19	25	the	the	DET
easat-4163	19	26	clinical	clinical	ADJ
easat-4163	19	27	context	context	NOUN
easat-4163	19	28	.	.	PUNCT
easat-4163	20	1	although	although	SCONJ
easat-4163	20	2	some	some	DET
easat-4163	20	3	covid-19	covid-19	PROPN
easat-4163	20	4	patients	patient	NOUN
easat-4163	20	5	may	may	AUX
easat-4163	20	6	not	not	PART
easat-4163	20	7	exhibit	exhibit	VERB
easat-4163	20	8	any	any	DET
easat-4163	20	9	symptoms	symptom	NOUN
easat-4163	20	10	,	,	PUNCT
easat-4163	20	11	they	they	PRON
easat-4163	20	12	can	can	AUX
easat-4163	20	13	still	still	ADV
easat-4163	20	14	spread	spread	VERB
easat-4163	20	15	the	the	DET
easat-4163	20	16	virus	virus	NOUN
easat-4163	20	17	to	to	ADP
easat-4163	20	18	others	other	NOUN
easat-4163	20	19	,	,	PUNCT
easat-4163	20	20	and	and	CCONJ
easat-4163	20	21	there	there	PRON
easat-4163	20	22	is	be	VERB
easat-4163	20	23	proof	proof	NOUN
easat-4163	20	24	that	that	SCONJ
easat-4163	20	25	the	the	DET
easat-4163	20	26	virus	virus	NOUN
easat-4163	20	27	can	can	AUX
easat-4163	20	28	spread	spread	VERB
easat-4163	20	29	via	via	ADP
easat-4163	20	30	the	the	DET
easat-4163	20	31	air	air	NOUN
easat-4163	20	32	in	in	ADP
easat-4163	20	33	some	some	DET
easat-4163	20	34	environments	environment	NOUN
easat-4163	20	35	,	,	PUNCT
easat-4163	20	36	especially	especially	ADV
easat-4163	20	37	confined	confine	VERB
easat-4163	20	38	areas	area	NOUN
easat-4163	20	39	with	with	ADP
easat-4163	20	40	inadequate	inadequate	ADJ
easat-4163	20	41	ventilation	ventilation	NOUN
easat-4163	20	42	.	.	PUNCT
easat-4163	21	1	vaccines	vaccine	NOUN
easat-4163	21	2	have	have	AUX
easat-4163	21	3	been	be	AUX
easat-4163	21	4	developed	develop	VERB
easat-4163	21	5	and	and	CCONJ
easat-4163	21	6	deployed	deploy	VERB
easat-4163	21	7	globally	globally	ADV
easat-4163	21	8	to	to	PART
easat-4163	21	9	prevent	prevent	VERB
easat-4163	21	10	covid-19	covid-19	PROPN
easat-4163	21	11	infection	infection	NOUN
easat-4163	21	12	and	and	CCONJ
easat-4163	21	13	reduce	reduce	VERB
easat-4163	21	14	severe	severe	ADJ
easat-4163	21	15	illness	illness	NOUN
easat-4163	21	16	,	,	PUNCT
easat-4163	21	17	hospitalizations	hospitalization	NOUN
easat-4163	21	18	,	,	PUNCT
easat-4163	21	19	and	and	CCONJ
easat-4163	21	20	deaths	death	NOUN
easat-4163	21	21	.	.	PUNCT
easat-4163	22	1	governments	government	NOUN
easat-4163	22	2	and	and	CCONJ
easat-4163	22	3	health	health	NOUN
easat-4163	22	4	authorities	authority	NOUN
easat-4163	22	5	worldwide	worldwide	ADV
easat-4163	22	6	have	have	AUX
easat-4163	22	7	implemented	implement	VERB
easat-4163	22	8	policies	policy	NOUN
easat-4163	22	9	including	include	VERB
easat-4163	22	10	lockdowns	lockdown	NOUN
easat-4163	22	11	,	,	PUNCT
easat-4163	22	12	social	social	ADJ
easat-4163	22	13	isolation	isolation	NOUN
easat-4163	22	14	,	,	PUNCT
easat-4163	22	15	mask	mask	NOUN
easat-4163	22	16	-	-	PUNCT
easat-4163	22	17	wearing	wear	VERB
easat-4163	22	18	,	,	PUNCT
easat-4163	22	19	investigation	investigation	NOUN
easat-4163	22	20	,	,	PUNCT
easat-4163	22	21	contact	contact	NOUN
easat-4163	22	22	tracking	tracking	NOUN
easat-4163	22	23	,	,	PUNCT
easat-4163	22	24	and	and	CCONJ
easat-4163	22	25	vaccination	vaccination	NOUN
easat-4163	22	26	campaigns	campaign	NOUN
easat-4163	22	27	to	to	PART
easat-4163	22	28	control	control	VERB
easat-4163	22	29	transmission	transmission	NOUN
easat-4163	22	30	and	and	CCONJ
easat-4163	22	31	reduce	reduce	VERB
easat-4163	22	32	the	the	DET
easat-4163	22	33	impact	impact	NOUN
easat-4163	22	34	of	of	ADP
easat-4163	22	35	the	the	DET
easat-4163	22	36	virus	virus	NOUN
easat-4163	22	37	.	.	PUNCT
easat-4163	23	1	data	datum	NOUN
easat-4163	23	2	were	be	AUX
easat-4163	23	3	sorted	sort	VERB
easat-4163	23	4	from	from	ADP
easat-4163	23	5	pubmed	pubmed	PROPN
easat-4163	23	6	,	,	PUNCT
easat-4163	23	7	google	google	PROPN
easat-4163	23	8	scholar	scholar	NOUN
easat-4163	23	9	,	,	PUNCT
easat-4163	23	10	springer	springer	NOUN
easat-4163	23	11	,	,	PUNCT
easat-4163	23	12	nature	nature	NOUN
easat-4163	23	13	,	,	PUNCT
easat-4163	23	14	tailor	tailor	NOUN
easat-4163	23	15	and	and	CCONJ
easat-4163	23	16	francis	francis	PROPN
easat-4163	23	17	,	,	PUNCT
easat-4163	23	18	mdpi	mdpi	PROPN
easat-4163	23	19	,	,	PUNCT
easat-4163	23	20	bmc	bmc	NOUN
easat-4163	23	21	and	and	CCONJ
easat-4163	23	22	some	some	DET
easat-4163	23	23	other	other	ADJ
easat-4163	23	24	related	related	ADJ
easat-4163	23	25	data	datum	NOUN
easat-4163	23	26	.	.	PUNCT
easat-4163	24	1	this	this	DET
easat-4163	24	2	review	review	NOUN
easat-4163	24	3	provides	provide	VERB
easat-4163	24	4	appreciable	appreciable	ADJ
easat-4163	24	5	information	information	NOUN
easat-4163	24	6	on	on	ADP
easat-4163	24	7	the	the	DET
easat-4163	24	8	pathophysiology	pathophysiology	NOUN
easat-4163	24	9	,	,	PUNCT
easat-4163	24	10	management	management	NOUN
easat-4163	24	11	and	and	CCONJ
easat-4163	24	12	therapeutic	therapeutic	ADJ
easat-4163	24	13	challenges	challenge	NOUN
easat-4163	24	14	of	of	ADP
easat-4163	24	15	coagulopathy	coagulopathy	ADJ
easat-4163	24	16	in	in	ADP
easat-4163	24	17	covid-19	covid-19	PROPN
easat-4163	24	18	patients	patient	NOUN
easat-4163	24	19	.	.	PUNCT
easat-4163	25	1	keywords	keyword	NOUN
easat-4163	25	2	:	:	PUNCT
easat-4163	25	3	covid-19	covid-19	PROPN
easat-4163	25	4	virus	virus	NOUN
easat-4163	25	5	,	,	PUNCT
easat-4163	25	6	pathophysiology	pathophysiology	NOUN
easat-4163	25	7	,	,	PUNCT
easat-4163	25	8	management	management	NOUN
easat-4163	25	9	and	and	CCONJ
easat-4163	25	10	therapeutic	therapeutic	ADJ
easat-4163	25	11	challenges	challenge	NOUN
easat-4163	25	12	.	.	PUNCT
easat-4163	26	1	1	1	X
easat-4163	26	2	.	.	X
easat-4163	26	3	introduction	introduction	NOUN
easat-4163	26	4	coronavirus	coronavirus	NOUN
easat-4163	26	5	disease	disease	NOUN
easat-4163	26	6	2019	2019	NUM
easat-4163	26	7	(	(	PUNCT
easat-4163	26	8	covid-19	covid-19	PROPN
easat-4163	26	9	)	)	PUNCT
easat-4163	26	10	is	be	AUX
easat-4163	26	11	caused	cause	VERB
easat-4163	26	12	by	by	ADP
easat-4163	26	13	the	the	DET
easat-4163	26	14	emerging	emerge	VERB
easat-4163	26	15	coronavirus	coronavirus	NOUN
easat-4163	26	16	sars	sar	NOUN
easat-4163	26	17	-	-	PUNCT
easat-4163	26	18	cov-2	cov-2	NOUN
easat-4163	26	19	.	.	PUNCT
easat-4163	27	1	in	in	ADP
easat-4163	27	2	several	several	ADJ
easat-4163	27	3	studies	study	NOUN
easat-4163	27	4	,	,	PUNCT
easat-4163	27	5	it	it	PRON
easat-4163	27	6	was	be	AUX
easat-4163	27	7	described	describe	VERB
easat-4163	27	8	as	as	ADP
easat-4163	27	9	sars	sar	NOUN
easat-4163	27	10	-	-	PUNCT
easat-4163	27	11	cov-2	cov-2	NOUN
easat-4163	27	12	due	due	ADP
easat-4163	27	13	to	to	ADP
easat-4163	27	14	its	its	PRON
easat-4163	27	15	resemblance	resemblance	NOUN
easat-4163	27	16	to	to	ADP
easat-4163	27	17	severe	severe	ADJ
easat-4163	27	18	acute	acute	ADJ
easat-4163	27	19	respiratory	respiratory	ADJ
easat-4163	27	20	syndrome	syndrome	NOUN
easat-4163	27	21	(	(	PUNCT
easat-4163	27	22	sars	sars	PROPN
easat-4163	27	23	)	)	PUNCT
easat-4163	28	1	[	[	X
easat-4163	28	2	1	1	NUM
easat-4163	28	3	]	]	PUNCT
easat-4163	28	4	.	.	PUNCT
easat-4163	29	1	since	since	SCONJ
easat-4163	29	2	december	december	PROPN
easat-4163	29	3	2019	2019	NUM
easat-4163	29	4	,	,	PUNCT
easat-4163	29	5	a	a	DET
easat-4163	29	6	coronavirus	coronavirus	NOUN
easat-4163	29	7	disease	disease	NOUN
easat-4163	29	8	2019	2019	NUM
easat-4163	29	9	(	(	PUNCT
easat-4163	29	10	covid-19	covid-19	PROPN
easat-4163	29	11	)	)	PUNCT
easat-4163	29	12	outbreak	outbreak	NOUN
easat-4163	29	13	has	have	AUX
easat-4163	29	14	spread	spread	VERB
easat-4163	29	15	around	around	ADP
easat-4163	29	16	the	the	DET
easat-4163	29	17	world	world	NOUN
easat-4163	29	18	,	,	PUNCT
easat-4163	29	19	originating	originate	VERB
easat-4163	29	20	in	in	ADP
easat-4163	29	21	the	the	DET
easat-4163	29	22	chinese	chinese	ADJ
easat-4163	29	23	city	city	NOUN
easat-4163	29	24	of	of	ADP
easat-4163	29	25	wuhan	wuhan	PROPN
easat-4163	29	26	in	in	ADP
easat-4163	29	27	the	the	DET
easat-4163	29	28	hubei	hubei	PROPN
easat-4163	29	29	province	province	NOUN
easat-4163	29	30	[	[	X
easat-4163	29	31	2	2	NUM
easat-4163	29	32	]	]	PUNCT
easat-4163	29	33	.	.	PUNCT
easat-4163	30	1	on	on	ADP
easat-4163	30	2	february	february	PROPN
easat-4163	30	3	11	11	NUM
easat-4163	30	4	,	,	PUNCT
easat-4163	30	5	2020	2020	NUM
easat-4163	30	6	,	,	PUNCT
easat-4163	30	7	the	the	DET
easat-4163	30	8	international	international	ADJ
easat-4163	30	9	committee	committee	NOUN
easat-4163	30	10	on	on	ADP
easat-4163	30	11	taxonomy	taxonomy	NOUN
easat-4163	30	12	of	of	ADP
easat-4163	30	13	viruses	virus	NOUN
easat-4163	30	14	'	'	PART
easat-4163	30	15	coronavirus	coronavirus	NOUN
easat-4163	30	16	study	study	NOUN
easat-4163	30	17	group	group	NOUN
easat-4163	30	18	formally	formally	ADV
easat-4163	30	19	designated	designate	VERB
easat-4163	30	20	the	the	DET
easat-4163	30	21	novel	novel	ADJ
easat-4163	30	22	coronavirus	coronavirus	NOUN
easat-4163	30	23	that	that	PRON
easat-4163	30	24	causes	cause	VERB
easat-4163	30	25	covid-19	covid-19	PROPN
easat-4163	30	26	as	as	ADP
easat-4163	30	27	"	"	PUNCT
easat-4163	30	28	severe	severe	ADJ
easat-4163	30	29	acute	acute	ADJ
easat-4163	30	30	respiratory	respiratory	ADJ
easat-4163	30	31	syndrome	syndrome	NOUN
easat-4163	30	32	coronavirus	coronavirus	NOUN
easat-4163	30	33	2	2	NUM
easat-4163	30	34	(	(	PUNCT
easat-4163	30	35	sars	sar	NOUN
easat-4163	30	36	-	-	PUNCT
easat-4163	30	37	cov-2	cov-2	NOUN
easat-4163	30	38	)	)	PUNCT
easat-4163	30	39	,	,	PUNCT
easat-4163	30	40	"	"	PUNCT
easat-4163	30	41	and	and	CCONJ
easat-4163	30	42	on	on	ADP
easat-4163	30	43	march	march	PROPN
easat-4163	30	44	11	11	NUM
easat-4163	30	45	,	,	PUNCT
easat-4163	30	46	2020	2020	NUM
easat-4163	30	47	,	,	PUNCT
easat-4163	30	48	the	the	DET
easat-4163	30	49	world	world	PROPN
easat-4163	30	50	health	health	NOUN
easat-4163	30	51	organisation	organisation	NOUN
easat-4163	30	52	declared	declare	VERB
easat-4163	30	53	the	the	DET
easat-4163	30	54	https://orcid.org/0000-0002-0580-9453	https://orcid.org/0000-0002-0580-9453	NOUN
easat-4163	30	55	506	506	NUM
easat-4163	30	56	edelweiss	edelweiss	PROPN
easat-4163	30	57	applied	apply	VERB
easat-4163	30	58	science	science	NOUN
easat-4163	30	59	and	and	CCONJ
easat-4163	30	60	technology	technology	NOUN
easat-4163	30	61	issn	issn	PROPN
easat-4163	30	62	:	:	PUNCT
easat-4163	30	63	2576	2576	NUM
easat-4163	30	64	-	-	SYM
easat-4163	30	65	8484	8484	NUM
easat-4163	30	66	vol	vol	NOUN
easat-4163	30	67	.	.	PROPN
easat-4163	31	1	9	9	NUM
easat-4163	31	2	,	,	PUNCT
easat-4163	31	3	no	no	INTJ
easat-4163	31	4	.	.	NOUN
easat-4163	31	5	1	1	NUM
easat-4163	31	6	:	:	PUNCT
easat-4163	31	7	505	505	NUM
easat-4163	31	8	-	-	SYM
easat-4163	31	9	514	514	NUM
easat-4163	31	10	,	,	PUNCT
easat-4163	31	11	2025	2025	NUM
easat-4163	31	12	doi	doi	NOUN
easat-4163	31	13	:	:	PUNCT
easat-4163	31	14	10.55214/25768484.v9i1.4163	10.55214/25768484.v9i1.4163	NUM
easat-4163	31	15	©	©	PROPN
easat-4163	31	16	2025	2025	NUM
easat-4163	31	17	by	by	ADP
easat-4163	31	18	the	the	DET
easat-4163	31	19	authors	author	NOUN
easat-4163	31	20	;	;	PUNCT
easat-4163	31	21	licensee	licensee	PROPN
easat-4163	31	22	learning	learning	NOUN
easat-4163	31	23	gate	gate	VERB
easat-4163	31	24	new	new	PROPN
easat-4163	31	25	covid-19	covid-19	PROPN
easat-4163	31	26	to	to	PART
easat-4163	31	27	be	be	AUX
easat-4163	31	28	a	a	DET
easat-4163	31	29	pandemic	pandemic	NOUN
easat-4163	31	30	because	because	SCONJ
easat-4163	31	31	of	of	ADP
easat-4163	31	32	its	its	PRON
easat-4163	31	33	widespread	widespread	ADJ
easat-4163	31	34	distribution	distribution	NOUN
easat-4163	31	35	and	and	CCONJ
easat-4163	31	36	severity	severity	NOUN
easat-4163	31	37	[	[	X
easat-4163	31	38	3	3	NUM
easat-4163	31	39	]	]	PUNCT
easat-4163	31	40	.	.	PUNCT
easat-4163	32	1	this	this	DET
easat-4163	32	2	virus	virus	NOUN
easat-4163	32	3	is	be	AUX
easat-4163	32	4	a	a	DET
easat-4163	32	5	member	member	NOUN
easat-4163	32	6	of	of	ADP
easat-4163	32	7	the	the	DET
easat-4163	32	8	coronavirus	coronavirus	NOUN
easat-4163	32	9	family	family	NOUN
easat-4163	32	10	,	,	PUNCT
easat-4163	32	11	which	which	PRON
easat-4163	32	12	also	also	ADV
easat-4163	32	13	contains	contain	VERB
easat-4163	32	14	viruses	virus	NOUN
easat-4163	32	15	that	that	PRON
easat-4163	32	16	cause	cause	VERB
easat-4163	32	17	more	more	ADV
easat-4163	32	18	serious	serious	ADJ
easat-4163	32	19	conditions	condition	NOUN
easat-4163	32	20	including	include	VERB
easat-4163	32	21	mers	mer	NOUN
easat-4163	32	22	(	(	PUNCT
easat-4163	32	23	middle	middle	PROPN
easat-4163	32	24	east	east	PROPN
easat-4163	32	25	respiratory	respiratory	ADJ
easat-4163	32	26	syndrome	syndrome	NOUN
easat-4163	32	27	)	)	PUNCT
easat-4163	32	28	and	and	CCONJ
easat-4163	32	29	sars	sars	PROPN
easat-4163	32	30	(	(	PUNCT
easat-4163	32	31	severe	severe	ADJ
easat-4163	32	32	acute	acute	ADJ
easat-4163	32	33	respiratory	respiratory	ADJ
easat-4163	32	34	syndrome	syndrome	NOUN
easat-4163	32	35	)	)	PUNCT
easat-4163	32	36	.	.	PUNCT
easat-4163	33	1	the	the	DET
easat-4163	33	2	single	single	ADJ
easat-4163	33	3	-	-	PUNCT
easat-4163	33	4	stranded	strand	VERB
easat-4163	33	5	rna	rna	NOUN
easat-4163	33	6	coronavirus	coronavirus	NOUN
easat-4163	33	7	known	know	VERB
easat-4163	33	8	as	as	ADP
easat-4163	33	9	"	"	PUNCT
easat-4163	33	10	severe	severe	ADJ
easat-4163	33	11	acute	acute	ADJ
easat-4163	33	12	respiratory	respiratory	ADJ
easat-4163	33	13	syndrome	syndrome	NOUN
easat-4163	33	14	coronavirus	coronavirus	NOUN
easat-4163	33	15	2	2	NUM
easat-4163	33	16	"	"	PUNCT
easat-4163	33	17	(	(	PUNCT
easat-4163	33	18	sars	sar	NOUN
easat-4163	33	19	-	-	PUNCT
easat-4163	33	20	cov-2	cov-2	NOUN
easat-4163	33	21	)	)	PUNCT
easat-4163	33	22	primarily	primarily	ADV
easat-4163	33	23	enters	enter	VERB
easat-4163	33	24	human	human	ADJ
easat-4163	33	25	cells	cell	NOUN
easat-4163	33	26	by	by	ADP
easat-4163	33	27	attaching	attach	VERB
easat-4163	33	28	itself	itself	PRON
easat-4163	33	29	to	to	PART
easat-4163	33	30	angiotensin	angiotensin	VERB
easat-4163	33	31	converting	convert	VERB
easat-4163	33	32	enzyme	enzyme	NOUN
easat-4163	33	33	2	2	NUM
easat-4163	33	34	(	(	PUNCT
easat-4163	33	35	ace	ace	NOUN
easat-4163	33	36	2	2	NUM
easat-4163	33	37	)	)	PUNCT
easat-4163	33	38	,	,	PUNCT
easat-4163	33	39	which	which	PRON
easat-4163	33	40	is	be	AUX
easat-4163	33	41	expressed	express	VERB
easat-4163	33	42	in	in	ADP
easat-4163	33	43	higher	high	ADJ
easat-4163	33	44	quantities	quantity	NOUN
easat-4163	33	45	in	in	ADP
easat-4163	33	46	the	the	DET
easat-4163	33	47	lung	lung	NOUN
easat-4163	33	48	's	's	PART
easat-4163	33	49	alveolar	alveolar	ADJ
easat-4163	33	50	cells	cell	NOUN
easat-4163	33	51	,	,	PUNCT
easat-4163	33	52	cardiac	cardiac	ADJ
easat-4163	33	53	myocytes	myocyte	NOUN
easat-4163	33	54	,	,	PUNCT
easat-4163	33	55	vascular	vascular	ADJ
easat-4163	33	56	endothelium	endothelium	NOUN
easat-4163	33	57	,	,	PUNCT
easat-4163	33	58	and	and	CCONJ
easat-4163	33	59	other	other	ADJ
easat-4163	33	60	cells	cell	NOUN
easat-4163	33	61	.	.	PUNCT
easat-4163	34	1	sars	sar	NOUN
easat-4163	34	2	-	-	PUNCT
easat-4163	34	3	cov-2	cov-2	PART
easat-4163	34	4	is	be	AUX
easat-4163	34	5	mostly	mostly	ADV
easat-4163	34	6	spread	spread	VERB
easat-4163	34	7	by	by	ADP
easat-4163	34	8	inhaling	inhale	VERB
easat-4163	34	9	virus	virus	NOUN
easat-4163	34	10	particles	particle	NOUN
easat-4163	34	11	,	,	PUNCT
easat-4163	34	12	making	make	VERB
easat-4163	34	13	it	it	PRON
easat-4163	34	14	possible	possible	ADJ
easat-4163	34	15	to	to	PART
easat-4163	34	16	get	get	VERB
easat-4163	34	17	into	into	ADP
easat-4163	34	18	the	the	DET
easat-4163	34	19	respiratory	respiratory	ADJ
easat-4163	34	20	system	system	NOUN
easat-4163	34	21	[	[	X
easat-4163	34	22	4	4	NUM
easat-4163	34	23	]	]	PUNCT
easat-4163	34	24	.	.	PUNCT
easat-4163	35	1	on	on	ADP
easat-4163	35	2	surfaces	surface	NOUN
easat-4163	35	3	that	that	PRON
easat-4163	35	4	permit	permit	VERB
easat-4163	35	5	transmission	transmission	NOUN
easat-4163	35	6	,	,	PUNCT
easat-4163	35	7	this	this	DET
easat-4163	35	8	virus	virus	NOUN
easat-4163	35	9	can	can	AUX
easat-4163	35	10	persist	persist	VERB
easat-4163	35	11	for	for	ADP
easat-4163	35	12	up	up	ADP
easat-4163	35	13	to	to	PART
easat-4163	35	14	24	24	NUM
easat-4163	35	15	to	to	PART
easat-4163	35	16	72	72	NUM
easat-4163	35	17	hours	hour	NOUN
easat-4163	35	18	[	[	X
easat-4163	35	19	5	5	NUM
easat-4163	35	20	]	]	PUNCT
easat-4163	35	21	.	.	PUNCT
easat-4163	36	1	due	due	ADP
easat-4163	36	2	to	to	ADP
easat-4163	36	3	mutations	mutation	NOUN
easat-4163	36	4	in	in	ADP
easat-4163	36	5	sars	sar	NOUN
easat-4163	36	6	-	-	PUNCT
easat-4163	36	7	cov-2	cov-2	NOUN
easat-4163	36	8	,	,	PUNCT
easat-4163	36	9	variations	variation	NOUN
easat-4163	36	10	with	with	ADP
easat-4163	36	11	distinct	distinct	ADJ
easat-4163	36	12	traits	trait	NOUN
easat-4163	36	13	,	,	PUNCT
easat-4163	36	14	such	such	ADJ
easat-4163	36	15	as	as	ADP
easat-4163	36	16	greater	great	ADJ
easat-4163	36	17	transmissibility	transmissibility	NOUN
easat-4163	36	18	or	or	CCONJ
easat-4163	36	19	antibody	antibody	NOUN
easat-4163	36	20	resistance	resistance	NOUN
easat-4163	36	21	,	,	PUNCT
easat-4163	36	22	have	have	AUX
easat-4163	36	23	emerged	emerge	VERB
easat-4163	36	24	.	.	PUNCT
easat-4163	37	1	worldwide	worldwide	ADV
easat-4163	37	2	,	,	PUNCT
easat-4163	37	3	vaccines	vaccine	NOUN
easat-4163	37	4	have	have	AUX
easat-4163	37	5	been	be	AUX
easat-4163	37	6	created	create	VERB
easat-4163	37	7	and	and	CCONJ
easat-4163	37	8	implemented	implement	VERB
easat-4163	37	9	to	to	PART
easat-4163	37	10	stop	stop	VERB
easat-4163	37	11	covid-19	covid-19	PROPN
easat-4163	37	12	infections	infection	NOUN
easat-4163	37	13	and	and	CCONJ
easat-4163	37	14	lower	low	ADJ
easat-4163	37	15	the	the	DET
easat-4163	37	16	number	number	NOUN
easat-4163	37	17	of	of	ADP
easat-4163	37	18	serious	serious	ADJ
easat-4163	37	19	illnesses	illness	NOUN
easat-4163	37	20	,	,	PUNCT
easat-4163	37	21	hospital	hospital	NOUN
easat-4163	37	22	stays	stay	NOUN
easat-4163	37	23	,	,	PUNCT
easat-4163	37	24	and	and	CCONJ
easat-4163	37	25	fatalities	fatality	NOUN
easat-4163	37	26	.	.	PUNCT
easat-4163	38	1	the	the	DET
easat-4163	38	2	main	main	ADJ
easat-4163	38	3	way	way	NOUN
easat-4163	38	4	that	that	PRON
easat-4163	38	5	covid-19	covid-19	PROPN
easat-4163	38	6	is	be	AUX
easat-4163	38	7	transmitted	transmit	VERB
easat-4163	38	8	is	be	AUX
easat-4163	38	9	by	by	ADP
easat-4163	38	10	respiratory	respiratory	ADJ
easat-4163	38	11	droplets	droplet	NOUN
easat-4163	38	12	released	release	VERB
easat-4163	38	13	by	by	ADP
easat-4163	38	14	an	an	DET
easat-4163	38	15	infected	infected	ADJ
easat-4163	38	16	individual	individual	NOUN
easat-4163	38	17	when	when	SCONJ
easat-4163	38	18	they	they	PRON
easat-4163	38	19	cough	cough	VERB
easat-4163	38	20	,	,	PUNCT
easat-4163	38	21	sneeze	sneeze	NOUN
easat-4163	38	22	,	,	PUNCT
easat-4163	38	23	or	or	CCONJ
easat-4163	38	24	speak	speak	VERB
easat-4163	38	25	.	.	PUNCT
easat-4163	39	1	additionally	additionally	ADV
easat-4163	39	2	,	,	PUNCT
easat-4163	39	3	it	it	PRON
easat-4163	39	4	can	can	AUX
easat-4163	39	5	be	be	AUX
easat-4163	39	6	transmitted	transmit	VERB
easat-4163	39	7	by	by	ADP
easat-4163	39	8	contacting	contact	VERB
easat-4163	39	9	infected	infected	ADJ
easat-4163	39	10	surfaces	surface	NOUN
easat-4163	39	11	and	and	CCONJ
easat-4163	39	12	then	then	ADV
easat-4163	39	13	rubbing	rub	VERB
easat-4163	39	14	the	the	DET
easat-4163	39	15	face	face	NOUN
easat-4163	39	16	.	.	PUNCT
easat-4163	40	1	fever	fever	NOUN
easat-4163	40	2	,	,	PUNCT
easat-4163	40	3	coughing	coughing	NOUN
easat-4163	40	4	,	,	PUNCT
easat-4163	40	5	exhaustion	exhaustion	NOUN
easat-4163	40	6	,	,	PUNCT
easat-4163	40	7	and	and	CCONJ
easat-4163	40	8	shortness	shortness	NOUN
easat-4163	40	9	of	of	ADP
easat-4163	40	10	breath	breath	NOUN
easat-4163	40	11	or	or	CCONJ
easat-4163	40	12	trouble	trouble	NOUN
easat-4163	40	13	breathing	breathing	NOUN
easat-4163	40	14	are	be	AUX
easat-4163	40	15	the	the	DET
easat-4163	40	16	most	most	ADV
easat-4163	40	17	typical	typical	ADJ
easat-4163	40	18	symptoms	symptom	NOUN
easat-4163	40	19	.	.	PUNCT
easat-4163	41	1	muscle	muscle	NOUN
easat-4163	41	2	pains	pain	NOUN
easat-4163	41	3	,	,	PUNCT
easat-4163	41	4	nausea	nausea	NOUN
easat-4163	41	5	,	,	PUNCT
easat-4163	41	6	diarrhoea	diarrhoea	NOUN
easat-4163	41	7	,	,	PUNCT
easat-4163	41	8	congestion	congestion	NOUN
easat-4163	41	9	,	,	PUNCT
easat-4163	41	10	sore	sore	ADJ
easat-4163	41	11	throats	throat	NOUN
easat-4163	41	12	,	,	PUNCT
easat-4163	41	13	and	and	CCONJ
easat-4163	41	14	loss	loss	NOUN
easat-4163	41	15	of	of	ADP
easat-4163	41	16	taste	taste	NOUN
easat-4163	41	17	are	be	AUX
easat-4163	41	18	other	other	ADJ
easat-4163	41	19	symptoms	symptom	NOUN
easat-4163	41	20	.	.	PUNCT
easat-4163	42	1	mild	mild	ADJ
easat-4163	42	2	to	to	ADP
easat-4163	42	3	severe	severe	ADJ
easat-4163	42	4	symptoms	symptom	NOUN
easat-4163	42	5	are	be	AUX
easat-4163	42	6	possible	possible	ADJ
easat-4163	42	7	,	,	PUNCT
easat-4163	42	8	and	and	CCONJ
easat-4163	42	9	some	some	DET
easat-4163	42	10	people	people	NOUN
easat-4163	42	11	get	get	VERB
easat-4163	42	12	severe	severe	ADJ
easat-4163	42	13	respiratory	respiratory	ADJ
easat-4163	42	14	illnesses	illness	NOUN
easat-4163	42	15	that	that	PRON
easat-4163	42	16	necessitate	necessitate	ADJ
easat-4163	42	17	hospitalisation	hospitalisation	NOUN
easat-4163	42	18	[	[	X
easat-4163	42	19	6	6	NUM
easat-4163	42	20	]	]	PUNCT
easat-4163	42	21	.	.	PUNCT
easat-4163	43	1	an	an	DET
easat-4163	43	2	infected	infected	ADJ
easat-4163	43	3	individual	individual	NOUN
easat-4163	43	4	may	may	AUX
easat-4163	43	5	not	not	PART
easat-4163	43	6	exhibit	exhibit	VERB
easat-4163	43	7	symptoms	symptom	NOUN
easat-4163	43	8	throughout	throughout	ADP
easat-4163	43	9	the	the	DET
easat-4163	43	10	2–14day	2–14day	NUM
easat-4163	43	11	incubation	incubation	NOUN
easat-4163	43	12	period	period	NOUN
easat-4163	43	13	following	follow	VERB
easat-4163	43	14	infection	infection	NOUN
easat-4163	43	15	,	,	PUNCT
easat-4163	43	16	but	but	CCONJ
easat-4163	43	17	they	they	PRON
easat-4163	43	18	can	can	AUX
easat-4163	43	19	still	still	ADV
easat-4163	43	20	transmit	transmit	VERB
easat-4163	43	21	the	the	DET
easat-4163	43	22	virus	virus	NOUN
easat-4163	43	23	during	during	ADP
easat-4163	43	24	this	this	DET
easat-4163	43	25	time	time	NOUN
easat-4163	43	26	.	.	PUNCT
easat-4163	44	1	although	although	SCONJ
easat-4163	44	2	some	some	DET
easat-4163	44	3	covid-19	covid-19	PROPN
easat-4163	44	4	patients	patient	NOUN
easat-4163	44	5	may	may	AUX
easat-4163	44	6	not	not	PART
easat-4163	44	7	exhibit	exhibit	VERB
easat-4163	44	8	any	any	DET
easat-4163	44	9	symptoms	symptom	NOUN
easat-4163	44	10	,	,	PUNCT
easat-4163	44	11	they	they	PRON
easat-4163	44	12	can	can	AUX
easat-4163	44	13	still	still	ADV
easat-4163	44	14	spread	spread	VERB
easat-4163	44	15	the	the	DET
easat-4163	44	16	virus	virus	NOUN
easat-4163	44	17	to	to	ADP
easat-4163	44	18	others	other	NOUN
easat-4163	44	19	,	,	PUNCT
easat-4163	44	20	and	and	CCONJ
easat-4163	44	21	there	there	PRON
easat-4163	44	22	is	be	VERB
easat-4163	44	23	proof	proof	NOUN
easat-4163	44	24	that	that	SCONJ
easat-4163	44	25	the	the	DET
easat-4163	44	26	virus	virus	NOUN
easat-4163	44	27	can	can	AUX
easat-4163	44	28	spread	spread	VERB
easat-4163	44	29	via	via	ADP
easat-4163	44	30	the	the	DET
easat-4163	44	31	air	air	NOUN
easat-4163	44	32	in	in	ADP
easat-4163	44	33	specific	specific	ADJ
easat-4163	44	34	environments	environment	NOUN
easat-4163	44	35	,	,	PUNCT
easat-4163	44	36	especially	especially	ADV
easat-4163	44	37	confined	confine	VERB
easat-4163	44	38	areas	area	NOUN
easat-4163	44	39	with	with	ADP
easat-4163	44	40	inadequate	inadequate	ADJ
easat-4163	44	41	ventilation	ventilation	NOUN
easat-4163	44	42	[	[	X
easat-4163	44	43	7	7	NUM
easat-4163	44	44	]	]	PUNCT
easat-4163	44	45	.	.	PUNCT
easat-4163	45	1	to	to	PART
easat-4163	45	2	stop	stop	VERB
easat-4163	45	3	the	the	DET
easat-4163	45	4	virus	virus	NOUN
easat-4163	45	5	's	's	PART
easat-4163	45	6	spread	spread	NOUN
easat-4163	45	7	and	and	CCONJ
easat-4163	45	8	lessen	lessen	VERB
easat-4163	45	9	its	its	PRON
easat-4163	45	10	effects	effect	NOUN
easat-4163	45	11	,	,	PUNCT
easat-4163	45	12	governments	government	NOUN
easat-4163	45	13	and	and	CCONJ
easat-4163	45	14	health	health	NOUN
easat-4163	45	15	authorities	authority	NOUN
easat-4163	45	16	throughout	throughout	ADP
easat-4163	45	17	the	the	DET
easat-4163	45	18	world	world	NOUN
easat-4163	45	19	have	have	AUX
easat-4163	45	20	put	put	VERB
easat-4163	45	21	policies	policy	NOUN
easat-4163	45	22	in	in	ADP
easat-4163	45	23	place	place	NOUN
easat-4163	45	24	including	include	VERB
easat-4163	45	25	lockdowns	lockdown	NOUN
easat-4163	45	26	,	,	PUNCT
easat-4163	45	27	social	social	ADJ
easat-4163	45	28	distance	distance	NOUN
easat-4163	45	29	,	,	PUNCT
easat-4163	45	30	mask	mask	NOUN
easat-4163	45	31	wearing	wearing	NOUN
easat-4163	45	32	,	,	PUNCT
easat-4163	45	33	testing	testing	NOUN
easat-4163	45	34	,	,	PUNCT
easat-4163	45	35	contact	contact	NOUN
easat-4163	45	36	tracking	tracking	NOUN
easat-4163	45	37	,	,	PUNCT
easat-4163	45	38	and	and	CCONJ
easat-4163	45	39	vaccine	vaccine	NOUN
easat-4163	45	40	programs	program	NOUN
easat-4163	45	41	.	.	PUNCT
easat-4163	46	1	1.2	1.2	NUM
easat-4163	46	2	.	.	X
easat-4163	46	3	coagulopathy	coagulopathy	ADJ
easat-4163	46	4	(	(	PUNCT
easat-4163	46	5	coagulation	coagulation	NOUN
easat-4163	46	6	disorder	disorder	NOUN
easat-4163	46	7	)	)	PUNCT
easat-4163	46	8	coagulopathy	coagulopathy	ADJ
easat-4163	46	9	(	(	PUNCT
easat-4163	46	10	often	often	ADV
easat-4163	46	11	referred	refer	VERB
easat-4163	46	12	to	to	ADP
easat-4163	46	13	bleeding	bleed	VERB
easat-4163	46	14	disorder	disorder	NOUN
easat-4163	46	15	)	)	PUNCT
easat-4163	46	16	,	,	PUNCT
easat-4163	46	17	is	be	AUX
easat-4163	46	18	a	a	DET
easat-4163	46	19	disorder	disorder	NOUN
easat-4163	46	20	that	that	PRON
easat-4163	46	21	affects	affect	VERB
easat-4163	46	22	the	the	DET
easat-4163	46	23	blood	blood	NOUN
easat-4163	46	24	's	's	PART
easat-4163	46	25	capacity	capacity	NOUN
easat-4163	46	26	to	to	PART
easat-4163	46	27	coagulate	coagulate	VERB
easat-4163	46	28	[	[	X
easat-4163	46	29	8	8	NUM
easat-4163	46	30	]	]	PUNCT
easat-4163	46	31	.	.	PUNCT
easat-4163	47	1	this	this	DET
easat-4163	47	2	disorder	disorder	NOUN
easat-4163	47	3	can	can	AUX
easat-4163	47	4	result	result	VERB
easat-4163	47	5	in	in	ADP
easat-4163	47	6	bleeding	bleed	VERB
easat-4163	47	7	diathesis	diathesis	NOUN
easat-4163	47	8	,	,	PUNCT
easat-4163	47	9	a	a	DET
easat-4163	47	10	propensity	propensity	NOUN
easat-4163	47	11	for	for	ADP
easat-4163	47	12	excessive	excessive	ADJ
easat-4163	47	13	or	or	CCONJ
easat-4163	47	14	protracted	protract	VERB
easat-4163	47	15	bleeding	bleeding	NOUN
easat-4163	47	16	that	that	PRON
easat-4163	47	17	can	can	AUX
easat-4163	47	18	happen	happen	VERB
easat-4163	47	19	on	on	ADP
easat-4163	47	20	its	its	PRON
easat-4163	47	21	own	own	ADJ
easat-4163	47	22	or	or	CCONJ
easat-4163	47	23	after	after	ADP
easat-4163	47	24	an	an	DET
easat-4163	47	25	accident	accident	NOUN
easat-4163	47	26	or	or	CCONJ
easat-4163	47	27	medical	medical	ADJ
easat-4163	47	28	or	or	CCONJ
easat-4163	47	29	dental	dental	ADJ
easat-4163	47	30	operations	operation	NOUN
easat-4163	47	31	.	.	PUNCT
easat-4163	48	1	1.3	1.3	NUM
easat-4163	48	2	.	.	PUNCT
easat-4163	48	3	clotting	clot	VERB
easat-4163	48	4	mechanisms	mechanism	NOUN
easat-4163	48	5	in	in	ADP
easat-4163	48	6	the	the	DET
easat-4163	48	7	body	body	NOUN
easat-4163	48	8	1.3.1	1.3.1	NUM
easat-4163	48	9	.	.	PUNCT
easat-4163	48	10	primary	primary	ADJ
easat-4163	48	11	hemostasis	hemostasis	NOUN
easat-4163	48	12	:	:	PUNCT
easat-4163	48	13	vascular	vascular	ADJ
easat-4163	48	14	spasm	spasm	NOUN
easat-4163	48	15	:	:	PUNCT
easat-4163	48	16	when	when	SCONJ
easat-4163	48	17	a	a	DET
easat-4163	48	18	blood	blood	NOUN
easat-4163	48	19	vessel	vessel	NOUN
easat-4163	48	20	is	be	AUX
easat-4163	48	21	damaged	damage	VERB
easat-4163	48	22	,	,	PUNCT
easat-4163	48	23	platelets	platelet	NOUN
easat-4163	48	24	stick	stick	VERB
easat-4163	48	25	to	to	ADP
easat-4163	48	26	the	the	DET
easat-4163	48	27	area	area	NOUN
easat-4163	48	28	,	,	PUNCT
easat-4163	48	29	activate	activate	VERB
easat-4163	48	30	,	,	PUNCT
easat-4163	48	31	and	and	CCONJ
easat-4163	48	32	group	group	NOUN
easat-4163	48	33	together	together	ADV
easat-4163	48	34	to	to	PART
easat-4163	48	35	create	create	VERB
easat-4163	48	36	a	a	DET
easat-4163	48	37	transient	transient	ADJ
easat-4163	48	38	platelet	platelet	NOUN
easat-4163	48	39	plug	plug	NOUN
easat-4163	48	40	.	.	PUNCT
easat-4163	49	1	1.3.2	1.3.2	X
easat-4163	49	2	.	.	PUNCT
easat-4163	49	3	secondary	secondary	ADJ
easat-4163	49	4	hemostasis	hemostasis	NOUN
easat-4163	49	5	coagulation	coagulation	NOUN
easat-4163	49	6	cascade	cascade	NOUN
easat-4163	49	7	:	:	PUNCT
easat-4163	49	8	a	a	DET
easat-4163	49	9	series	series	NOUN
easat-4163	49	10	of	of	ADP
easat-4163	49	11	complex	complex	ADJ
easat-4163	49	12	biochemical	biochemical	ADJ
easat-4163	49	13	reactions	reaction	NOUN
easat-4163	49	14	involving	involve	VERB
easat-4163	49	15	clotting	clot	VERB
easat-4163	49	16	factors	factor	NOUN
easat-4163	49	17	(	(	PUNCT
easat-4163	49	18	proteins	protein	NOUN
easat-4163	49	19	in	in	ADP
easat-4163	49	20	the	the	DET
easat-4163	49	21	blood	blood	NOUN
easat-4163	49	22	plasma	plasma	NOUN
easat-4163	49	23	)	)	PUNCT
easat-4163	49	24	are	be	AUX
easat-4163	49	25	triggered	trigger	VERB
easat-4163	49	26	to	to	PART
easat-4163	49	27	reinforce	reinforce	VERB
easat-4163	49	28	the	the	DET
easat-4163	49	29	platelet	platelet	NOUN
easat-4163	49	30	plug	plug	NOUN
easat-4163	49	31	and	and	CCONJ
easat-4163	49	32	form	form	VERB
easat-4163	49	33	a	a	DET
easat-4163	49	34	stable	stable	ADJ
easat-4163	49	35	fibrin	fibrin	NOUN
easat-4163	49	36	clot	clot	NOUN
easat-4163	49	37	.	.	PUNCT
easat-4163	50	1	this	this	DET
easat-4163	50	2	cascade	cascade	NOUN
easat-4163	50	3	includes	include	VERB
easat-4163	50	4	activation	activation	NOUN
easat-4163	50	5	of	of	ADP
easat-4163	50	6	clotting	clot	VERB
easat-4163	50	7	factors	factor	NOUN
easat-4163	50	8	,	,	PUNCT
easat-4163	50	9	formation	formation	NOUN
easat-4163	50	10	of	of	ADP
easat-4163	50	11	thrombin	thrombin	NOUN
easat-4163	50	12	(	(	PUNCT
easat-4163	50	13	enzyme	enzyme	NOUN
easat-4163	50	14	that	that	PRON
easat-4163	50	15	converts	convert	VERB
easat-4163	50	16	fibrinogen	fibrinogen	NOUN
easat-4163	50	17	to	to	PART
easat-4163	50	18	fibrin	fibrin	VERB
easat-4163	50	19	)	)	PUNCT
easat-4163	50	20	,	,	PUNCT
easat-4163	50	21	and	and	CCONJ
easat-4163	50	22	cross	cross	ADJ
easat-4163	50	23	-	-	ADJ
easat-4163	50	24	linking	linking	NOUN
easat-4163	50	25	of	of	ADP
easat-4163	50	26	fibrin	fibrin	NOUN
easat-4163	50	27	strands	strand	NOUN
easat-4163	50	28	to	to	PART
easat-4163	50	29	stabilize	stabilize	VERB
easat-4163	50	30	the	the	DET
easat-4163	50	31	clot	clot	NOUN
easat-4163	50	32	.	.	PUNCT
easat-4163	51	1	1.3.3	1.3.3	X
easat-4163	51	2	.	.	PUNCT
easat-4163	51	3	fibrinolysis	fibrinolysis	NOUN
easat-4163	51	4	clot	clot	NOUN
easat-4163	51	5	removal	removal	NOUN
easat-4163	51	6	:	:	PUNCT
easat-4163	51	7	once	once	SCONJ
easat-4163	51	8	the	the	DET
easat-4163	51	9	injury	injury	NOUN
easat-4163	51	10	is	be	AUX
easat-4163	51	11	healed	heal	VERB
easat-4163	51	12	,	,	PUNCT
easat-4163	51	13	fibrinolysis	fibrinolysis	NOUN
easat-4163	51	14	(	(	PUNCT
easat-4163	51	15	breakdown	breakdown	NOUN
easat-4163	51	16	of	of	ADP
easat-4163	51	17	fibrin	fibrin	NOUN
easat-4163	51	18	)	)	PUNCT
easat-4163	51	19	occurs	occur	VERB
easat-4163	51	20	to	to	PART
easat-4163	51	21	dissolve	dissolve	VERB
easat-4163	51	22	the	the	DET
easat-4163	51	23	excess	excess	ADJ
easat-4163	51	24	clot	clot	NOUN
easat-4163	51	25	and	and	CCONJ
easat-4163	51	26	restore	restore	VERB
easat-4163	51	27	blood	blood	NOUN
easat-4163	51	28	flow	flow	NOUN
easat-4163	51	29	.	.	PUNCT
easat-4163	52	1	1.4	1.4	NUM
easat-4163	52	2	.	.	PUNCT
easat-4163	52	3	types	type	NOUN
easat-4163	52	4	of	of	ADP
easat-4163	52	5	coagulation	coagulation	NOUN
easat-4163	52	6	disorders	disorder	NOUN
easat-4163	52	7	1.4.1	1.4.1	NUM
easat-4163	52	8	hemophilia	hemophilia	NOUN
easat-4163	52	9	it	it	PRON
easat-4163	52	10	is	be	AUX
easat-4163	52	11	typically	typically	ADV
easat-4163	52	12	inherited	inherit	VERB
easat-4163	52	13	as	as	ADP
easat-4163	52	14	x	x	NOUN
easat-4163	52	15	-	-	VERB
easat-4163	52	16	linked	link	VERB
easat-4163	52	17	recessive	recessive	ADJ
easat-4163	52	18	disorders	disorder	NOUN
easat-4163	52	19	,	,	PUNCT
easat-4163	52	20	affecting	affect	VERB
easat-4163	52	21	males	male	NOUN
easat-4163	52	22	more	more	ADV
easat-4163	52	23	severely	severely	ADV
easat-4163	52	24	than	than	ADP
easat-4163	52	25	females	female	NOUN
easat-4163	52	26	.	.	PUNCT
easat-4163	53	1	it	it	PRON
easat-4163	53	2	has	have	VERB
easat-4163	53	3	symptoms	symptom	NOUN
easat-4163	53	4	of	of	ADP
easat-4163	53	5	prolonged	prolonged	ADJ
easat-4163	53	6	bleeding	bleeding	NOUN
easat-4163	53	7	,	,	PUNCT
easat-4163	53	8	especially	especially	ADV
easat-4163	53	9	into	into	ADP
easat-4163	53	10	joints	joint	NOUN
easat-4163	53	11	and	and	CCONJ
easat-4163	53	12	muscles	muscle	NOUN
easat-4163	53	13	after	after	ADP
easat-4163	53	14	minor	minor	ADJ
easat-4163	53	15	trauma	trauma	NOUN
easat-4163	53	16	or	or	CCONJ
easat-4163	53	17	spontaneously	spontaneously	ADV
easat-4163	53	18	.	.	PUNCT
easat-4163	54	1	the	the	DET
easat-4163	54	2	two	two	NUM
easat-4163	54	3	types	type	NOUN
easat-4163	54	4	of	of	ADP
easat-4163	54	5	haemophilia	haemophilia	NOUN
easat-4163	54	6	are	be	AUX
easat-4163	54	7	haemophilia	haemophilia	PROPN
easat-4163	54	8	a	a	PRON
easat-4163	54	9	and	and	CCONJ
easat-4163	54	10	haemophilia	haemophilia	PROPN
easat-4163	54	11	b.	b.	PROPN
easat-4163	54	12	deficits	deficit	NOUN
easat-4163	54	13	in	in	ADP
easat-4163	54	14	factor	factor	NOUN
easat-4163	54	15	viii	viii	NOUN
easat-4163	54	16	result	result	NOUN
easat-4163	54	17	in	in	ADP
easat-4163	54	18	haemophilia	haemophilia	PROPN
easat-4163	54	19	a	a	PRON
easat-4163	54	20	,	,	PUNCT
easat-4163	54	21	while	while	SCONJ
easat-4163	54	22	deficiencies	deficiency	NOUN
easat-4163	54	23	in	in	ADP
easat-4163	54	24	factor	factor	NOUN
easat-4163	54	25	ix	ix	ADP
easat-4163	54	26	result	result	NOUN
easat-4163	54	27	in	in	ADP
easat-4163	54	28	haemophilia	haemophilia	PROPN
easat-4163	54	29	b.	b.	PROPN
easat-4163	55	1	507	507	NUM
easat-4163	55	2	edelweiss	edelweiss	PROPN
easat-4163	55	3	applied	apply	VERB
easat-4163	55	4	science	science	NOUN
easat-4163	55	5	and	and	CCONJ
easat-4163	55	6	technology	technology	NOUN
easat-4163	55	7	issn	issn	PROPN
easat-4163	55	8	:	:	PUNCT
easat-4163	55	9	2576	2576	NUM
easat-4163	55	10	-	-	SYM
easat-4163	55	11	8484	8484	NUM
easat-4163	55	12	vol	vol	NOUN
easat-4163	55	13	.	.	PROPN
easat-4163	56	1	9	9	NUM
easat-4163	56	2	,	,	PUNCT
easat-4163	56	3	no	no	INTJ
easat-4163	56	4	.	.	NOUN
easat-4163	56	5	1	1	NUM
easat-4163	56	6	:	:	PUNCT
easat-4163	56	7	505	505	NUM
easat-4163	56	8	-	-	SYM
easat-4163	56	9	514	514	NUM
easat-4163	56	10	,	,	PUNCT
easat-4163	56	11	2025	2025	NUM
easat-4163	56	12	doi	doi	NOUN
easat-4163	56	13	:	:	PUNCT
easat-4163	56	14	10.55214/25768484.v9i1.4163	10.55214/25768484.v9i1.4163	NUM
easat-4163	56	15	©	©	PROPN
easat-4163	56	16	2025	2025	NUM
easat-4163	56	17	by	by	ADP
easat-4163	56	18	the	the	DET
easat-4163	56	19	authors	author	NOUN
easat-4163	56	20	;	;	PUNCT
easat-4163	57	1	licensee	licensee	NOUN
easat-4163	57	2	learning	learn	VERB
easat-4163	57	3	gate	gate	NOUN
easat-4163	57	4	1.4.2	1.4.2	NUM
easat-4163	57	5	.	.	PUNCT
easat-4163	58	1	von	von	PROPN
easat-4163	58	2	willebrand	willebrand	PROPN
easat-4163	58	3	disease	disease	NOUN
easat-4163	58	4	(	(	PUNCT
easat-4163	58	5	vwd	vwd	NUM
easat-4163	58	6	)	)	PUNCT
easat-4163	58	7	it	it	PRON
easat-4163	58	8	is	be	AUX
easat-4163	58	9	due	due	ADJ
easat-4163	58	10	to	to	ADP
easat-4163	58	11	deficiency	deficiency	NOUN
easat-4163	58	12	or	or	CCONJ
easat-4163	58	13	dysfunction	dysfunction	NOUN
easat-4163	58	14	of	of	ADP
easat-4163	58	15	von	von	PROPN
easat-4163	58	16	willebrand	willebrand	PROPN
easat-4163	58	17	factor	factor	NOUN
easat-4163	58	18	(	(	PUNCT
easat-4163	58	19	vwf	vwf	PROPN
easat-4163	58	20	)	)	PUNCT
easat-4163	58	21	,	,	PUNCT
easat-4163	58	22	a	a	DET
easat-4163	58	23	protein	protein	NOUN
easat-4163	58	24	that	that	PRON
easat-4163	58	25	helps	help	VERB
easat-4163	58	26	platelets	platelet	NOUN
easat-4163	58	27	adhere	adhere	VERB
easat-4163	58	28	to	to	ADP
easat-4163	58	29	blood	blood	NOUN
easat-4163	58	30	vessel	vessel	NOUN
easat-4163	58	31	walls	wall	NOUN
easat-4163	58	32	.	.	PUNCT
easat-4163	59	1	it	it	PRON
easat-4163	59	2	has	have	VERB
easat-4163	59	3	symptoms	symptom	NOUN
easat-4163	59	4	similar	similar	ADJ
easat-4163	59	5	to	to	ADP
easat-4163	59	6	hemophilia	hemophilia	NOUN
easat-4163	59	7	but	but	CCONJ
easat-4163	59	8	generally	generally	ADV
easat-4163	59	9	milder	mild	ADJ
easat-4163	59	10	,	,	PUNCT
easat-4163	59	11	with	with	ADP
easat-4163	59	12	mucocutaneous	mucocutaneous	ADJ
easat-4163	59	13	bleeding	bleeding	NOUN
easat-4163	59	14	(	(	PUNCT
easat-4163	59	15	nosebleeds	nosebleed	NOUN
easat-4163	59	16	,	,	PUNCT
easat-4163	59	17	excessive	excessive	ADJ
easat-4163	59	18	menstrual	menstrual	ADJ
easat-4163	59	19	bleeding	bleeding	NOUN
easat-4163	59	20	)	)	PUNCT
easat-4163	59	21	.	.	PUNCT
easat-4163	60	1	1.4.3	1.4.3	NUM
easat-4163	60	2	.	.	NUM
easat-4163	60	3	disseminated	disseminate	VERB
easat-4163	60	4	intravascular	intravascular	ADJ
easat-4163	60	5	coagulation	coagulation	NOUN
easat-4163	60	6	(	(	PUNCT
easat-4163	60	7	dic	dic	ADJ
easat-4163	60	8	)	)	PUNCT
easat-4163	60	9	it	it	PRON
easat-4163	60	10	is	be	AUX
easat-4163	60	11	due	due	ADJ
easat-4163	60	12	to	to	ADP
easat-4163	60	13	widespread	widespread	ADJ
easat-4163	60	14	activation	activation	NOUN
easat-4163	60	15	of	of	ADP
easat-4163	60	16	clotting	clot	VERB
easat-4163	60	17	factors	factor	NOUN
easat-4163	60	18	throughout	throughout	ADP
easat-4163	60	19	the	the	DET
easat-4163	60	20	body	body	NOUN
easat-4163	60	21	,	,	PUNCT
easat-4163	60	22	often	often	ADV
easat-4163	60	23	due	due	ADP
easat-4163	60	24	to	to	ADP
easat-4163	60	25	severe	severe	ADJ
easat-4163	60	26	infections	infection	NOUN
easat-4163	60	27	,	,	PUNCT
easat-4163	60	28	trauma	trauma	NOUN
easat-4163	60	29	,	,	PUNCT
easat-4163	60	30	or	or	CCONJ
easat-4163	60	31	certain	certain	ADJ
easat-4163	60	32	cancers	cancer	NOUN
easat-4163	60	33	.	.	PUNCT
easat-4163	61	1	initially	initially	ADV
easat-4163	61	2	it	it	PRON
easat-4163	61	3	causes	cause	VERB
easat-4163	61	4	excessive	excessive	ADJ
easat-4163	61	5	clotting	clotting	NOUN
easat-4163	61	6	(	(	PUNCT
easat-4163	61	7	thrombosis	thrombosis	NOUN
easat-4163	61	8	)	)	PUNCT
easat-4163	61	9	followed	follow	VERB
easat-4163	61	10	by	by	ADP
easat-4163	61	11	consumption	consumption	NOUN
easat-4163	61	12	of	of	ADP
easat-4163	61	13	clotting	clot	VERB
easat-4163	61	14	factors	factor	NOUN
easat-4163	61	15	,	,	PUNCT
easat-4163	61	16	leading	lead	VERB
easat-4163	61	17	to	to	ADP
easat-4163	61	18	bleeding	bleed	VERB
easat-4163	61	19	tendencies	tendency	NOUN
easat-4163	61	20	.	.	PUNCT
easat-4163	62	1	clinically	clinically	ADV
easat-4163	62	2	,	,	PUNCT
easat-4163	62	3	patient	patient	NOUN
easat-4163	62	4	can	can	AUX
easat-4163	62	5	present	present	VERB
easat-4163	62	6	with	with	ADP
easat-4163	62	7	both	both	CCONJ
easat-4163	62	8	thrombotic	thrombotic	ADJ
easat-4163	62	9	and	and	CCONJ
easat-4163	62	10	bleeding	bleed	VERB
easat-4163	62	11	manifestations	manifestation	NOUN
easat-4163	62	12	,	,	PUNCT
easat-4163	62	13	often	often	ADV
easat-4163	62	14	critically	critically	ADV
easat-4163	62	15	ill	ill	ADJ
easat-4163	62	16	.	.	PUNCT
easat-4163	63	1	1.4.4	1.4.4	X
easat-4163	63	2	.	.	PUNCT
easat-4163	64	1	thrombophilia	thrombophilia	VERB
easat-4163	64	2	this	this	DET
easat-4163	64	3	medical	medical	ADJ
easat-4163	64	4	condition	condition	NOUN
easat-4163	64	5	increases	increase	VERB
easat-4163	64	6	the	the	DET
easat-4163	64	7	risk	risk	NOUN
easat-4163	64	8	of	of	ADP
easat-4163	64	9	venous	venous	ADJ
easat-4163	64	10	thromboembolism	thromboembolism	NOUN
easat-4163	64	11	(	(	PUNCT
easat-4163	64	12	pulmonary	pulmonary	ADJ
easat-4163	64	13	embolism	embolism	NOUN
easat-4163	64	14	,	,	PUNCT
easat-4163	64	15	deep	deep	ADJ
easat-4163	64	16	vein	vein	ADJ
easat-4163	64	17	thrombosis	thrombosis	NOUN
easat-4163	64	18	)	)	PUNCT
easat-4163	64	19	and	and	CCONJ
easat-4163	64	20	excessive	excessive	ADJ
easat-4163	64	21	clot	clot	NOUN
easat-4163	64	22	formation	formation	NOUN
easat-4163	64	23	(	(	PUNCT
easat-4163	64	24	thrombosis	thrombosis	NOUN
easat-4163	64	25	)	)	PUNCT
easat-4163	64	26	.	.	PUNCT
easat-4163	65	1	these	these	PRON
easat-4163	65	2	include	include	VERB
easat-4163	65	3	acquired	acquire	VERB
easat-4163	65	4	illnesses	illness	NOUN
easat-4163	65	5	like	like	ADP
easat-4163	65	6	antiphospholipid	antiphospholipid	NOUN
easat-4163	65	7	syndrome	syndrome	NOUN
easat-4163	65	8	and	and	CCONJ
easat-4163	65	9	hereditary	hereditary	ADJ
easat-4163	65	10	abnormalities	abnormality	NOUN
easat-4163	65	11	like	like	ADP
easat-4163	65	12	factor	factor	NOUN
easat-4163	65	13	v	v	NOUN
easat-4163	65	14	leiden	leiden	PROPN
easat-4163	65	15	mutation	mutation	NOUN
easat-4163	65	16	and	and	CCONJ
easat-4163	65	17	prothrombin	prothrombin	ADJ
easat-4163	65	18	gene	gene	NOUN
easat-4163	65	19	mutation	mutation	NOUN
easat-4163	65	20	.	.	PUNCT
easat-4163	66	1	1.4.5	1.4.5	X
easat-4163	66	2	.	.	PUNCT
easat-4163	66	3	acquired	acquire	VERB
easat-4163	66	4	coagulation	coagulation	NOUN
easat-4163	66	5	disorders	disorder	NOUN
easat-4163	66	6	it	it	PRON
easat-4163	66	7	may	may	AUX
easat-4163	66	8	be	be	AUX
easat-4163	66	9	caused	cause	VERB
easat-4163	66	10	by	by	ADP
easat-4163	66	11	vitamin	vitamin	NOUN
easat-4163	66	12	k	k	PROPN
easat-4163	66	13	insufficiency	insufficiency	NOUN
easat-4163	66	14	,	,	PUNCT
easat-4163	66	15	which	which	PRON
easat-4163	66	16	is	be	AUX
easat-4163	66	17	necessary	necessary	ADJ
easat-4163	66	18	for	for	SCONJ
easat-4163	66	19	the	the	DET
easat-4163	66	20	synthesis	synthesis	NOUN
easat-4163	66	21	of	of	ADP
easat-4163	66	22	clotting	clot	VERB
easat-4163	66	23	factors	factor	NOUN
easat-4163	66	24	ii	ii	PROPN
easat-4163	66	25	,	,	PUNCT
easat-4163	66	26	vii	vii	PROPN
easat-4163	66	27	,	,	PUNCT
easat-4163	66	28	ix	ix	ADV
easat-4163	66	29	,	,	PUNCT
easat-4163	66	30	and	and	CCONJ
easat-4163	66	31	x	x	NOUN
easat-4163	66	32	,	,	PUNCT
easat-4163	66	33	or	or	CCONJ
easat-4163	66	34	liver	liver	NOUN
easat-4163	66	35	illness	illness	NOUN
easat-4163	66	36	,	,	PUNCT
easat-4163	66	37	which	which	PRON
easat-4163	66	38	hinders	hinder	VERB
easat-4163	66	39	the	the	DET
easat-4163	66	40	synthesis	synthesis	NOUN
easat-4163	66	41	of	of	ADP
easat-4163	66	42	clotting	clot	VERB
easat-4163	66	43	factors	factor	NOUN
easat-4163	66	44	.	.	PUNCT
easat-4163	67	1	figure	figure	NOUN
easat-4163	67	2	1	1	NUM
easat-4163	67	3	.	.	PUNCT
easat-4163	68	1	mechanism	mechanism	NOUN
easat-4163	68	2	of	of	ADP
easat-4163	68	3	covid-19	covid-19	PROPN
easat-4163	68	4	associated	associate	VERB
easat-4163	68	5	coagulopathy	coagulopathy	ADJ
easat-4163	68	6	[	[	X
easat-4163	68	7	9	9	NUM
easat-4163	68	8	]	]	SYM
easat-4163	68	9	.	.	PUNCT
easat-4163	69	1	2	2	X
easat-4163	69	2	.	.	X
easat-4163	69	3	coagulation	coagulation	NOUN
easat-4163	69	4	disordes	disorde	NOUN
easat-4163	69	5	in	in	ADP
easat-4163	69	6	covid-19	covid-19	PROPN
easat-4163	69	7	patients	patient	NOUN
easat-4163	69	8	coagulopathy	coagulopathy	ADJ
easat-4163	69	9	in	in	ADP
easat-4163	69	10	covid-19	covid-19	PROPN
easat-4163	69	11	patients	patient	NOUN
easat-4163	69	12	occur	occur	VERB
easat-4163	69	13	through	through	ADP
easat-4163	69	14	the	the	DET
easat-4163	69	15	following	follow	VERB
easat-4163	69	16	process	process	NOUN
easat-4163	69	17	.	.	PUNCT
easat-4163	70	1	2.1	2.1	NUM
easat-4163	70	2	.	.	PUNCT
easat-4163	71	1	endothelial	endothelial	ADJ
easat-4163	71	2	dysfunction	dysfunction	NOUN
easat-4163	71	3	and	and	CCONJ
easat-4163	71	4	thrombosis	thrombosis	NOUN
easat-4163	71	5	:	:	PUNCT
easat-4163	71	6	research	research	NOUN
easat-4163	71	7	has	have	AUX
easat-4163	71	8	shown	show	VERB
easat-4163	71	9	that	that	SCONJ
easat-4163	71	10	covid-19	covid-19	PROPN
easat-4163	71	11	can	can	AUX
easat-4163	71	12	induce	induce	VERB
easat-4163	71	13	endothelial	endothelial	ADJ
easat-4163	71	14	cell	cell	NOUN
easat-4163	71	15	inflammation	inflammation	NOUN
easat-4163	71	16	and	and	CCONJ
easat-4163	71	17	dysfunction	dysfunction	NOUN
easat-4163	71	18	,	,	PUNCT
easat-4163	71	19	leading	lead	VERB
easat-4163	71	20	to	to	ADP
easat-4163	71	21	increased	increase	VERB
easat-4163	71	22	expression	expression	NOUN
easat-4163	71	23	of	of	ADP
easat-4163	71	24	pro	pro	ADJ
easat-4163	71	25	-	-	ADJ
easat-4163	71	26	inflammatory	inflammatory	ADJ
easat-4163	71	27	and	and	CCONJ
easat-4163	71	28	pro	pro	ADJ
easat-4163	71	29	-	-	ADJ
easat-4163	71	30	thrombotic	thrombotic	ADJ
easat-4163	71	31	molecules	molecule	NOUN
easat-4163	71	32	such	such	ADJ
easat-4163	71	33	as	as	ADP
easat-4163	71	34	von	von	PROPN
easat-4163	71	35	willebrand	willebrand	NOUN
easat-4163	71	36	factor	factor	NOUN
easat-4163	71	37	and	and	CCONJ
easat-4163	71	38	tissue	tissue	NOUN
easat-4163	71	39	factor	factor	NOUN
easat-4163	71	40	[	[	NOUN
easat-4163	71	41	10	10	NUM
easat-4163	71	42	]	]	PUNCT
easat-4163	71	43	.	.	PUNCT
easat-4163	72	1	endothelial	endothelial	ADJ
easat-4163	72	2	dysfunction	dysfunction	NOUN
easat-4163	72	3	is	be	AUX
easat-4163	72	4	linked	link	VERB
easat-4163	72	5	to	to	ADP
easat-4163	72	6	worse	bad	ADJ
easat-4163	72	7	outcomes	outcome	NOUN
easat-4163	72	8	in	in	ADP
easat-4163	72	9	covid-19	covid-19	PROPN
easat-4163	72	10	patients	patient	NOUN
easat-4163	72	11	and	and	CCONJ
easat-4163	72	12	is	be	AUX
easat-4163	72	13	a	a	DET
easat-4163	72	14	contributing	contribute	VERB
easat-4163	72	15	factor	factor	NOUN
easat-4163	72	16	to	to	AUX
easat-4163	72	17	microvascular	microvascular	ADJ
easat-4163	72	18	thrombosis	thrombosis	NOUN
easat-4163	72	19	.	.	PUNCT
easat-4163	73	1	2.2	2.2	NUM
easat-4163	73	2	.	.	PUNCT
easat-4163	73	3	hypercoagulability	hypercoagulability	NOUN
easat-4163	73	4	and	and	CCONJ
easat-4163	73	5	thrombotic	thrombotic	ADJ
easat-4163	73	6	events	event	NOUN
easat-4163	73	7	:	:	PUNCT
easat-4163	73	8	despite	despite	SCONJ
easat-4163	73	9	preventative	preventative	ADJ
easat-4163	73	10	anticoagulation	anticoagulation	NOUN
easat-4163	73	11	,	,	PUNCT
easat-4163	73	12	studies	study	NOUN
easat-4163	73	13	have	have	AUX
easat-4163	73	14	shown	show	VERB
easat-4163	73	15	a	a	DET
easat-4163	73	16	considerable	considerable	ADJ
easat-4163	73	17	rate	rate	NOUN
easat-4163	73	18	of	of	ADP
easat-4163	73	19	venous	venous	ADJ
easat-4163	73	20	and	and	CCONJ
easat-4163	73	21	arterial	arterial	ADJ
easat-4163	73	22	thrombotic	thrombotic	ADJ
easat-4163	73	23	events	event	NOUN
easat-4163	73	24	in	in	ADP
easat-4163	73	25	severe	severe	ADJ
easat-4163	73	26	covid-19	covid-19	PROPN
easat-4163	73	27	patients	patient	NOUN
easat-4163	73	28	[	[	X
easat-4163	73	29	11	11	NUM
easat-4163	73	30	]	]	PUNCT
easat-4163	73	31	.	.	PUNCT
easat-4163	74	1	the	the	DET
easat-4163	74	2	coagulation	coagulation	NOUN
easat-4163	74	3	cascade	cascade	NOUN
easat-4163	74	4	is	be	AUX
easat-4163	74	5	activated	activate	VERB
easat-4163	74	6	in	in	ADP
easat-4163	74	7	covid508	covid508	PROPN
easat-4163	74	8	edelweiss	edelweiss	PROPN
easat-4163	74	9	applied	apply	VERB
easat-4163	74	10	science	science	NOUN
easat-4163	74	11	and	and	CCONJ
easat-4163	74	12	technology	technology	NOUN
easat-4163	74	13	issn	issn	PROPN
easat-4163	74	14	:	:	PUNCT
easat-4163	74	15	2576	2576	NUM
easat-4163	74	16	-	-	SYM
easat-4163	74	17	8484	8484	NUM
easat-4163	74	18	vol	vol	NOUN
easat-4163	74	19	.	.	PROPN
easat-4163	75	1	9	9	NUM
easat-4163	75	2	,	,	PUNCT
easat-4163	75	3	no	no	INTJ
easat-4163	75	4	.	.	NOUN
easat-4163	75	5	1	1	NUM
easat-4163	75	6	:	:	PUNCT
easat-4163	75	7	505	505	NUM
easat-4163	75	8	-	-	SYM
easat-4163	75	9	514	514	NUM
easat-4163	75	10	,	,	PUNCT
easat-4163	75	11	2025	2025	NUM
easat-4163	75	12	doi	doi	NOUN
easat-4163	75	13	:	:	PUNCT
easat-4163	75	14	10.55214/25768484.v9i1.4163	10.55214/25768484.v9i1.4163	NUM
easat-4163	75	15	©	©	PROPN
easat-4163	75	16	2025	2025	NUM
easat-4163	75	17	by	by	ADP
easat-4163	75	18	the	the	DET
easat-4163	75	19	authors	author	NOUN
easat-4163	75	20	;	;	PUNCT
easat-4163	75	21	licensee	licensee	PROPN
easat-4163	75	22	learning	learning	NOUN
easat-4163	75	23	gate	gate	PROPN
easat-4163	75	24	19	19	NUM
easat-4163	75	25	-	-	PUNCT
easat-4163	75	26	associated	associate	VERB
easat-4163	75	27	coagulopathy	coagulopathy	ADJ
easat-4163	75	28	,	,	PUNCT
easat-4163	75	29	as	as	SCONJ
easat-4163	75	30	shown	show	VERB
easat-4163	75	31	by	by	ADP
easat-4163	75	32	increased	increase	VERB
easat-4163	75	33	levels	level	NOUN
easat-4163	75	34	of	of	ADP
easat-4163	75	35	d	d	NOUN
easat-4163	75	36	-	-	PUNCT
easat-4163	75	37	dimer	dimer	ADJ
easat-4163	75	38	,	,	PUNCT
easat-4163	75	39	fibrinogen	fibrinogen	NOUN
easat-4163	75	40	,	,	PUNCT
easat-4163	75	41	and	and	CCONJ
easat-4163	75	42	fibrin	fibrin	NOUN
easat-4163	75	43	degradation	degradation	NOUN
easat-4163	75	44	products	product	NOUN
easat-4163	75	45	[	[	X
easat-4163	75	46	12	12	NUM
easat-4163	75	47	]	]	PUNCT
easat-4163	75	48	.	.	PUNCT
easat-4163	76	1	2.3	2.3	NUM
easat-4163	76	2	.	.	PUNCT
easat-4163	77	1	inflammatory	inflammatory	ADJ
easat-4163	77	2	response	response	NOUN
easat-4163	77	3	and	and	CCONJ
easat-4163	77	4	coagulation	coagulation	NOUN
easat-4163	77	5	cascade	cascade	NOUN
easat-4163	77	6	:	:	PUNCT
easat-4163	77	7	a	a	DET
easat-4163	77	8	hyperinflammatory	hyperinflammatory	ADJ
easat-4163	77	9	condition	condition	NOUN
easat-4163	77	10	that	that	PRON
easat-4163	77	11	upsets	upset	VERB
easat-4163	77	12	the	the	DET
easat-4163	77	13	equilibrium	equilibrium	NOUN
easat-4163	77	14	between	between	ADP
easat-4163	77	15	pro	pro	ADJ
easat-4163	77	16	-	-	ADJ
easat-4163	77	17	coagulant	coagulant	ADJ
easat-4163	77	18	and	and	CCONJ
easat-4163	77	19	anticoagulant	anticoagulant	ADJ
easat-4163	77	20	components	component	NOUN
easat-4163	77	21	is	be	AUX
easat-4163	77	22	a	a	DET
easat-4163	77	23	result	result	NOUN
easat-4163	77	24	of	of	ADP
easat-4163	77	25	the	the	DET
easat-4163	77	26	cytokine	cytokine	NOUN
easat-4163	77	27	storm	storm	NOUN
easat-4163	77	28	seen	see	VERB
easat-4163	77	29	in	in	ADP
easat-4163	77	30	severe	severe	ADJ
easat-4163	77	31	covid-19	covid-19	PROPN
easat-4163	77	32	patients	patient	NOUN
easat-4163	77	33	[	[	X
easat-4163	77	34	13	13	NUM
easat-4163	77	35	]	]	PUNCT
easat-4163	77	36	.	.	PUNCT
easat-4163	78	1	patients	patient	NOUN
easat-4163	78	2	with	with	ADP
easat-4163	78	3	covid-19	covid-19	PROPN
easat-4163	78	4	have	have	VERB
easat-4163	78	5	a	a	DET
easat-4163	78	6	higher	high	ADJ
easat-4163	78	7	risk	risk	NOUN
easat-4163	78	8	of	of	ADP
easat-4163	78	9	thrombosis	thrombosis	NOUN
easat-4163	78	10	when	when	SCONJ
easat-4163	78	11	their	their	PRON
easat-4163	78	12	levels	level	NOUN
easat-4163	78	13	of	of	ADP
easat-4163	78	14	interleukin-6	interleukin-6	PROPN
easat-4163	78	15	(	(	PUNCT
easat-4163	78	16	il-6	il-6	NUM
easat-4163	78	17	)	)	PUNCT
easat-4163	78	18	and	and	CCONJ
easat-4163	78	19	other	other	ADJ
easat-4163	78	20	inflammatory	inflammatory	ADJ
easat-4163	78	21	markers	marker	NOUN
easat-4163	78	22	are	be	AUX
easat-4163	78	23	elevated	elevate	VERB
easat-4163	78	24	.	.	PUNCT
easat-4163	79	1	2.4	2.4	NUM
easat-4163	79	2	.	.	PUNCT
easat-4163	80	1	antiphospholipid	antiphospholipid	NOUN
easat-4163	80	2	antibodies	antibody	NOUN
easat-4163	80	3	(	(	PUNCT
easat-4163	80	4	aplas	apla	NOUN
easat-4163	80	5	)	)	PUNCT
easat-4163	80	6	antiphospholipid	antiphospholipid	NOUN
easat-4163	80	7	antibodies	antibody	NOUN
easat-4163	80	8	,	,	PUNCT
easat-4163	80	9	which	which	PRON
easat-4163	80	10	are	be	AUX
easat-4163	80	11	linked	link	VERB
easat-4163	80	12	to	to	ADP
easat-4163	80	13	an	an	DET
easat-4163	80	14	elevated	elevated	ADJ
easat-4163	80	15	risk	risk	NOUN
easat-4163	80	16	of	of	ADP
easat-4163	80	17	thrombotic	thrombotic	ADJ
easat-4163	80	18	events	event	NOUN
easat-4163	80	19	and	and	CCONJ
easat-4163	80	20	sequelae	sequelae	NOUN
easat-4163	80	21	,	,	PUNCT
easat-4163	80	22	may	may	AUX
easat-4163	80	23	develop	develop	VERB
easat-4163	80	24	in	in	ADP
easat-4163	80	25	some	some	DET
easat-4163	80	26	covid-19	covid-19	PROPN
easat-4163	80	27	patients	patient	NOUN
easat-4163	80	28	,	,	PUNCT
easat-4163	80	29	according	accord	VERB
easat-4163	80	30	to	to	ADP
easat-4163	80	31	new	new	ADJ
easat-4163	80	32	research	research	NOUN
easat-4163	80	33	zuo	zuo	PROPN
easat-4163	80	34	,	,	PUNCT
easat-4163	80	35	et	et	PROPN
easat-4163	80	36	al	al	PROPN
easat-4163	80	37	.	.	PUNCT
easat-4163	81	1	[	[	X
easat-4163	81	2	14	14	NUM
easat-4163	81	3	]	]	PUNCT
easat-4163	81	4	.	.	PUNCT
easat-4163	82	1	aplas	aplas	PROPN
easat-4163	82	2	may	may	AUX
easat-4163	82	3	play	play	VERB
easat-4163	82	4	a	a	DET
easat-4163	82	5	part	part	NOUN
easat-4163	82	6	in	in	ADP
easat-4163	82	7	the	the	DET
easat-4163	82	8	pathophysiology	pathophysiology	NOUN
easat-4163	82	9	of	of	ADP
easat-4163	82	10	coagulopathy	coagulopathy	ADJ
easat-4163	82	11	linked	link	VERB
easat-4163	82	12	to	to	ADP
easat-4163	82	13	covid-19	covid-19	PROPN
easat-4163	82	14	,	,	PUNCT
easat-4163	82	15	but	but	CCONJ
easat-4163	82	16	further	further	ADJ
easat-4163	82	17	study	study	NOUN
easat-4163	82	18	is	be	AUX
easat-4163	82	19	required	require	VERB
easat-4163	82	20	to	to	PART
easat-4163	82	21	fully	fully	ADV
easat-4163	82	22	understand	understand	VERB
easat-4163	82	23	their	their	PRON
easat-4163	82	24	function	function	NOUN
easat-4163	82	25	.	.	PUNCT
easat-4163	83	1	3	3	X
easat-4163	83	2	.	.	X
easat-4163	83	3	pathophysiology	pathophysiology	NOUN
easat-4163	83	4	viral	viral	ADJ
easat-4163	83	5	pathogenesis	pathogenesis	NOUN
easat-4163	83	6	and	and	CCONJ
easat-4163	83	7	the	the	DET
easat-4163	83	8	host	host	NOUN
easat-4163	83	9	immune	immune	ADJ
easat-4163	83	10	response	response	NOUN
easat-4163	83	11	interact	interact	VERB
easat-4163	83	12	intricately	intricately	ADV
easat-4163	83	13	in	in	ADP
easat-4163	83	14	covid-19	covid-19	PROPN
easat-4163	83	15	-	-	PUNCT
easat-4163	83	16	associated	associate	VERB
easat-4163	83	17	coagulopathy	coagulopathy	ADJ
easat-4163	83	18	,	,	PUNCT
easat-4163	83	19	resulting	result	VERB
easat-4163	83	20	in	in	ADP
easat-4163	83	21	abnormal	abnormal	ADJ
easat-4163	83	22	coagulation	coagulation	NOUN
easat-4163	83	23	cascade	cascade	NOUN
easat-4163	83	24	activation	activation	NOUN
easat-4163	83	25	and	and	CCONJ
easat-4163	83	26	endothelial	endothelial	ADJ
easat-4163	83	27	dysfunction	dysfunction	NOUN
easat-4163	83	28	.	.	PUNCT
easat-4163	84	1	figure	figure	NOUN
easat-4163	84	2	2	2	NUM
easat-4163	84	3	.	.	PUNCT
easat-4163	84	4	mechanism	mechanism	NOUN
easat-4163	84	5	of	of	ADP
easat-4163	84	6	clot	clot	NOUN
easat-4163	84	7	formation	formation	NOUN
easat-4163	84	8	in	in	ADP
easat-4163	84	9	covid-19	covid-19	PROPN
easat-4163	84	10	associated	associate	VERB
easat-4163	84	11	endothelial	endothelial	ADJ
easat-4163	84	12	dysfunctions	dysfunction	NOUN
easat-4163	84	13	[	[	X
easat-4163	84	14	15	15	NUM
easat-4163	84	15	]	]	SYM
easat-4163	84	16	.	.	PUNCT
easat-4163	85	1	3.1	3.1	NUM
easat-4163	85	2	.	.	PUNCT
easat-4163	85	3	viral	viral	ADJ
easat-4163	85	4	entry	entry	NOUN
easat-4163	85	5	the	the	DET
easat-4163	85	6	angiotensin	angiotensin	NOUN
easat-4163	85	7	-	-	PUNCT
easat-4163	85	8	converting	convert	VERB
easat-4163	85	9	enzyme	enzyme	NOUN
easat-4163	85	10	2	2	NUM
easat-4163	85	11	(	(	PUNCT
easat-4163	85	12	ace2	ace2	NOUN
easat-4163	85	13	)	)	PUNCT
easat-4163	85	14	receptor	receptor	NOUN
easat-4163	85	15	,	,	PUNCT
easat-4163	85	16	which	which	PRON
easat-4163	85	17	is	be	AUX
easat-4163	85	18	found	find	VERB
easat-4163	85	19	on	on	ADP
easat-4163	85	20	respiratory	respiratory	ADJ
easat-4163	85	21	tract	tract	ADJ
easat-4163	85	22	epithelial	epithelial	ADJ
easat-4163	85	23	cells	cell	NOUN
easat-4163	85	24	,	,	PUNCT
easat-4163	85	25	endothelial	endothelial	ADJ
easat-4163	85	26	cells	cell	NOUN
easat-4163	85	27	,	,	PUNCT
easat-4163	85	28	and	and	CCONJ
easat-4163	85	29	other	other	ADJ
easat-4163	85	30	organs	organ	NOUN
easat-4163	85	31	,	,	PUNCT
easat-4163	85	32	is	be	AUX
easat-4163	85	33	the	the	DET
easat-4163	85	34	main	main	ADJ
easat-4163	85	35	way	way	NOUN
easat-4163	85	36	that	that	PRON
easat-4163	85	37	sars	sar	NOUN
easat-4163	85	38	-	-	PUNCT
easat-4163	85	39	cov-2	cov-2	NOUN
easat-4163	85	40	,	,	PUNCT
easat-4163	85	41	the	the	DET
easat-4163	85	42	virus	virus	NOUN
easat-4163	85	43	that	that	PRON
easat-4163	85	44	causes	cause	VERB
easat-4163	85	45	covid-19	covid-19	PROPN
easat-4163	85	46	,	,	PUNCT
easat-4163	85	47	penetrates	penetrate	VERB
easat-4163	85	48	human	human	ADJ
easat-4163	85	49	cells	cell	NOUN
easat-4163	85	50	.	.	PUNCT
easat-4163	86	1	cell	cell	NOUN
easat-4163	86	2	death	death	NOUN
easat-4163	86	3	,	,	PUNCT
easat-4163	86	4	immune	immune	ADJ
easat-4163	86	5	response	response	NOUN
easat-4163	86	6	activation	activation	NOUN
easat-4163	86	7	,	,	PUNCT
easat-4163	86	8	and	and	CCONJ
easat-4163	86	9	the	the	DET
easat-4163	86	10	production	production	NOUN
easat-4163	86	11	of	of	ADP
easat-4163	86	12	inflammatory	inflammatory	ADJ
easat-4163	86	13	mediators	mediator	NOUN
easat-4163	86	14	are	be	AUX
easat-4163	86	15	all	all	PRON
easat-4163	86	16	consequences	consequence	NOUN
easat-4163	86	17	of	of	ADP
easat-4163	86	18	viral	viral	ADJ
easat-4163	86	19	invasion	invasion	NOUN
easat-4163	86	20	[	[	X
easat-4163	86	21	5	5	NUM
easat-4163	86	22	]	]	PUNCT
easat-4163	86	23	.	.	PUNCT
easat-4163	87	1	3.2	3.2	NUM
easat-4163	87	2	.	.	PUNCT
easat-4163	88	1	inflammatory	inflammatory	ADJ
easat-4163	88	2	response	response	NOUN
easat-4163	88	3	and	and	CCONJ
easat-4163	88	4	cytokine	cytokine	NOUN
easat-4163	88	5	storm	storm	NOUN
easat-4163	88	6	a	a	DET
easat-4163	88	7	cytokine	cytokine	NOUN
easat-4163	88	8	storm	storm	NOUN
easat-4163	88	9	—	—	PUNCT
easat-4163	88	10	an	an	DET
easat-4163	88	11	excessive	excessive	ADJ
easat-4163	88	12	immune	immune	ADJ
easat-4163	88	13	response	response	NOUN
easat-4163	88	14	that	that	PRON
easat-4163	88	15	involves	involve	VERB
easat-4163	88	16	the	the	DET
easat-4163	88	17	production	production	NOUN
easat-4163	88	18	of	of	ADP
easat-4163	88	19	pro	pro	ADJ
easat-4163	88	20	-	-	ADJ
easat-4163	88	21	inflammatory	inflammatory	ADJ
easat-4163	88	22	cytokines	cytokine	NOUN
easat-4163	88	23	including	include	VERB
easat-4163	88	24	interleukin-6	interleukin-6	NUM
easat-4163	88	25	and	and	CCONJ
easat-4163	88	26	tumour	tumour	NOUN
easat-4163	88	27	necrosis	necrosis	NOUN
easat-4163	88	28	factor	factor	NOUN
easat-4163	88	29	-	-	PUNCT
easat-4163	88	30	alpha	alpha	NOUN
easat-4163	88	31	—	—	PUNCT
easat-4163	88	32	is	be	AUX
easat-4163	88	33	frequently	frequently	ADV
easat-4163	88	34	a	a	DET
easat-4163	88	35	defining	define	VERB
easat-4163	88	36	feature	feature	NOUN
easat-4163	88	37	of	of	ADP
easat-4163	88	38	severe	severe	ADJ
easat-4163	88	39	covid-19	covid-19	PROPN
easat-4163	88	40	patients	patient	NOUN
easat-4163	88	41	.	.	PUNCT
easat-4163	89	1	the	the	DET
easat-4163	89	2	equilibrium	equilibrium	NOUN
easat-4163	89	3	between	between	ADP
easat-4163	89	4	procoagulant	procoagulant	NOUN
easat-4163	89	5	and	and	CCONJ
easat-4163	89	6	anticoagulant	anticoagulant	ADJ
easat-4163	89	7	factors	factor	NOUN
easat-4163	89	8	is	be	AUX
easat-4163	89	9	upset	upset	VERB
easat-4163	89	10	by	by	ADP
easat-4163	89	11	the	the	DET
easat-4163	89	12	cytokine	cytokine	NOUN
easat-4163	89	13	storm	storm	NOUN
easat-4163	89	14	,	,	PUNCT
easat-4163	89	15	which	which	PRON
easat-4163	89	16	also	also	ADV
easat-4163	89	17	causes	cause	VERB
easat-4163	89	18	endothelial	endothelial	ADJ
easat-4163	89	19	activation	activation	NOUN
easat-4163	89	20	and	and	CCONJ
easat-4163	89	21	extensive	extensive	ADJ
easat-4163	89	22	inflammation	inflammation	NOUN
easat-4163	89	23	[	[	X
easat-4163	89	24	16	16	NUM
easat-4163	89	25	]	]	PUNCT
easat-4163	89	26	.	.	PUNCT
easat-4163	90	1	3.3	3.3	NUM
easat-4163	90	2	.	.	PUNCT
easat-4163	91	1	endothelial	endothelial	ADJ
easat-4163	91	2	dysfunction	dysfunction	NOUN
easat-4163	91	3	endothelial	endothelial	ADJ
easat-4163	91	4	dysfunction	dysfunction	NOUN
easat-4163	91	5	and	and	CCONJ
easat-4163	91	6	activation	activation	NOUN
easat-4163	91	7	can	can	AUX
easat-4163	91	8	result	result	VERB
easat-4163	91	9	from	from	ADP
easat-4163	91	10	direct	direct	ADJ
easat-4163	91	11	endothelial	endothelial	ADJ
easat-4163	91	12	cell	cell	NOUN
easat-4163	91	13	infection	infection	NOUN
easat-4163	91	14	by	by	ADP
easat-4163	91	15	sarscov-2	sarscov-2	PROPN
easat-4163	91	16	.	.	PUNCT
easat-4163	92	1	increased	increase	VERB
easat-4163	92	2	production	production	NOUN
easat-4163	92	3	of	of	ADP
easat-4163	92	4	adhesion	adhesion	NOUN
easat-4163	92	5	molecules	molecule	NOUN
easat-4163	92	6	,	,	PUNCT
easat-4163	92	7	pro	pro	ADJ
easat-4163	92	8	-	-	ADJ
easat-4163	92	9	inflammatory	inflammatory	ADJ
easat-4163	92	10	cytokines	cytokine	NOUN
easat-4163	92	11	,	,	PUNCT
easat-4163	92	12	and	and	CCONJ
easat-4163	92	13	tissue	tissue	NOUN
easat-4163	92	14	factor	factor	NOUN
easat-4163	92	15	,	,	PUNCT
easat-4163	92	16	which	which	PRON
easat-4163	92	17	promote	promote	VERB
easat-4163	92	18	a	a	DET
easat-4163	92	19	pro	pro	ADJ
easat-4163	92	20	-	-	ADJ
easat-4163	92	21	thrombotic	thrombotic	ADJ
easat-4163	92	22	state	state	NOUN
easat-4163	92	23	,	,	PUNCT
easat-4163	92	24	are	be	AUX
easat-4163	92	25	characteristics	characteristic	NOUN
easat-4163	92	26	of	of	ADP
easat-4163	92	27	endothelial	endothelial	ADJ
easat-4163	92	28	dysfunction	dysfunction	NOUN
easat-4163	92	29	[	[	X
easat-4163	92	30	17	17	NUM
easat-4163	92	31	]	]	PUNCT
easat-4163	92	32	.	.	PUNCT
easat-4163	93	1	509	509	NUM
easat-4163	93	2	edelweiss	edelweiss	PROPN
easat-4163	93	3	applied	apply	VERB
easat-4163	93	4	science	science	NOUN
easat-4163	93	5	and	and	CCONJ
easat-4163	93	6	technology	technology	NOUN
easat-4163	93	7	issn	issn	PROPN
easat-4163	93	8	:	:	PUNCT
easat-4163	93	9	2576	2576	NUM
easat-4163	93	10	-	-	SYM
easat-4163	93	11	8484	8484	NUM
easat-4163	93	12	vol	vol	NOUN
easat-4163	93	13	.	.	PROPN
easat-4163	94	1	9	9	NUM
easat-4163	94	2	,	,	PUNCT
easat-4163	94	3	no	no	INTJ
easat-4163	94	4	.	.	NOUN
easat-4163	94	5	1	1	NUM
easat-4163	94	6	:	:	PUNCT
easat-4163	94	7	505	505	NUM
easat-4163	94	8	-	-	SYM
easat-4163	94	9	514	514	NUM
easat-4163	94	10	,	,	PUNCT
easat-4163	94	11	2025	2025	NUM
easat-4163	94	12	doi	doi	NOUN
easat-4163	94	13	:	:	PUNCT
easat-4163	94	14	10.55214/25768484.v9i1.4163	10.55214/25768484.v9i1.4163	NUM
easat-4163	94	15	©	©	PROPN
easat-4163	94	16	2025	2025	NUM
easat-4163	94	17	by	by	ADP
easat-4163	94	18	the	the	DET
easat-4163	94	19	authors	author	NOUN
easat-4163	94	20	;	;	PUNCT
easat-4163	94	21	licensee	licensee	PROPN
easat-4163	94	22	learning	learning	NOUN
easat-4163	94	23	gate	gate	NOUN
easat-4163	94	24	3.4	3.4	NUM
easat-4163	94	25	.	.	PUNCT
easat-4163	95	1	activation	activation	NOUN
easat-4163	95	2	of	of	ADP
easat-4163	95	3	coagulation	coagulation	NOUN
easat-4163	95	4	cascade	cascade	NOUN
easat-4163	95	5	when	when	SCONJ
easat-4163	95	6	the	the	DET
easat-4163	95	7	coagulation	coagulation	NOUN
easat-4163	95	8	cascade	cascade	NOUN
easat-4163	95	9	is	be	AUX
easat-4163	95	10	activated	activate	VERB
easat-4163	95	11	by	by	ADP
easat-4163	95	12	endothelial	endothelial	ADJ
easat-4163	95	13	dysfunction	dysfunction	NOUN
easat-4163	95	14	and	and	CCONJ
easat-4163	95	15	systemic	systemic	ADJ
easat-4163	95	16	inflammation	inflammation	NOUN
easat-4163	95	17	,	,	PUNCT
easat-4163	95	18	more	more	ADJ
easat-4163	95	19	fibrinogen	fibrinogen	NOUN
easat-4163	95	20	,	,	PUNCT
easat-4163	95	21	fibrin	fibrin	NOUN
easat-4163	95	22	,	,	PUNCT
easat-4163	95	23	and	and	CCONJ
easat-4163	95	24	von	von	PROPN
easat-4163	95	25	willebrand	willebrand	NOUN
easat-4163	95	26	factor	factor	NOUN
easat-4163	95	27	are	be	AUX
easat-4163	95	28	produced	produce	VERB
easat-4163	95	29	,	,	PUNCT
easat-4163	95	30	which	which	PRON
easat-4163	95	31	encourages	encourage	VERB
easat-4163	95	32	the	the	DET
easat-4163	95	33	development	development	NOUN
easat-4163	95	34	of	of	ADP
easat-4163	95	35	microthrombi	microthrombi	NOUN
easat-4163	95	36	in	in	ADP
easat-4163	95	37	tiny	tiny	ADJ
easat-4163	95	38	blood	blood	NOUN
easat-4163	95	39	vessels	vessel	NOUN
easat-4163	95	40	[	[	X
easat-4163	95	41	18	18	NUM
easat-4163	95	42	]	]	PUNCT
easat-4163	95	43	.	.	PUNCT
easat-4163	96	1	3.5	3.5	NUM
easat-4163	96	2	.	.	PUNCT
easat-4163	97	1	platelet	platelet	NOUN
easat-4163	97	2	activation	activation	NOUN
easat-4163	97	3	and	and	CCONJ
easat-4163	97	4	aggregation	aggregation	NOUN
easat-4163	97	5	covid-19	covid-19	PROPN
easat-4163	97	6	can	can	AUX
easat-4163	97	7	induce	induce	VERB
easat-4163	97	8	platelet	platelet	NOUN
easat-4163	97	9	activation	activation	NOUN
easat-4163	97	10	and	and	CCONJ
easat-4163	97	11	aggregation	aggregation	NOUN
easat-4163	97	12	through	through	ADP
easat-4163	97	13	various	various	ADJ
easat-4163	97	14	mechanisms	mechanism	NOUN
easat-4163	97	15	,	,	PUNCT
easat-4163	97	16	including	include	VERB
easat-4163	97	17	direct	direct	ADJ
easat-4163	97	18	viral	viral	ADJ
easat-4163	97	19	effects	effect	NOUN
easat-4163	97	20	and	and	CCONJ
easat-4163	97	21	inflammatory	inflammatory	ADJ
easat-4163	97	22	mediators	mediator	NOUN
easat-4163	97	23	.	.	PUNCT
easat-4163	98	1	activated	activate	VERB
easat-4163	98	2	platelets	platelet	NOUN
easat-4163	98	3	release	release	NOUN
easat-4163	98	4	pro	pro	ADJ
easat-4163	98	5	-	-	ADJ
easat-4163	98	6	thrombotic	thrombotic	ADJ
easat-4163	98	7	factors	factor	NOUN
easat-4163	98	8	,	,	PUNCT
easat-4163	98	9	further	far	ADV
easat-4163	98	10	contributing	contribute	VERB
easat-4163	98	11	to	to	PART
easat-4163	98	12	thrombus	thrombus	VERB
easat-4163	98	13	formation	formation	NOUN
easat-4163	98	14	and	and	CCONJ
easat-4163	98	15	vascular	vascular	ADJ
easat-4163	98	16	complications	complication	NOUN
easat-4163	98	17	.	.	PUNCT
easat-4163	99	1	the	the	DET
easat-4163	99	2	microthrombi	microthrombi	NOUN
easat-4163	99	3	formation	formation	NOUN
easat-4163	99	4	in	in	ADP
easat-4163	99	5	small	small	ADJ
easat-4163	99	6	vessels	vessel	NOUN
easat-4163	99	7	contributes	contribute	VERB
easat-4163	99	8	to	to	ADP
easat-4163	99	9	tissue	tissue	NOUN
easat-4163	99	10	ischemia	ischemia	NOUN
easat-4163	99	11	and	and	CCONJ
easat-4163	99	12	multi	multi	ADJ
easat-4163	99	13	-	-	ADJ
easat-4163	99	14	organ	organ	ADJ
easat-4163	99	15	dysfunction	dysfunction	NOUN
easat-4163	99	16	,	,	PUNCT
easat-4163	99	17	affecting	affect	VERB
easat-4163	99	18	the	the	DET
easat-4163	99	19	lungs	lung	NOUN
easat-4163	99	20	(	(	PUNCT
easat-4163	99	21	acute	acute	ADJ
easat-4163	99	22	respiratory	respiratory	ADJ
easat-4163	99	23	distress	distress	NOUN
easat-4163	99	24	syndrome	syndrome	NOUN
easat-4163	99	25	,	,	PUNCT
easat-4163	99	26	ards	ard	NOUN
easat-4163	99	27	)	)	PUNCT
easat-4163	99	28	,	,	PUNCT
easat-4163	99	29	heart	heart	NOUN
easat-4163	99	30	,	,	PUNCT
easat-4163	99	31	kidneys	kidney	NOUN
easat-4163	99	32	,	,	PUNCT
easat-4163	99	33	and	and	CCONJ
easat-4163	99	34	brain	brain	NOUN
easat-4163	99	35	[	[	X
easat-4163	99	36	19	19	NUM
easat-4163	99	37	]	]	PUNCT
easat-4163	99	38	.	.	PUNCT
easat-4163	100	1	3.6	3.6	NUM
easat-4163	100	2	.	.	PUNCT
easat-4163	101	1	antiphospholipid	antiphospholipid	NOUN
easat-4163	101	2	antibodies	antibody	NOUN
easat-4163	101	3	(	(	PUNCT
easat-4163	101	4	aplas	aplas	PROPN
easat-4163	101	5	)	)	PUNCT
easat-4163	101	6	some	some	DET
easat-4163	101	7	covid-19	covid-19	PROPN
easat-4163	101	8	patients	patient	NOUN
easat-4163	101	9	develop	develop	VERB
easat-4163	101	10	antiphospholipid	antiphospholipid	ADJ
easat-4163	101	11	antibodies	antibody	NOUN
easat-4163	101	12	,	,	PUNCT
easat-4163	101	13	which	which	PRON
easat-4163	101	14	can	can	AUX
easat-4163	101	15	contribute	contribute	VERB
easat-4163	101	16	to	to	ADP
easat-4163	101	17	thrombotic	thrombotic	ADJ
easat-4163	101	18	events	event	NOUN
easat-4163	101	19	.	.	PUNCT
easat-4163	102	1	aplas	apla	NOUN
easat-4163	102	2	interfere	interfere	VERB
easat-4163	102	3	with	with	ADP
easat-4163	102	4	phospholipid	phospholipid	NOUN
easat-4163	102	5	-	-	PUNCT
easat-4163	102	6	dependent	dependent	ADJ
easat-4163	102	7	coagulation	coagulation	NOUN
easat-4163	102	8	tests	test	NOUN
easat-4163	102	9	and	and	CCONJ
easat-4163	102	10	are	be	AUX
easat-4163	102	11	associated	associate	VERB
easat-4163	102	12	with	with	ADP
easat-4163	102	13	increased	increase	VERB
easat-4163	102	14	thrombotic	thrombotic	ADJ
easat-4163	102	15	risk	risk	NOUN
easat-4163	102	16	in	in	ADP
easat-4163	102	17	affected	affect	VERB
easat-4163	102	18	individuals	individual	NOUN
easat-4163	102	19	[	[	X
easat-4163	102	20	14	14	NUM
easat-4163	102	21	]	]	SYM
easat-4163	102	22	.	.	PUNCT
easat-4163	103	1	3.7	3.7	NUM
easat-4163	103	2	.	.	PUNCT
easat-4163	103	3	disseminated	disseminate	VERB
easat-4163	103	4	intravascular	intravascular	ADJ
easat-4163	103	5	coagulation	coagulation	NOUN
easat-4163	103	6	(	(	PUNCT
easat-4163	103	7	dic	dic	ADJ
easat-4163	103	8	)	)	PUNCT
easat-4163	103	9	in	in	ADP
easat-4163	103	10	extreme	extreme	ADJ
easat-4163	103	11	situations	situation	NOUN
easat-4163	103	12	,	,	PUNCT
easat-4163	103	13	covid-19	covid-19	PROPN
easat-4163	103	14	-	-	PUNCT
easat-4163	103	15	induced	induce	VERB
easat-4163	103	16	coagulopathy	coagulopathy	ADJ
easat-4163	103	17	may	may	AUX
easat-4163	103	18	develop	develop	VERB
easat-4163	103	19	into	into	ADP
easat-4163	103	20	dic	dic	PROPN
easat-4163	103	21	,	,	PUNCT
easat-4163	103	22	which	which	PRON
easat-4163	103	23	is	be	AUX
easat-4163	103	24	typified	typify	VERB
easat-4163	103	25	by	by	ADP
easat-4163	103	26	extensive	extensive	ADJ
easat-4163	103	27	coagulation	coagulation	NOUN
easat-4163	103	28	cascade	cascade	NOUN
easat-4163	103	29	activation	activation	NOUN
easat-4163	103	30	and	and	CCONJ
easat-4163	103	31	clotting	clotting	NOUN
easat-4163	103	32	factor	factor	NOUN
easat-4163	103	33	consumption	consumption	NOUN
easat-4163	103	34	.	.	PUNCT
easat-4163	104	1	dic	dic	ADJ
easat-4163	104	2	results	result	NOUN
easat-4163	104	3	in	in	ADP
easat-4163	104	4	both	both	CCONJ
easat-4163	104	5	thrombotic	thrombotic	ADJ
easat-4163	104	6	and	and	CCONJ
easat-4163	104	7	hemorrhagic	hemorrhagic	ADJ
easat-4163	104	8	complications	complication	NOUN
easat-4163	104	9	,	,	PUNCT
easat-4163	104	10	contributing	contribute	VERB
easat-4163	104	11	to	to	PART
easat-4163	104	12	multi	multi	ADJ
easat-4163	104	13	-	-	ADJ
easat-4163	104	14	organ	organ	ADJ
easat-4163	104	15	dysfunction	dysfunction	NOUN
easat-4163	104	16	and	and	CCONJ
easat-4163	104	17	poor	poor	ADJ
easat-4163	104	18	clinical	clinical	ADJ
easat-4163	104	19	outcomes	outcome	NOUN
easat-4163	104	20	[	[	X
easat-4163	104	21	20	20	NUM
easat-4163	104	22	]	]	PUNCT
easat-4163	104	23	.	.	PUNCT
easat-4163	105	1	figure	figure	NOUN
easat-4163	105	2	3	3	NUM
easat-4163	105	3	.	.	PUNCT
easat-4163	105	4	potential	potential	ADJ
easat-4163	105	5	causes	cause	NOUN
easat-4163	105	6	of	of	ADP
easat-4163	105	7	covid-19	covid-19	PROPN
easat-4163	105	8	thrombosis	thrombosis	NOUN
easat-4163	105	9	and	and	CCONJ
easat-4163	105	10	its	its	PRON
easat-4163	105	11	clinical	clinical	ADJ
easat-4163	105	12	implications	implication	NOUN
easat-4163	105	13	[	[	X
easat-4163	105	14	21	21	NUM
easat-4163	105	15	]	]	PUNCT
easat-4163	105	16	.	.	PUNCT
easat-4163	106	1	4	4	X
easat-4163	106	2	.	.	X
easat-4163	106	3	clinical	clinical	ADJ
easat-4163	106	4	manifestation	manifestation	NOUN
easat-4163	106	5	(	(	PUNCT
easat-4163	106	6	a	a	X
easat-4163	106	7	)	)	PUNCT
easat-4163	106	8	diffuse	diffuse	NOUN
easat-4163	106	9	endotheliitis	endotheliitis	PROPN
easat-4163	106	10	is	be	AUX
easat-4163	106	11	believed	believe	VERB
easat-4163	106	12	to	to	PART
easat-4163	106	13	result	result	VERB
easat-4163	106	14	from	from	ADP
easat-4163	106	15	endothelium	endothelium	NOUN
easat-4163	106	16	damage	damage	NOUN
easat-4163	106	17	brought	bring	VERB
easat-4163	106	18	on	on	ADP
easat-4163	106	19	by	by	ADP
easat-4163	106	20	the	the	DET
easat-4163	106	21	entrance	entrance	NOUN
easat-4163	106	22	of	of	ADP
easat-4163	106	23	the	the	DET
easat-4163	106	24	severe	severe	ADJ
easat-4163	106	25	acute	acute	ADJ
easat-4163	106	26	respiratory	respiratory	ADJ
easat-4163	106	27	syndrome	syndrome	NOUN
easat-4163	106	28	coronavirus	coronavirus	NOUN
easat-4163	106	29	2	2	NUM
easat-4163	106	30	(	(	PUNCT
easat-4163	106	31	sars	sar	NOUN
easat-4163	106	32	-	-	PUNCT
easat-4163	106	33	cov-2	cov-2	NOUN
easat-4163	106	34	)	)	PUNCT
easat-4163	106	35	into	into	ADP
easat-4163	106	36	cells	cell	NOUN
easat-4163	106	37	through	through	ADP
easat-4163	106	38	the	the	DET
easat-4163	106	39	angiotensin	angiotensin	NOUN
easat-4163	106	40	-	-	PUNCT
easat-4163	106	41	converting	convert	VERB
easat-4163	106	42	enzyme	enzyme	NOUN
easat-4163	106	43	2	2	NUM
easat-4163	106	44	(	(	PUNCT
easat-4163	106	45	ace2	ace2	NOUN
easat-4163	106	46	)	)	PUNCT
easat-4163	106	47	receptor	receptor	NOUN
easat-4163	106	48	.	.	PUNCT
easat-4163	107	1	the	the	DET
easat-4163	107	2	inflammatory	inflammatory	ADJ
easat-4163	107	3	host	host	NOUN
easat-4163	107	4	response	response	NOUN
easat-4163	107	5	brought	bring	VERB
easat-4163	107	6	on	on	ADP
easat-4163	107	7	by	by	ADP
easat-4163	107	8	endothelial	endothelial	ADJ
easat-4163	107	9	injury	injury	NOUN
easat-4163	107	10	may	may	AUX
easat-4163	107	11	be	be	AUX
easat-4163	107	12	typified	typify	VERB
easat-4163	107	13	by	by	ADP
easat-4163	107	14	a	a	DET
easat-4163	107	15	cytokine	cytokine	ADJ
easat-4163	107	16	storm	storm	NOUN
easat-4163	107	17	and	and	CCONJ
easat-4163	107	18	excessive	excessive	ADJ
easat-4163	107	19	immunological	immunological	ADJ
easat-4163	107	20	activation	activation	NOUN
easat-4163	107	21	,	,	PUNCT
easat-4163	107	22	which	which	PRON
easat-4163	107	23	encourages	encourage	VERB
easat-4163	107	24	thrombosis	thrombosis	NOUN
easat-4163	107	25	and	and	CCONJ
easat-4163	107	26	hypercoagulability	hypercoagulability	NOUN
easat-4163	107	27	.	.	PUNCT
easat-4163	108	1	(	(	PUNCT
easat-4163	108	2	b	b	NOUN
easat-4163	108	3	):	):	PUNCT
easat-4163	108	4	potential	potential	ADJ
easat-4163	108	5	covid-19	covid-19	PROPN
easat-4163	108	6	-	-	PUNCT
easat-4163	108	7	related	relate	VERB
easat-4163	108	8	venous	venous	ADJ
easat-4163	108	9	and	and	CCONJ
easat-4163	108	10	arterial	arterial	ADJ
easat-4163	108	11	thrombotic	thrombotic	ADJ
easat-4163	108	12	consequences	consequence	NOUN
easat-4163	108	13	.	.	PUNCT
easat-4163	109	1	note	note	NOUN
easat-4163	109	2	:	:	PUNCT
easat-4163	109	3	tf	tf	PROPN
easat-4163	109	4	stands	stand	VERB
easat-4163	109	5	for	for	ADP
easat-4163	109	6	tissue	tissue	NOUN
easat-4163	109	7	factor	factor	NOUN
easat-4163	109	8	,	,	PUNCT
easat-4163	109	9	tnf	tnf	PROPN
easat-4163	109	10	for	for	ADP
easat-4163	109	11	tumour	tumour	NOUN
easat-4163	109	12	necrosis	necrosis	NOUN
easat-4163	109	13	factor	factor	NOUN
easat-4163	109	14	α	α	NOUN
easat-4163	109	15	,	,	PUNCT
easat-4163	109	16	pe	pe	X
easat-4163	109	17	for	for	ADP
easat-4163	109	18	pulmonary	pulmonary	ADJ
easat-4163	109	19	embolism	embolism	NOUN
easat-4163	109	20	,	,	PUNCT
easat-4163	109	21	il-6	il-6	NOUN
easat-4163	109	22	for	for	ADP
easat-4163	109	23	interleukin	interleukin	NOUN
easat-4163	109	24	6	6	NUM
easat-4163	109	25	,	,	PUNCT
easat-4163	109	26	dvt	dvt	PROPN
easat-4163	109	27	for	for	ADP
easat-4163	109	28	deep	deep	ADJ
easat-4163	109	29	vein	vein	NOUN
easat-4163	109	30	thrombosis	thrombosis	NOUN
easat-4163	109	31	,	,	PUNCT
easat-4163	109	32	and	and	CCONJ
easat-4163	109	33	fviia	fviia	VERB
easat-4163	109	34	for	for	ADP
easat-4163	109	35	factor	factor	NOUN
easat-4163	109	36	viia	viia	NOUN
easat-4163	109	37	.	.	PUNCT
easat-4163	110	1	4.1	4.1	NUM
easat-4163	110	2	.	.	PUNCT
easat-4163	111	1	deep	deep	ADJ
easat-4163	111	2	vein	vein	ADJ
easat-4163	111	3	thrombosis	thrombosis	NOUN
easat-4163	111	4	(	(	PUNCT
easat-4163	111	5	dvt	dvt	PROPN
easat-4163	111	6	)	)	PUNCT
easat-4163	111	7	because	because	SCONJ
easat-4163	111	8	of	of	ADP
easat-4163	111	9	their	their	PRON
easat-4163	111	10	immobility	immobility	NOUN
easat-4163	111	11	and	and	CCONJ
easat-4163	111	12	hypercoagulable	hypercoagulable	ADJ
easat-4163	111	13	status	status	NOUN
easat-4163	111	14	,	,	PUNCT
easat-4163	111	15	covid-19	covid-19	PROPN
easat-4163	111	16	patients	patient	NOUN
easat-4163	111	17	are	be	AUX
easat-4163	111	18	more	more	ADV
easat-4163	111	19	likely	likely	ADJ
easat-4163	111	20	to	to	PART
easat-4163	111	21	develop	develop	VERB
easat-4163	111	22	dvt	dvt	PROPN
easat-4163	111	23	,	,	PUNCT
easat-4163	111	24	especially	especially	ADV
easat-4163	111	25	in	in	ADP
easat-4163	111	26	the	the	DET
easat-4163	111	27	lower	low	ADJ
easat-4163	111	28	extremities	extremity	NOUN
easat-4163	111	29	[	[	X
easat-4163	111	30	22	22	NUM
easat-4163	111	31	]	]	PUNCT
easat-4163	111	32	.	.	PUNCT
easat-4163	112	1	510	510	NUM
easat-4163	112	2	edelweiss	edelweiss	PROPN
easat-4163	112	3	applied	apply	VERB
easat-4163	112	4	science	science	NOUN
easat-4163	112	5	and	and	CCONJ
easat-4163	112	6	technology	technology	NOUN
easat-4163	112	7	issn	issn	PROPN
easat-4163	112	8	:	:	PUNCT
easat-4163	112	9	2576	2576	NUM
easat-4163	112	10	-	-	SYM
easat-4163	112	11	8484	8484	NUM
easat-4163	112	12	vol	vol	NOUN
easat-4163	112	13	.	.	PROPN
easat-4163	113	1	9	9	NUM
easat-4163	113	2	,	,	PUNCT
easat-4163	113	3	no	no	INTJ
easat-4163	113	4	.	.	NOUN
easat-4163	113	5	1	1	NUM
easat-4163	113	6	:	:	PUNCT
easat-4163	113	7	505	505	NUM
easat-4163	113	8	-	-	SYM
easat-4163	113	9	514	514	NUM
easat-4163	113	10	,	,	PUNCT
easat-4163	113	11	2025	2025	NUM
easat-4163	113	12	doi	doi	NOUN
easat-4163	113	13	:	:	PUNCT
easat-4163	113	14	10.55214/25768484.v9i1.4163	10.55214/25768484.v9i1.4163	NUM
easat-4163	113	15	©	©	PROPN
easat-4163	113	16	2025	2025	NUM
easat-4163	113	17	by	by	ADP
easat-4163	113	18	the	the	DET
easat-4163	113	19	authors	author	NOUN
easat-4163	113	20	;	;	PUNCT
easat-4163	113	21	licensee	licensee	PROPN
easat-4163	113	22	learning	learning	NOUN
easat-4163	113	23	gate	gate	VERB
easat-4163	113	24	4.2	4.2	NUM
easat-4163	113	25	.	.	PUNCT
easat-4163	114	1	pulmonary	pulmonary	ADJ
easat-4163	114	2	embolism	embolism	NOUN
easat-4163	114	3	(	(	PUNCT
easat-4163	114	4	pe	pe	INTJ
easat-4163	114	5	)	)	PUNCT
easat-4163	114	6	this	this	PRON
easat-4163	114	7	is	be	AUX
easat-4163	114	8	a	a	DET
easat-4163	114	9	serious	serious	ADJ
easat-4163	114	10	complication	complication	NOUN
easat-4163	114	11	where	where	SCONJ
easat-4163	114	12	thrombi	thrombi	NOUN
easat-4163	114	13	from	from	ADP
easat-4163	114	14	peripheral	peripheral	ADJ
easat-4163	114	15	veins	vein	NOUN
easat-4163	114	16	migrate	migrate	VERB
easat-4163	114	17	to	to	ADP
easat-4163	114	18	the	the	DET
easat-4163	114	19	lungs	lung	NOUN
easat-4163	114	20	,	,	PUNCT
easat-4163	114	21	causing	cause	VERB
easat-4163	114	22	potentially	potentially	ADV
easat-4163	114	23	life	life	NOUN
easat-4163	114	24	-	-	PUNCT
easat-4163	114	25	threatening	threaten	VERB
easat-4163	114	26	respiratory	respiratory	ADJ
easat-4163	114	27	distress	distress	NOUN
easat-4163	114	28	[	[	X
easat-4163	114	29	22	22	NUM
easat-4163	114	30	]	]	PUNCT
easat-4163	114	31	.	.	PUNCT
easat-4163	115	1	4.3	4.3	NUM
easat-4163	115	2	.	.	PUNCT
easat-4163	115	3	disseminated	disseminate	VERB
easat-4163	115	4	intravascular	intravascular	ADJ
easat-4163	115	5	coagulation	coagulation	NOUN
easat-4163	115	6	(	(	PUNCT
easat-4163	115	7	dic	dic	ADJ
easat-4163	115	8	)	)	PUNCT
easat-4163	115	9	widespread	widespread	ADJ
easat-4163	115	10	clotting	clotting	NOUN
easat-4163	115	11	cascade	cascade	NOUN
easat-4163	115	12	activation	activation	NOUN
easat-4163	115	13	,	,	PUNCT
easat-4163	115	14	which	which	PRON
easat-4163	115	15	results	result	VERB
easat-4163	115	16	in	in	ADP
easat-4163	115	17	thrombosis	thrombosis	NOUN
easat-4163	115	18	and	and	CCONJ
easat-4163	115	19	clotting	clotting	NOUN
easat-4163	115	20	factor	factor	NOUN
easat-4163	115	21	consumption	consumption	NOUN
easat-4163	115	22	,	,	PUNCT
easat-4163	115	23	is	be	AUX
easat-4163	115	24	a	a	DET
easat-4163	115	25	hallmark	hallmark	NOUN
easat-4163	115	26	of	of	ADP
easat-4163	115	27	covid-19	covid-19	PROPN
easat-4163	115	28	-	-	PUNCT
easat-4163	115	29	induced	induce	VERB
easat-4163	115	30	dic	dic	NOUN
easat-4163	115	31	.	.	PUNCT
easat-4163	116	1	the	the	DET
easat-4163	116	2	systemic	systemic	ADJ
easat-4163	116	3	aspect	aspect	NOUN
easat-4163	116	4	of	of	ADP
easat-4163	116	5	dic	dic	PROPN
easat-4163	116	6	is	be	AUX
easat-4163	116	7	reflected	reflect	VERB
easat-4163	116	8	in	in	ADP
easat-4163	116	9	the	the	DET
easat-4163	116	10	manifestations	manifestation	NOUN
easat-4163	116	11	,	,	PUNCT
easat-4163	116	12	which	which	PRON
easat-4163	116	13	include	include	VERB
easat-4163	116	14	thrombotic	thrombotic	ADJ
easat-4163	116	15	events	event	NOUN
easat-4163	116	16	and	and	CCONJ
easat-4163	116	17	bleeding	bleed	VERB
easat-4163	116	18	tendencies	tendency	NOUN
easat-4163	116	19	[	[	X
easat-4163	116	20	20	20	NUM
easat-4163	116	21	]	]	PUNCT
easat-4163	116	22	.	.	PUNCT
easat-4163	117	1	4.4	4.4	NUM
easat-4163	117	2	.	.	PUNCT
easat-4163	117	3	microvascular	microvascular	ADJ
easat-4163	117	4	thrombosis	thrombosis	NOUN
easat-4163	117	5	microthrombi	microthrombi	NOUN
easat-4163	117	6	can	can	AUX
easat-4163	117	7	form	form	VERB
easat-4163	117	8	in	in	ADP
easat-4163	117	9	tiny	tiny	ADJ
easat-4163	117	10	blood	blood	NOUN
easat-4163	117	11	arteries	artery	NOUN
easat-4163	117	12	all	all	ADV
easat-4163	117	13	throughout	throughout	ADP
easat-4163	117	14	the	the	DET
easat-4163	117	15	body	body	NOUN
easat-4163	117	16	as	as	ADP
easat-4163	117	17	a	a	DET
easat-4163	117	18	result	result	NOUN
easat-4163	117	19	of	of	ADP
easat-4163	117	20	covid-19	covid-19	PROPN
easat-4163	117	21	,	,	PUNCT
easat-4163	117	22	which	which	PRON
easat-4163	117	23	can	can	AUX
easat-4163	117	24	lead	lead	VERB
easat-4163	117	25	to	to	ADP
easat-4163	117	26	multi	multi	ADJ
easat-4163	117	27	-	-	ADJ
easat-4163	117	28	organ	organ	ADJ
easat-4163	117	29	dysfunction	dysfunction	NOUN
easat-4163	117	30	.	.	PUNCT
easat-4163	118	1	this	this	PRON
easat-4163	118	2	can	can	AUX
easat-4163	118	3	lead	lead	VERB
easat-4163	118	4	to	to	ADP
easat-4163	118	5	complications	complication	NOUN
easat-4163	118	6	such	such	ADJ
easat-4163	118	7	as	as	ADP
easat-4163	118	8	renal	renal	ADJ
easat-4163	118	9	impairment	impairment	NOUN
easat-4163	118	10	,	,	PUNCT
easat-4163	118	11	hepatic	hepatic	ADJ
easat-4163	118	12	dysfunction	dysfunction	NOUN
easat-4163	118	13	,	,	PUNCT
easat-4163	118	14	and	and	CCONJ
easat-4163	118	15	neurological	neurological	ADJ
easat-4163	118	16	deficits	deficit	NOUN
easat-4163	118	17	due	due	ADJ
easat-4163	118	18	to	to	ADP
easat-4163	118	19	impaired	impaired	ADJ
easat-4163	118	20	blood	blood	NOUN
easat-4163	118	21	flow	flow	NOUN
easat-4163	118	22	in	in	ADP
easat-4163	118	23	affected	affected	ADJ
easat-4163	118	24	organs	organ	NOUN
easat-4163	118	25	[	[	X
easat-4163	118	26	10	10	NUM
easat-4163	118	27	]	]	PUNCT
easat-4163	118	28	.	.	PUNCT
easat-4163	119	1	4.5	4.5	NUM
easat-4163	119	2	.	.	PUNCT
easat-4163	120	1	stroke	stroke	NOUN
easat-4163	120	2	and	and	CCONJ
easat-4163	120	3	cardiovascular	cardiovascular	ADJ
easat-4163	120	4	complications	complication	NOUN
easat-4163	120	5	large	large	ADJ
easat-4163	120	6	vascular	vascular	ADJ
easat-4163	120	7	occlusion	occlusion	NOUN
easat-4163	120	8	or	or	CCONJ
easat-4163	120	9	small	small	ADJ
easat-4163	120	10	vessel	vessel	NOUN
easat-4163	120	11	disease	disease	NOUN
easat-4163	120	12	brought	bring	VERB
easat-4163	120	13	on	on	ADP
easat-4163	120	14	by	by	ADP
easat-4163	120	15	coagulation	coagulation	NOUN
easat-4163	120	16	disorders	disorder	NOUN
easat-4163	120	17	can	can	AUX
easat-4163	120	18	cause	cause	VERB
easat-4163	120	19	ischaemic	ischaemic	ADJ
easat-4163	120	20	strokes	stroke	NOUN
easat-4163	120	21	in	in	ADP
easat-4163	120	22	covid-19	covid-19	PROPN
easat-4163	120	23	patients	patient	NOUN
easat-4163	120	24	.	.	PUNCT
easat-4163	121	1	arrhythmias	arrhythmia	NOUN
easat-4163	121	2	and	and	CCONJ
easat-4163	121	3	myocardial	myocardial	ADJ
easat-4163	121	4	damage	damage	NOUN
easat-4163	121	5	are	be	AUX
easat-4163	121	6	also	also	ADV
easat-4163	121	7	possible	possible	ADJ
easat-4163	121	8	,	,	PUNCT
easat-4163	121	9	which	which	PRON
easat-4163	121	10	in	in	ADP
easat-4163	121	11	extreme	extreme	ADJ
easat-4163	121	12	situations	situation	NOUN
easat-4163	121	13	may	may	AUX
easat-4163	121	14	exacerbate	exacerbate	VERB
easat-4163	121	15	cardiovascular	cardiovascular	ADJ
easat-4163	121	16	problems	problem	NOUN
easat-4163	121	17	[	[	X
easat-4163	121	18	23	23	NUM
easat-4163	121	19	]	]	PUNCT
easat-4163	121	20	.	.	PUNCT
easat-4163	122	1	4.6	4.6	NUM
easat-4163	122	2	.	.	PUNCT
easat-4163	123	1	skin	skin	NOUN
easat-4163	123	2	manifestations	manifestation	NOUN
easat-4163	123	3	cutaneous	cutaneous	ADJ
easat-4163	123	4	manifestations	manifestation	NOUN
easat-4163	123	5	such	such	ADJ
easat-4163	123	6	as	as	ADP
easat-4163	123	7	livedo	livedo	PROPN
easat-4163	123	8	reticularis	reticularis	PROPN
easat-4163	123	9	(	(	PUNCT
easat-4163	123	10	mottled	mottled	ADJ
easat-4163	123	11	discoloration	discoloration	NOUN
easat-4163	123	12	of	of	ADP
easat-4163	123	13	the	the	DET
easat-4163	123	14	skin	skin	NOUN
easat-4163	123	15	)	)	PUNCT
easat-4163	123	16	,	,	PUNCT
easat-4163	123	17	acral	acral	ADJ
easat-4163	123	18	ischemia	ischemia	NOUN
easat-4163	123	19	(	(	PUNCT
easat-4163	123	20	bluish	bluish	ADJ
easat-4163	123	21	discoloration	discoloration	NOUN
easat-4163	123	22	of	of	ADP
easat-4163	123	23	fingers	finger	NOUN
easat-4163	123	24	or	or	CCONJ
easat-4163	123	25	toes	toe	NOUN
easat-4163	123	26	)	)	PUNCT
easat-4163	123	27	,	,	PUNCT
easat-4163	123	28	and	and	CCONJ
easat-4163	123	29	petechiae	petechiae	NOUN
easat-4163	123	30	may	may	AUX
easat-4163	123	31	indicate	indicate	VERB
easat-4163	123	32	underlying	underlie	VERB
easat-4163	123	33	coagulation	coagulation	NOUN
easat-4163	123	34	abnormalities	abnormality	NOUN
easat-4163	123	35	[	[	X
easat-4163	123	36	24	24	NUM
easat-4163	123	37	]	]	PUNCT
easat-4163	123	38	.	.	PUNCT
easat-4163	124	1	4.7	4.7	NUM
easat-4163	124	2	.	.	PUNCT
easat-4163	125	1	elevated	elevated	ADJ
easat-4163	125	2	d	d	ADJ
easat-4163	125	3	-	-	PUNCT
easat-4163	125	4	dimer	dimer	ADJ
easat-4163	125	5	level	level	NOUN
easat-4163	125	6	in	in	ADP
easat-4163	125	7	covid-19	covid-19	PROPN
easat-4163	125	8	patients	patient	NOUN
easat-4163	125	9	,	,	PUNCT
easat-4163	125	10	elevated	elevated	ADJ
easat-4163	125	11	d	d	ADJ
easat-4163	125	12	-	-	PUNCT
easat-4163	125	13	dimer	dimer	ADJ
easat-4163	125	14	levels	level	NOUN
easat-4163	125	15	(	(	PUNCT
easat-4163	125	16	>	>	SYM
easat-4163	125	17	1	1	NUM
easat-4163	125	18	μg	μg	NOUN
easat-4163	125	19	/	/	SYM
easat-4163	125	20	ml	ml	NOUN
easat-4163	125	21	)	)	PUNCT
easat-4163	125	22	are	be	AUX
easat-4163	125	23	linked	link	VERB
easat-4163	125	24	to	to	ADP
easat-4163	125	25	a	a	DET
easat-4163	125	26	higher	high	ADJ
easat-4163	125	27	risk	risk	NOUN
easat-4163	125	28	of	of	ADP
easat-4163	125	29	thrombosis	thrombosis	NOUN
easat-4163	125	30	and	and	CCONJ
easat-4163	125	31	a	a	DET
easat-4163	125	32	more	more	ADV
easat-4163	125	33	severe	severe	ADJ
easat-4163	125	34	disease	disease	NOUN
easat-4163	125	35	.	.	PUNCT
easat-4163	126	1	d	d	X
easat-4163	126	2	-	-	PUNCT
easat-4163	126	3	dimer	dimer	NOUN
easat-4163	126	4	by	by	ADP
easat-4163	126	5	itself	itself	PRON
easat-4163	126	6	,	,	PUNCT
easat-4163	126	7	however	however	ADV
easat-4163	126	8	,	,	PUNCT
easat-4163	126	9	is	be	AUX
easat-4163	126	10	non	non	ADJ
easat-4163	126	11	-	-	ADJ
easat-4163	126	12	specific	specific	ADJ
easat-4163	126	13	and	and	CCONJ
easat-4163	126	14	may	may	AUX
easat-4163	126	15	also	also	ADV
easat-4163	126	16	be	be	AUX
easat-4163	126	17	raised	raise	VERB
easat-4163	126	18	under	under	ADP
easat-4163	126	19	other	other	ADJ
easat-4163	126	20	circumstances	circumstance	NOUN
easat-4163	126	21	.	.	PUNCT
easat-4163	127	1	4.8	4.8	NUM
easat-4163	127	2	.	.	PUNCT
easat-4163	128	1	prolonged	prolonged	ADJ
easat-4163	128	2	pt	pt	PROPN
easat-4163	128	3	/	/	SYM
easat-4163	128	4	pttk	pttk	ADJ
easat-4163	128	5	prolonged	prolong	VERB
easat-4163	128	6	pt	pt	NOUN
easat-4163	128	7	or	or	CCONJ
easat-4163	128	8	aptt	aptt	PROPN
easat-4163	128	9	may	may	AUX
easat-4163	128	10	indicate	indicate	VERB
easat-4163	128	11	deficiencies	deficiency	NOUN
easat-4163	128	12	in	in	ADP
easat-4163	128	13	clotting	clot	VERB
easat-4163	128	14	factors	factor	NOUN
easat-4163	128	15	or	or	CCONJ
easat-4163	128	16	the	the	DET
easat-4163	128	17	presence	presence	NOUN
easat-4163	128	18	of	of	ADP
easat-4163	128	19	anticoagulant	anticoagulant	ADJ
easat-4163	128	20	therapies	therapy	NOUN
easat-4163	128	21	.	.	PUNCT
easat-4163	129	1	in	in	ADP
easat-4163	129	2	covid-19	covid-19	PROPN
easat-4163	129	3	,	,	PUNCT
easat-4163	129	4	these	these	DET
easat-4163	129	5	tests	test	NOUN
easat-4163	129	6	may	may	AUX
easat-4163	129	7	be	be	AUX
easat-4163	129	8	prolonged	prolong	VERB
easat-4163	129	9	due	due	ADP
easat-4163	129	10	to	to	ADP
easat-4163	129	11	consumption	consumption	NOUN
easat-4163	129	12	of	of	ADP
easat-4163	129	13	clotting	clot	VERB
easat-4163	129	14	factors	factor	NOUN
easat-4163	129	15	in	in	ADP
easat-4163	129	16	dic	dic	ADJ
easat-4163	129	17	or	or	CCONJ
easat-4163	129	18	liver	liver	NOUN
easat-4163	129	19	dysfunction	dysfunction	NOUN
easat-4163	129	20	.	.	PUNCT
easat-4163	130	1	4.9	4.9	NUM
easat-4163	130	2	.	.	PUNCT
easat-4163	131	1	thrombocytopenia	thrombocytopenia	PROPN
easat-4163	131	2	thrombocytopenia	thrombocytopenia	PROPN
easat-4163	131	3	(	(	PUNCT
easat-4163	131	4	low	low	ADJ
easat-4163	131	5	platelet	platelet	NOUN
easat-4163	131	6	count	count	NOUN
easat-4163	131	7	)	)	PUNCT
easat-4163	131	8	in	in	ADP
easat-4163	131	9	covid-19	covid-19	PROPN
easat-4163	131	10	patients	patient	NOUN
easat-4163	131	11	can	can	AUX
easat-4163	131	12	indicate	indicate	VERB
easat-4163	131	13	dic	dic	ADJ
easat-4163	131	14	or	or	CCONJ
easat-4163	131	15	increased	increase	VERB
easat-4163	131	16	consumption	consumption	NOUN
easat-4163	131	17	due	due	ADP
easat-4163	131	18	to	to	ADP
easat-4163	131	19	systemic	systemic	ADJ
easat-4163	131	20	inflammation	inflammation	NOUN
easat-4163	131	21	and	and	CCONJ
easat-4163	131	22	microthrombi	microthrombi	NOUN
easat-4163	131	23	formation	formation	NOUN
easat-4163	131	24	.	.	PUNCT
easat-4163	132	1	4.10	4.10	NUM
easat-4163	132	2	.	.	PUNCT
easat-4163	132	3	elevated	elevated	ADJ
easat-4163	132	4	fibrinogen	fibrinogen	NOUN
easat-4163	132	5	level	level	NOUN
easat-4163	132	6	in	in	ADP
easat-4163	132	7	covid-19	covid-19	PROPN
easat-4163	132	8	individuals	individual	NOUN
easat-4163	132	9	,	,	PUNCT
easat-4163	132	10	elevated	elevated	ADJ
easat-4163	132	11	fibrinogen	fibrinogen	NOUN
easat-4163	132	12	levels	level	NOUN
easat-4163	132	13	are	be	AUX
easat-4163	132	14	linked	link	VERB
easat-4163	132	15	to	to	ADP
easat-4163	132	16	a	a	DET
easat-4163	132	17	hypercoagulable	hypercoagulable	ADJ
easat-4163	132	18	condition	condition	NOUN
easat-4163	132	19	and	and	CCONJ
easat-4163	132	20	may	may	AUX
easat-4163	132	21	be	be	AUX
easat-4163	132	22	a	a	DET
easat-4163	132	23	sign	sign	NOUN
easat-4163	132	24	of	of	ADP
easat-4163	132	25	thrombosis	thrombosis	NOUN
easat-4163	132	26	and	and	CCONJ
easat-4163	132	27	a	a	DET
easat-4163	132	28	continuing	continue	VERB
easat-4163	132	29	inflammatory	inflammatory	ADJ
easat-4163	132	30	response	response	NOUN
easat-4163	132	31	.	.	PUNCT
easat-4163	133	1	4.11	4.11	NUM
easat-4163	133	2	.	.	PUNCT
easat-4163	134	1	image	image	NOUN
easat-4163	134	2	studies	study	NOUN
easat-4163	134	3	pulmonary	pulmonary	ADJ
easat-4163	134	4	embolism	embolism	NOUN
easat-4163	134	5	and	and	CCONJ
easat-4163	134	6	deep	deep	ADJ
easat-4163	134	7	vein	vein	ADJ
easat-4163	134	8	thrombosis	thrombosis	NOUN
easat-4163	135	1	[	[	X
easat-4163	135	2	12	12	NUM
easat-4163	135	3	]	]	PUNCT
easat-4163	135	4	.	.	PUNCT
easat-4163	136	1	5	5	X
easat-4163	136	2	.	.	X
easat-4163	136	3	management	management	NOUN
easat-4163	136	4	effective	effective	ADJ
easat-4163	136	5	management	management	NOUN
easat-4163	136	6	involves	involve	VERB
easat-4163	136	7	a	a	DET
easat-4163	136	8	multifaceted	multifaceted	ADJ
easat-4163	136	9	approach	approach	NOUN
easat-4163	136	10	aimed	aim	VERB
easat-4163	136	11	at	at	ADP
easat-4163	136	12	preventing	prevent	VERB
easat-4163	136	13	thrombotic	thrombotic	ADJ
easat-4163	136	14	complications	complication	NOUN
easat-4163	136	15	while	while	SCONJ
easat-4163	136	16	minimizing	minimize	VERB
easat-4163	136	17	bleeding	bleed	VERB
easat-4163	136	18	risks	risk	NOUN
easat-4163	136	19	:	:	PUNCT
easat-4163	136	20	511	511	NUM
easat-4163	136	21	edelweiss	edelweiss	PROPN
easat-4163	136	22	applied	apply	VERB
easat-4163	136	23	science	science	NOUN
easat-4163	136	24	and	and	CCONJ
easat-4163	136	25	technology	technology	NOUN
easat-4163	136	26	issn	issn	PROPN
easat-4163	136	27	:	:	PUNCT
easat-4163	136	28	2576	2576	NUM
easat-4163	136	29	-	-	SYM
easat-4163	136	30	8484	8484	NUM
easat-4163	136	31	vol	vol	NOUN
easat-4163	136	32	.	.	PROPN
easat-4163	137	1	9	9	NUM
easat-4163	137	2	,	,	PUNCT
easat-4163	137	3	no	no	INTJ
easat-4163	137	4	.	.	NOUN
easat-4163	137	5	1	1	NUM
easat-4163	137	6	:	:	PUNCT
easat-4163	137	7	505	505	NUM
easat-4163	137	8	-	-	SYM
easat-4163	137	9	514	514	NUM
easat-4163	137	10	,	,	PUNCT
easat-4163	137	11	2025	2025	NUM
easat-4163	137	12	doi	doi	NOUN
easat-4163	137	13	:	:	PUNCT
easat-4163	137	14	10.55214/25768484.v9i1.4163	10.55214/25768484.v9i1.4163	NUM
easat-4163	137	15	©	©	PROPN
easat-4163	137	16	2025	2025	NUM
easat-4163	137	17	by	by	ADP
easat-4163	137	18	the	the	DET
easat-4163	137	19	authors	author	NOUN
easat-4163	137	20	;	;	PUNCT
easat-4163	137	21	licensee	licensee	PROPN
easat-4163	137	22	learning	learn	VERB
easat-4163	137	23	gate	gate	NOUN
easat-4163	137	24	figure	figure	NOUN
easat-4163	137	25	4	4	NUM
easat-4163	137	26	.	.	PUNCT
easat-4163	138	1	the	the	DET
easat-4163	138	2	covid-19	covid-19	PROPN
easat-4163	138	3	associated	associate	VERB
easat-4163	138	4	coagulopathy	coagulopathy	ADJ
easat-4163	138	5	management	management	NOUN
easat-4163	138	6	algorithm	algorithm	NOUN
easat-4163	138	7	.	.	PUNCT
easat-4163	139	1	lmwh	lmwh	NOUN
easat-4163	139	2	:	:	PUNCT
easat-4163	139	3	low	low	ADJ
easat-4163	139	4	molecular	molecular	ADJ
easat-4163	139	5	weight	weight	NOUN
easat-4163	139	6	heparin	heparin	NOUN
easat-4163	139	7	;	;	PUNCT
easat-4163	139	8	isth	isth	NOUN
easat-4163	139	9	:	:	PUNCT
easat-4163	139	10	international	international	ADJ
easat-4163	139	11	society	society	NOUN
easat-4163	139	12	of	of	ADP
easat-4163	139	13	thrombosis	thrombosis	NOUN
easat-4163	139	14	and	and	CCONJ
easat-4163	139	15	haemostasis	haemostasis	NOUN
easat-4163	139	16	vte	vte	NOUN
easat-4163	139	17	stands	stand	VERB
easat-4163	139	18	for	for	ADP
easat-4163	139	19	venous	venous	ADJ
easat-4163	139	20	thromboembolism	thromboembolism	NOUN
easat-4163	139	21	;	;	PUNCT
easat-4163	139	22	plt	plt	NOUN
easat-4163	139	23	for	for	ADP
easat-4163	139	24	platelets	platelet	NOUN
easat-4163	139	25	;	;	PUNCT
easat-4163	139	26	and	and	CCONJ
easat-4163	139	27	pt	pt	NOUN
easat-4163	139	28	for	for	ADP
easat-4163	139	29	prothrombin	prothrombin	ADJ
easat-4163	139	30	time	time	NOUN
easat-4163	139	31	[	[	X
easat-4163	139	32	25	25	NUM
easat-4163	139	33	]	]	PUNCT
easat-4163	139	34	.	.	PUNCT
easat-4163	140	1	5.1	5.1	NUM
easat-4163	140	2	.	.	PUNCT
easat-4163	141	1	prophylactic	prophylactic	ADJ
easat-4163	141	2	anticoagulation	anticoagulation	NOUN
easat-4163	141	3	hospitalized	hospitalize	VERB
easat-4163	141	4	covid-19	covid-19	PROPN
easat-4163	141	5	patients	patient	NOUN
easat-4163	141	6	receive	receive	VERB
easat-4163	141	7	prophylactic	prophylactic	ADJ
easat-4163	141	8	anticoagulation	anticoagulation	NOUN
easat-4163	141	9	to	to	PART
easat-4163	141	10	reduce	reduce	VERB
easat-4163	141	11	venous	venous	ADJ
easat-4163	141	12	thromboembolism	thromboembolism	NOUN
easat-4163	141	13	(	(	PUNCT
easat-4163	141	14	vte	vte	NOUN
easat-4163	141	15	)	)	PUNCT
easat-4163	141	16	risk	risk	NOUN
easat-4163	141	17	.	.	PUNCT
easat-4163	142	1	guidelines	guideline	NOUN
easat-4163	142	2	recommend	recommend	VERB
easat-4163	142	3	dosing	dose	VERB
easat-4163	142	4	based	base	VERB
easat-4163	142	5	on	on	ADP
easat-4163	142	6	risk	risk	NOUN
easat-4163	142	7	assessment	assessment	NOUN
easat-4163	142	8	tools	tool	NOUN
easat-4163	142	9	and	and	CCONJ
easat-4163	142	10	consideration	consideration	NOUN
easat-4163	142	11	of	of	ADP
easat-4163	142	12	patient	patient	NOUN
easat-4163	142	13	-	-	PUNCT
easat-4163	142	14	specific	specific	ADJ
easat-4163	142	15	factors	factor	NOUN
easat-4163	142	16	.	.	PUNCT
easat-4163	143	1	5.2	5.2	NUM
easat-4163	143	2	.	.	PUNCT
easat-4163	144	1	therapeutic	therapeutic	ADJ
easat-4163	144	2	anticoagulation	anticoagulation	NOUN
easat-4163	144	3	consideration	consideration	NOUN
easat-4163	144	4	for	for	ADP
easat-4163	144	5	therapeutic	therapeutic	ADJ
easat-4163	144	6	anticoagulation	anticoagulation	NOUN
easat-4163	144	7	in	in	ADP
easat-4163	144	8	covid-19	covid-19	PROPN
easat-4163	144	9	patients	patient	NOUN
easat-4163	144	10	with	with	ADP
easat-4163	144	11	confirmed	confirm	VERB
easat-4163	144	12	thrombosis	thrombosis	NOUN
easat-4163	144	13	or	or	CCONJ
easat-4163	144	14	high	high	ADJ
easat-4163	144	15	-	-	PUNCT
easat-4163	144	16	risk	risk	NOUN
easat-4163	144	17	features	feature	NOUN
easat-4163	144	18	despite	despite	SCONJ
easat-4163	144	19	prophylactic	prophylactic	ADJ
easat-4163	144	20	measures	measure	NOUN
easat-4163	144	21	.	.	PUNCT
easat-4163	145	1	challenges	challenge	NOUN
easat-4163	145	2	include	include	VERB
easat-4163	145	3	balancing	balance	VERB
easat-4163	145	4	benefits	benefit	NOUN
easat-4163	145	5	with	with	ADP
easat-4163	145	6	bleeding	bleed	VERB
easat-4163	145	7	risks	risk	NOUN
easat-4163	145	8	,	,	PUNCT
easat-4163	145	9	particularly	particularly	ADV
easat-4163	145	10	in	in	ADP
easat-4163	145	11	critically	critically	ADV
easat-4163	145	12	ill	ill	ADJ
easat-4163	145	13	patients	patient	NOUN
easat-4163	145	14	.	.	PUNCT
easat-4163	146	1	5.3	5.3	NUM
easat-4163	146	2	.	.	X
easat-4163	146	3	monitoring	monitoring	NOUN
easat-4163	146	4	and	and	CCONJ
easat-4163	146	5	adjustment	adjustment	NOUN
easat-4163	146	6	frequent	frequent	ADJ
easat-4163	146	7	evaluation	evaluation	NOUN
easat-4163	146	8	of	of	ADP
easat-4163	146	9	clinical	clinical	ADJ
easat-4163	146	10	state	state	NOUN
easat-4163	146	11	and	and	CCONJ
easat-4163	146	12	coagulation	coagulation	NOUN
easat-4163	146	13	measures	measure	NOUN
easat-4163	146	14	(	(	PUNCT
easat-4163	146	15	such	such	ADJ
easat-4163	146	16	as	as	ADP
easat-4163	146	17	d	d	NOUN
easat-4163	146	18	-	-	PUNCT
easat-4163	146	19	dimer	dimer	ADJ
easat-4163	146	20	levels	level	NOUN
easat-4163	146	21	)	)	PUNCT
easat-4163	146	22	to	to	PART
easat-4163	146	23	inform	inform	VERB
easat-4163	146	24	modifications	modification	NOUN
easat-4163	146	25	to	to	PART
easat-4163	146	26	anticoagulant	anticoagulant	VERB
easat-4163	146	27	treatment	treatment	NOUN
easat-4163	146	28	.	.	PUNCT
easat-4163	147	1	individualized	individualized	ADJ
easat-4163	147	2	approaches	approach	NOUN
easat-4163	147	3	based	base	VERB
easat-4163	147	4	on	on	ADP
easat-4163	147	5	evolving	evolve	VERB
easat-4163	147	6	clinical	clinical	ADJ
easat-4163	147	7	data	datum	NOUN
easat-4163	147	8	and	and	CCONJ
easat-4163	147	9	patient	patient	ADJ
easat-4163	147	10	response	response	NOUN
easat-4163	147	11	to	to	ADP
easat-4163	147	12	treatment	treatment	NOUN
easat-4163	147	13	.	.	PUNCT
easat-4163	148	1	6	6	X
easat-4163	148	2	.	.	X
easat-4163	148	3	treatment	treatment	NOUN
easat-4163	148	4	approaches	approach	VERB
easat-4163	148	5	6.1	6.1	NUM
easat-4163	148	6	.	.	PUNCT
easat-4163	149	1	anticoagulant	anticoagulant	ADJ
easat-4163	149	2	agents	agent	NOUN
easat-4163	149	3	are	be	AUX
easat-4163	149	4	a	a	DET
easat-4163	149	5	class	class	NOUN
easat-4163	149	6	of	of	ADP
easat-4163	149	7	drugs	drug	NOUN
easat-4163	149	8	that	that	PRON
easat-4163	149	9	prevent	prevent	VERB
easat-4163	149	10	blood	blood	NOUN
easat-4163	149	11	from	from	ADP
easat-4163	149	12	clotting	clot	VERB
easat-4163	149	13	.	.	PUNCT
easat-4163	150	1	heparin	heparin	ADJ
easat-4163	150	2	and	and	CCONJ
easat-4163	150	3	anti	anti	ADJ
easat-4163	150	4	-	-	ADJ
easat-4163	150	5	factor	factor	NOUN
easat-4163	150	6	xa	xa	NOUN
easat-4163	150	7	medications	medication	NOUN
easat-4163	150	8	(	(	PUNCT
easat-4163	150	9	rivaroxaban	rivaroxaban	NOUN
easat-4163	150	10	and	and	CCONJ
easat-4163	150	11	apixaban	apixaban	ADJ
easat-4163	150	12	)	)	PUNCT
easat-4163	150	13	are	be	AUX
easat-4163	150	14	two	two	NUM
easat-4163	150	15	examples	example	NOUN
easat-4163	150	16	.	.	PUNCT
easat-4163	151	1	low	low	ADJ
easat-4163	151	2	molecular	molecular	ADJ
easat-4163	151	3	weight	weight	NOUN
easat-4163	151	4	heparin	heparin	NOUN
easat-4163	151	5	(	(	PUNCT
easat-4163	151	6	lmwh	lmwh	NOUN
easat-4163	151	7	)	)	PUNCT
easat-4163	151	8	and	and	CCONJ
easat-4163	151	9	unfractionated	unfractionate	VERB
easat-4163	151	10	heparin	heparin	NOUN
easat-4163	151	11	(	(	PUNCT
easat-4163	151	12	ufh	ufh	PROPN
easat-4163	151	13	)	)	PUNCT
easat-4163	151	14	are	be	AUX
easat-4163	151	15	the	the	DET
easat-4163	151	16	heparins	heparin	NOUN
easat-4163	151	17	that	that	PRON
easat-4163	151	18	are	be	AUX
easat-4163	151	19	utilised	utilise	VERB
easat-4163	151	20	[	[	PUNCT
easat-4163	151	21	26	26	NUM
easat-4163	151	22	]	]	PUNCT
easat-4163	151	23	.	.	PUNCT
easat-4163	152	1	6.1.1	6.1.1	X
easat-4163	152	2	.	.	PUNCT
easat-4163	152	3	low	low	ADJ
easat-4163	152	4	molecular	molecular	ADJ
easat-4163	152	5	weight	weight	NOUN
easat-4163	152	6	heparin	heparin	NOUN
easat-4163	152	7	(	(	PUNCT
easat-4163	152	8	lmwh	lmwh	PROPN
easat-4163	152	9	)	)	PUNCT
easat-4163	152	10	because	because	SCONJ
easat-4163	152	11	ufh	ufh	PROPN
easat-4163	152	12	has	have	VERB
easat-4163	152	13	a	a	DET
easat-4163	152	14	longer	long	ADJ
easat-4163	152	15	duration	duration	NOUN
easat-4163	152	16	of	of	ADP
easat-4163	152	17	competitive	competitive	ADJ
easat-4163	152	18	spike	spike	ADJ
easat-4163	152	19	protein	protein	NOUN
easat-4163	152	20	,	,	PUNCT
easat-4163	152	21	heparin	heparin	NOUN
easat-4163	152	22	has	have	VERB
easat-4163	152	23	a	a	DET
easat-4163	152	24	less	less	ADV
easat-4163	152	25	direct	direct	ADJ
easat-4163	152	26	antiviral	antiviral	ADJ
easat-4163	152	27	effect	effect	NOUN
easat-4163	152	28	.	.	PUNCT
easat-4163	153	1	it	it	PRON
easat-4163	153	2	is	be	AUX
easat-4163	153	3	the	the	DET
easat-4163	153	4	preferred	preferred	ADJ
easat-4163	153	5	agent	agent	NOUN
easat-4163	153	6	for	for	ADP
easat-4163	153	7	prophylactic	prophylactic	ADJ
easat-4163	153	8	anticoagulation	anticoagulation	NOUN
easat-4163	153	9	due	due	ADP
easat-4163	153	10	to	to	ADP
easat-4163	153	11	its	its	PRON
easat-4163	153	12	predictable	predictable	ADJ
easat-4163	153	13	pharmacokinetics	pharmacokinetic	NOUN
easat-4163	153	14	and	and	CCONJ
easat-4163	153	15	reduced	reduce	VERB
easat-4163	153	16	risk	risk	NOUN
easat-4163	153	17	of	of	ADP
easat-4163	153	18	heparin	heparin	NOUN
easat-4163	153	19	-	-	PUNCT
easat-4163	153	20	induced	induce	VERB
easat-4163	153	21	thrombocytopenia	thrombocytopenia	NOUN
easat-4163	153	22	(	(	PUNCT
easat-4163	153	23	hit	hit	NOUN
easat-4163	153	24	)	)	PUNCT
easat-4163	154	1	[	[	X
easat-4163	154	2	27	27	NUM
easat-4163	154	3	]	]	PUNCT
easat-4163	154	4	.	.	PUNCT
easat-4163	155	1	512	512	NUM
easat-4163	155	2	edelweiss	edelweiss	PROPN
easat-4163	155	3	applied	apply	VERB
easat-4163	155	4	science	science	NOUN
easat-4163	155	5	and	and	CCONJ
easat-4163	155	6	technology	technology	NOUN
easat-4163	155	7	issn	issn	PROPN
easat-4163	155	8	:	:	PUNCT
easat-4163	155	9	2576	2576	NUM
easat-4163	155	10	-	-	SYM
easat-4163	155	11	8484	8484	NUM
easat-4163	155	12	vol	vol	NOUN
easat-4163	155	13	.	.	PROPN
easat-4163	156	1	9	9	NUM
easat-4163	156	2	,	,	PUNCT
easat-4163	156	3	no	no	INTJ
easat-4163	156	4	.	.	NOUN
easat-4163	156	5	1	1	NUM
easat-4163	156	6	:	:	PUNCT
easat-4163	156	7	505	505	NUM
easat-4163	156	8	-	-	SYM
easat-4163	156	9	514	514	NUM
easat-4163	156	10	,	,	PUNCT
easat-4163	156	11	2025	2025	NUM
easat-4163	156	12	doi	doi	NOUN
easat-4163	156	13	:	:	PUNCT
easat-4163	156	14	10.55214/25768484.v9i1.4163	10.55214/25768484.v9i1.4163	NUM
easat-4163	156	15	©	©	PROPN
easat-4163	156	16	2025	2025	NUM
easat-4163	156	17	by	by	ADP
easat-4163	156	18	the	the	DET
easat-4163	156	19	authors	author	NOUN
easat-4163	156	20	;	;	PUNCT
easat-4163	156	21	licensee	licensee	PROPN
easat-4163	156	22	learning	learn	VERB
easat-4163	156	23	gate	gate	PROPN
easat-4163	156	24	6.1.2	6.1.2	PROPN
easat-4163	156	25	.	.	PUNCT
easat-4163	157	1	unfractionated	unfractionate	VERB
easat-4163	157	2	heparin	heparin	NOUN
easat-4163	157	3	(	(	PUNCT
easat-4163	157	4	ufh	ufh	PROPN
easat-4163	157	5	)	)	PUNCT
easat-4163	157	6	is	be	AUX
easat-4163	157	7	the	the	DET
easat-4163	157	8	only	only	ADJ
easat-4163	157	9	agent	agent	NOUN
easat-4163	157	10	that	that	PRON
easat-4163	157	11	needs	need	VERB
easat-4163	157	12	regular	regular	ADJ
easat-4163	157	13	lab	lab	NOUN
easat-4163	157	14	testing	testing	NOUN
easat-4163	157	15	,	,	PUNCT
easat-4163	157	16	is	be	AUX
easat-4163	157	17	less	less	ADV
easat-4163	157	18	expensive	expensive	ADJ
easat-4163	157	19	,	,	PUNCT
easat-4163	157	20	has	have	AUX
easat-4163	157	21	a	a	DET
easat-4163	157	22	shorter	short	ADJ
easat-4163	157	23	half	half	ADJ
easat-4163	157	24	-	-	PUNCT
easat-4163	157	25	life	life	NOUN
easat-4163	157	26	,	,	PUNCT
easat-4163	157	27	and	and	CCONJ
easat-4163	157	28	is	be	AUX
easat-4163	157	29	readily	readily	ADV
easat-4163	157	30	eliminated	eliminate	VERB
easat-4163	157	31	from	from	ADP
easat-4163	157	32	the	the	DET
easat-4163	157	33	body	body	NOUN
easat-4163	157	34	.	.	PUNCT
easat-4163	158	1	it	it	PRON
easat-4163	158	2	is	be	AUX
easat-4163	158	3	used	use	VERB
easat-4163	158	4	in	in	ADP
easat-4163	158	5	hospitalized	hospitalize	VERB
easat-4163	158	6	patients	patient	NOUN
easat-4163	158	7	requiring	require	VERB
easat-4163	158	8	therapeutic	therapeutic	ADJ
easat-4163	158	9	anticoagulation	anticoagulation	NOUN
easat-4163	158	10	,	,	PUNCT
easat-4163	158	11	especially	especially	ADV
easat-4163	158	12	in	in	ADP
easat-4163	158	13	those	those	PRON
easat-4163	158	14	with	with	ADP
easat-4163	158	15	renal	renal	ADJ
easat-4163	158	16	dysfunction	dysfunction	NOUN
easat-4163	158	17	or	or	CCONJ
easat-4163	158	18	when	when	SCONJ
easat-4163	158	19	rapid	rapid	ADJ
easat-4163	158	20	reversal	reversal	NOUN
easat-4163	158	21	is	be	AUX
easat-4163	158	22	needed	need	VERB
easat-4163	158	23	[	[	X
easat-4163	158	24	28	28	NUM
easat-4163	158	25	]	]	PUNCT
easat-4163	158	26	.	.	PUNCT
easat-4163	159	1	6.2	6.2	NUM
easat-4163	159	2	.	.	PUNCT
easat-4163	160	1	direct	direct	ADJ
easat-4163	160	2	oral	oral	ADJ
easat-4163	160	3	anticoagulants	anticoagulant	NOUN
easat-4163	160	4	(	(	PUNCT
easat-4163	160	5	doacs	doac	NOUN
easat-4163	160	6	)	)	PUNCT
easat-4163	160	7	they	they	PRON
easat-4163	160	8	are	be	AUX
easat-4163	160	9	the	the	DET
easat-4163	160	10	best	good	ADJ
easat-4163	160	11	treatment	treatment	NOUN
easat-4163	160	12	option	option	NOUN
easat-4163	160	13	for	for	ADP
easat-4163	160	14	covid-19	covid-19	PROPN
easat-4163	160	15	patients	patient	NOUN
easat-4163	160	16	who	who	PRON
easat-4163	160	17	need	need	VERB
easat-4163	160	18	long	long	ADJ
easat-4163	160	19	-	-	PUNCT
easat-4163	160	20	term	term	NOUN
easat-4163	160	21	anticoagulation	anticoagulation	NOUN
easat-4163	160	22	after	after	ADP
easat-4163	160	23	being	be	AUX
easat-4163	160	24	released	release	VERB
easat-4163	160	25	from	from	ADP
easat-4163	160	26	the	the	DET
easat-4163	160	27	hospital	hospital	NOUN
easat-4163	160	28	[	[	X
easat-4163	160	29	29	29	NUM
easat-4163	160	30	]	]	PUNCT
easat-4163	160	31	.	.	PUNCT
easat-4163	161	1	these	these	DET
easat-4163	161	2	medicines	medicine	NOUN
easat-4163	161	3	are	be	AUX
easat-4163	161	4	recommended	recommend	VERB
easat-4163	161	5	over	over	ADP
easat-4163	161	6	vitamin	vitamin	NOUN
easat-4163	161	7	k	k	PROPN
easat-4163	161	8	antagonists	antagonist	NOUN
easat-4163	161	9	like	like	ADP
easat-4163	161	10	warfarin	warfarin	NOUN
easat-4163	161	11	because	because	SCONJ
easat-4163	161	12	they	they	PRON
easat-4163	161	13	do	do	AUX
easat-4163	161	14	not	not	PART
easat-4163	161	15	require	require	VERB
easat-4163	161	16	routine	routine	ADJ
easat-4163	161	17	international	international	ADJ
easat-4163	161	18	normalised	normalise	VERB
easat-4163	161	19	ratio	ratio	NOUN
easat-4163	161	20	monitoring	monitoring	NOUN
easat-4163	161	21	.	.	PUNCT
easat-4163	162	1	the	the	DET
easat-4163	162	2	most	most	ADV
easat-4163	162	3	effective	effective	ADJ
easat-4163	162	4	doavs	doavs	NOUN
easat-4163	162	5	to	to	PART
easat-4163	162	6	use	use	VERB
easat-4163	162	7	are	be	AUX
easat-4163	162	8	apixaban	apixaban	ADJ
easat-4163	162	9	,	,	PUNCT
easat-4163	162	10	betrixaban	betrixaban	ADJ
easat-4163	162	11	,	,	PUNCT
easat-4163	162	12	and	and	CCONJ
easat-4163	162	13	rivaroxaban	rivaroxaban	NOUN
easat-4163	163	1	[	[	X
easat-4163	163	2	30	30	NUM
easat-4163	163	3	]	]	SYM
easat-4163	163	4	.	.	PUNCT
easat-4163	164	1	6.3	6.3	NUM
easat-4163	164	2	.	.	PUNCT
easat-4163	165	1	adjunctive	adjunctive	ADJ
easat-4163	165	2	therapies	therapy	NOUN
easat-4163	165	3	is	be	AUX
easat-4163	165	4	a	a	DET
easat-4163	165	5	therapy	therapy	NOUN
easat-4163	165	6	that	that	PRON
easat-4163	165	7	is	be	AUX
easat-4163	165	8	given	give	VERB
easat-4163	165	9	in	in	ADP
easat-4163	165	10	addition	addition	NOUN
easat-4163	165	11	to	to	ADP
easat-4163	165	12	the	the	DET
easat-4163	165	13	primary	primary	ADJ
easat-4163	165	14	or	or	CCONJ
easat-4163	165	15	initial	initial	ADJ
easat-4163	165	16	therapy	therapy	NOUN
easat-4163	165	17	to	to	PART
easat-4163	165	18	maximize	maximize	VERB
easat-4163	165	19	its	its	PRON
easat-4163	165	20	effectiveness	effectiveness	NOUN
easat-4163	165	21	.	.	PUNCT
easat-4163	166	1	6.3.1	6.3.1	NUM
easat-4163	166	2	.	.	PUNCT
easat-4163	167	1	antiplatelet	antiplatelet	NOUN
easat-4163	167	2	agents	agent	NOUN
easat-4163	167	3	may	may	AUX
easat-4163	167	4	be	be	AUX
easat-4163	167	5	taken	take	VERB
easat-4163	167	6	into	into	ADP
easat-4163	167	7	consideration	consideration	NOUN
easat-4163	167	8	in	in	ADP
easat-4163	167	9	covid-19	covid-19	PROPN
easat-4163	167	10	patients	patient	NOUN
easat-4163	167	11	who	who	PRON
easat-4163	167	12	have	have	VERB
easat-4163	167	13	ischaemic	ischaemic	ADJ
easat-4163	167	14	stroke	stroke	NOUN
easat-4163	167	15	or	or	CCONJ
easat-4163	167	16	acute	acute	ADJ
easat-4163	167	17	coronary	coronary	ADJ
easat-4163	167	18	syndrome	syndrome	NOUN
easat-4163	167	19	,	,	PUNCT
easat-4163	167	20	weighing	weigh	VERB
easat-4163	167	21	the	the	DET
easat-4163	167	22	risks	risk	NOUN
easat-4163	167	23	of	of	ADP
easat-4163	167	24	bleeding	bleeding	NOUN
easat-4163	167	25	and	and	CCONJ
easat-4163	167	26	thrombosis	thrombosis	NOUN
easat-4163	167	27	.	.	PUNCT
easat-4163	168	1	for	for	ADP
easat-4163	168	2	instance	instance	NOUN
easat-4163	168	3	,	,	PUNCT
easat-4163	168	4	dipyridamole	dipyridamole	PROPN
easat-4163	168	5	,	,	PUNCT
easat-4163	168	6	ticagrelor	ticagrelor	NOUN
easat-4163	168	7	,	,	PUNCT
easat-4163	168	8	clopidogrel	clopidogrel	NOUN
easat-4163	168	9	,	,	PUNCT
easat-4163	168	10	aspirin	aspirin	NOUN
easat-4163	168	11	,	,	PUNCT
easat-4163	168	12	and	and	CCONJ
easat-4163	168	13	cilostazol	cilostazol	ADJ
easat-4163	168	14	.	.	PUNCT
easat-4163	169	1	6.3.2	6.3.2	X
easat-4163	169	2	.	.	PUNCT
easat-4163	170	1	immunomodulatory	immunomodulatory	ADJ
easat-4163	170	2	agents	agent	NOUN
easat-4163	170	3	are	be	AUX
easat-4163	170	4	substance	substance	NOUN
easat-4163	170	5	that	that	PRON
easat-4163	170	6	tamp	tamp	VERB
easat-4163	170	7	down	down	ADP
easat-4163	170	8	over	over	ADP
easat-4163	170	9	-	-	PUNCT
easat-4163	170	10	active	active	ADJ
easat-4163	170	11	immune	immune	ADJ
easat-4163	170	12	responses	response	NOUN
easat-4163	170	13	(	(	PUNCT
easat-4163	170	14	e.g.	e.g.	ADV
easat-4163	170	15	tocilizumab	tocilizumab	NOUN
easat-4163	170	16	/	/	SYM
easat-4163	170	17	sarilumab	sarilumab	NOUN
easat-4163	170	18	)	)	PUNCT
easat-4163	170	19	.	.	PUNCT
easat-4163	171	1	new	new	ADJ
easat-4163	171	2	treatments	treatment	NOUN
easat-4163	171	3	that	that	PRON
easat-4163	171	4	target	target	VERB
easat-4163	171	5	inflammation	inflammation	NOUN
easat-4163	171	6	,	,	PUNCT
easat-4163	171	7	such	such	ADJ
easat-4163	171	8	as	as	ADP
easat-4163	171	9	il-6	il-6	NUM
easat-4163	171	10	inhibitors	inhibitor	NOUN
easat-4163	171	11	and	and	CCONJ
easat-4163	171	12	corticosteroids	corticosteroid	NOUN
easat-4163	171	13	,	,	PUNCT
easat-4163	171	14	may	may	AUX
easat-4163	171	15	have	have	VERB
easat-4163	171	16	an	an	DET
easat-4163	171	17	indirect	indirect	ADJ
easat-4163	171	18	impact	impact	NOUN
easat-4163	171	19	on	on	ADP
easat-4163	171	20	coagulation	coagulation	NOUN
easat-4163	171	21	problems	problem	NOUN
easat-4163	171	22	in	in	ADP
easat-4163	171	23	severe	severe	ADJ
easat-4163	171	24	covid-19	covid-19	PROPN
easat-4163	171	25	patients	patient	NOUN
easat-4163	171	26	.	.	PUNCT
easat-4163	172	1	7	7	X
easat-4163	172	2	.	.	X
easat-4163	172	3	therapeutic	therapeutic	ADJ
easat-4163	172	4	challenges	challenge	NOUN
easat-4163	172	5	7.1	7.1	NUM
easat-4163	172	6	.	.	PUNCT
easat-4163	173	1	optimal	optimal	ADJ
easat-4163	173	2	anticoagulation	anticoagulation	NOUN
easat-4163	173	3	regimens	regimen	NOUN
easat-4163	173	4	determining	determine	VERB
easat-4163	173	5	the	the	DET
easat-4163	173	6	optimal	optimal	ADJ
easat-4163	173	7	timing	timing	NOUN
easat-4163	173	8	,	,	PUNCT
easat-4163	173	9	dosing	dosing	NOUN
easat-4163	173	10	,	,	PUNCT
easat-4163	173	11	and	and	CCONJ
easat-4163	173	12	duration	duration	NOUN
easat-4163	173	13	of	of	ADP
easat-4163	173	14	anticoagulation	anticoagulation	NOUN
easat-4163	173	15	therapy	therapy	NOUN
easat-4163	173	16	remains	remain	VERB
easat-4163	173	17	a	a	DET
easat-4163	173	18	challenge	challenge	NOUN
easat-4163	173	19	.	.	PUNCT
easat-4163	174	1	variability	variability	NOUN
easat-4163	174	2	in	in	ADP
easat-4163	174	3	clinical	clinical	ADJ
easat-4163	174	4	presentation	presentation	NOUN
easat-4163	174	5	and	and	CCONJ
easat-4163	174	6	coagulation	coagulation	NOUN
easat-4163	174	7	profiles	profile	NOUN
easat-4163	174	8	necessitates	necessitate	VERB
easat-4163	174	9	personalized	personalized	ADJ
easat-4163	174	10	approaches	approach	NOUN
easat-4163	174	11	.	.	PUNCT
easat-4163	175	1	7.2	7.2	NUM
easat-4163	175	2	.	.	PUNCT
easat-4163	175	3	risk	risk	NOUN
easat-4163	175	4	-	-	PUNCT
easat-4163	175	5	benefit	benefit	NOUN
easat-4163	175	6	assessment	assessment	NOUN
easat-4163	175	7	critically	critically	ADV
easat-4163	175	8	ill	ill	ADJ
easat-4163	175	9	patients	patient	NOUN
easat-4163	175	10	'	'	PART
easat-4163	175	11	thrombotic	thrombotic	ADJ
easat-4163	175	12	risk	risk	NOUN
easat-4163	175	13	versus	versus	ADP
easat-4163	175	14	bleeding	bleed	VERB
easat-4163	175	15	risk	risk	NOUN
easat-4163	175	16	must	must	AUX
easat-4163	175	17	be	be	AUX
easat-4163	175	18	carefully	carefully	ADV
easat-4163	175	19	considered	consider	VERB
easat-4163	175	20	,	,	PUNCT
easat-4163	175	21	and	and	CCONJ
easat-4163	175	22	multidisciplinary	multidisciplinary	ADJ
easat-4163	175	23	cooperation	cooperation	NOUN
easat-4163	175	24	is	be	AUX
easat-4163	175	25	frequently	frequently	ADV
easat-4163	175	26	required	require	VERB
easat-4163	175	27	.	.	PUNCT
easat-4163	176	1	there	there	PRON
easat-4163	176	2	are	be	VERB
easat-4163	176	3	extra	extra	ADJ
easat-4163	176	4	difficulties	difficulty	NOUN
easat-4163	176	5	in	in	ADP
easat-4163	176	6	managing	manage	VERB
easat-4163	176	7	anticoagulation	anticoagulation	NOUN
easat-4163	176	8	in	in	ADP
easat-4163	176	9	individuals	individual	NOUN
easat-4163	176	10	who	who	PRON
easat-4163	176	11	have	have	VERB
easat-4163	176	12	hepatic	hepatic	ADJ
easat-4163	176	13	or	or	CCONJ
easat-4163	176	14	renal	renal	ADJ
easat-4163	176	15	impairment	impairment	NOUN
easat-4163	176	16	.	.	PUNCT
easat-4163	177	1	7.3	7.3	NUM
easat-4163	177	2	.	.	PUNCT
easat-4163	178	1	emerging	emerge	VERB
easat-4163	178	2	evidence	evidence	NOUN
easat-4163	178	3	and	and	CCONJ
easat-4163	178	4	guidelines	guideline	VERB
easat-4163	178	5	rapidly	rapidly	ADV
easat-4163	178	6	evolving	evolve	VERB
easat-4163	178	7	evidence	evidence	NOUN
easat-4163	178	8	and	and	CCONJ
easat-4163	178	9	guidelines	guideline	NOUN
easat-4163	178	10	necessitate	necessitate	ADJ
easat-4163	178	11	ongoing	ongoing	ADJ
easat-4163	178	12	updates	update	NOUN
easat-4163	178	13	and	and	CCONJ
easat-4163	178	14	adaptation	adaptation	NOUN
easat-4163	178	15	of	of	ADP
easat-4163	178	16	clinical	clinical	ADJ
easat-4163	178	17	practices	practice	NOUN
easat-4163	178	18	.	.	PUNCT
easat-4163	179	1	incorporating	incorporate	VERB
easat-4163	179	2	new	new	ADJ
easat-4163	179	3	data	datum	NOUN
easat-4163	179	4	on	on	ADP
easat-4163	179	5	thrombotic	thrombotic	ADJ
easat-4163	179	6	mechanisms	mechanism	NOUN
easat-4163	179	7	and	and	CCONJ
easat-4163	179	8	treatment	treatment	NOUN
easat-4163	179	9	outcomes	outcome	NOUN
easat-4163	179	10	into	into	ADP
easat-4163	179	11	clinical	clinical	ADJ
easat-4163	179	12	decisionmaking	decisionmaking	NOUN
easat-4163	179	13	.	.	PUNCT
easat-4163	180	1	8	8	X
easat-4163	180	2	.	.	X
easat-4163	180	3	conclusion	conclusion	VERB
easat-4163	180	4	the	the	DET
easat-4163	180	5	pathophysiology	pathophysiology	NOUN
easat-4163	180	6	of	of	ADP
easat-4163	180	7	covid-19	covid-19	PROPN
easat-4163	180	8	-	-	PUNCT
easat-4163	180	9	associated	associate	VERB
easat-4163	180	10	coagulopathy	coagulopathy	ADJ
easat-4163	180	11	involves	involve	VERB
easat-4163	180	12	complex	complex	ADJ
easat-4163	180	13	interactions	interaction	NOUN
easat-4163	180	14	between	between	ADP
easat-4163	180	15	viral	viral	ADJ
easat-4163	180	16	factors	factor	NOUN
easat-4163	180	17	,	,	PUNCT
easat-4163	180	18	inflammatory	inflammatory	ADJ
easat-4163	180	19	responses	response	NOUN
easat-4163	180	20	,	,	PUNCT
easat-4163	180	21	endothelial	endothelial	ADJ
easat-4163	180	22	dysfunction	dysfunction	NOUN
easat-4163	180	23	,	,	PUNCT
easat-4163	180	24	and	and	CCONJ
easat-4163	180	25	dysregulated	dysregulated	ADJ
easat-4163	180	26	hemostasis	hemostasis	NOUN
easat-4163	180	27	,	,	PUNCT
easat-4163	180	28	necessitate	necessitate	ADJ
easat-4163	180	29	ongoing	ongoing	ADJ
easat-4163	180	30	research	research	NOUN
easat-4163	180	31	to	to	PART
easat-4163	180	32	elucidate	elucidate	VERB
easat-4163	180	33	underlying	underlying	ADJ
easat-4163	180	34	mechanisms	mechanism	NOUN
easat-4163	180	35	and	and	CCONJ
easat-4163	180	36	identify	identify	VERB
easat-4163	180	37	novel	novel	ADJ
easat-4163	180	38	therapeutic	therapeutic	ADJ
easat-4163	180	39	targets	target	NOUN
easat-4163	180	40	.	.	PUNCT
easat-4163	181	1	biomarkers	biomarker	NOUN
easat-4163	181	2	such	such	ADJ
easat-4163	181	3	as	as	ADP
easat-4163	181	4	d	d	NOUN
easat-4163	181	5	-	-	PUNCT
easat-4163	181	6	dimer	dimer	ADJ
easat-4163	181	7	levels	level	NOUN
easat-4163	181	8	serve	serve	VERB
easat-4163	181	9	as	as	ADP
easat-4163	181	10	valuable	valuable	ADJ
easat-4163	181	11	tools	tool	NOUN
easat-4163	181	12	in	in	ADP
easat-4163	181	13	risk	risk	NOUN
easat-4163	181	14	assessment	assessment	NOUN
easat-4163	181	15	and	and	CCONJ
easat-4163	181	16	monitoring	monitoring	NOUN
easat-4163	181	17	,	,	PUNCT
easat-4163	181	18	yet	yet	CCONJ
easat-4163	181	19	their	their	PRON
easat-4163	181	20	interpretation	interpretation	NOUN
easat-4163	181	21	requires	require	VERB
easat-4163	181	22	careful	careful	ADJ
easat-4163	181	23	consideration	consideration	NOUN
easat-4163	181	24	within	within	ADP
easat-4163	181	25	the	the	DET
easat-4163	181	26	clinical	clinical	ADJ
easat-4163	181	27	context	context	NOUN
easat-4163	181	28	.	.	PUNCT
easat-4163	182	1	looking	look	VERB
easat-4163	182	2	forward	forward	ADV
easat-4163	182	3	,	,	PUNCT
easat-4163	182	4	future	future	ADJ
easat-4163	182	5	research	research	NOUN
easat-4163	182	6	should	should	AUX
easat-4163	182	7	focus	focus	VERB
easat-4163	182	8	on	on	ADP
easat-4163	182	9	refining	refine	VERB
easat-4163	182	10	anticoagulation	anticoagulation	NOUN
easat-4163	182	11	strategies	strategy	NOUN
easat-4163	182	12	,	,	PUNCT
easat-4163	182	13	exploring	explore	VERB
easat-4163	182	14	adjunctive	adjunctive	ADJ
easat-4163	182	15	therapies	therapy	NOUN
easat-4163	182	16	,	,	PUNCT
easat-4163	182	17	and	and	CCONJ
easat-4163	182	18	513	513	NUM
easat-4163	182	19	edelweiss	edelweiss	PROPN
easat-4163	182	20	applied	apply	VERB
easat-4163	182	21	science	science	NOUN
easat-4163	182	22	and	and	CCONJ
easat-4163	182	23	technology	technology	NOUN
easat-4163	182	24	issn	issn	PROPN
easat-4163	182	25	:	:	PUNCT
easat-4163	182	26	2576	2576	NUM
easat-4163	182	27	-	-	SYM
easat-4163	182	28	8484	8484	NUM
easat-4163	182	29	vol	vol	NOUN
easat-4163	182	30	.	.	PROPN
easat-4163	183	1	9	9	NUM
easat-4163	183	2	,	,	PUNCT
easat-4163	183	3	no	no	INTJ
easat-4163	183	4	.	.	NOUN
easat-4163	183	5	1	1	NUM
easat-4163	183	6	:	:	PUNCT
easat-4163	183	7	505	505	NUM
easat-4163	183	8	-	-	SYM
easat-4163	183	9	514	514	NUM
easat-4163	183	10	,	,	PUNCT
easat-4163	183	11	2025	2025	NUM
easat-4163	183	12	doi	doi	NOUN
easat-4163	183	13	:	:	PUNCT
easat-4163	183	14	10.55214/25768484.v9i1.4163	10.55214/25768484.v9i1.4163	NUM
easat-4163	183	15	©	©	PROPN
easat-4163	183	16	2025	2025	NUM
easat-4163	183	17	by	by	ADP
easat-4163	183	18	the	the	DET
easat-4163	183	19	authors	author	NOUN
easat-4163	183	20	;	;	PUNCT
easat-4163	183	21	licensee	licensee	PROPN
easat-4163	183	22	learning	learn	VERB
easat-4163	183	23	gate	gate	NOUN
easat-4163	183	24	investigating	investigate	VERB
easat-4163	183	25	long	long	ADJ
easat-4163	183	26	-	-	PUNCT
easat-4163	183	27	term	term	NOUN
easat-4163	183	28	implications	implication	NOUN
easat-4163	183	29	for	for	ADP
easat-4163	183	30	survivors	survivor	NOUN
easat-4163	183	31	,	,	PUNCT
easat-4163	183	32	including	include	VERB
easat-4163	183	33	cardiovascular	cardiovascular	ADJ
easat-4163	183	34	and	and	CCONJ
easat-4163	183	35	pulmonary	pulmonary	ADJ
easat-4163	183	36	sequelae	sequelae	NOUN
easat-4163	183	37	.	.	PUNCT
easat-4163	184	1	additionally	additionally	ADV
easat-4163	184	2	,	,	PUNCT
easat-4163	184	3	interdisciplinary	interdisciplinary	ADJ
easat-4163	184	4	collaboration	collaboration	NOUN
easat-4163	184	5	and	and	CCONJ
easat-4163	184	6	integrated	integrate	VERB
easat-4163	184	7	care	care	NOUN
easat-4163	184	8	models	model	NOUN
easat-4163	184	9	are	be	AUX
easat-4163	184	10	essential	essential	ADJ
easat-4163	184	11	to	to	PART
easat-4163	184	12	optimize	optimize	VERB
easat-4163	184	13	outcomes	outcome	NOUN
easat-4163	184	14	and	and	CCONJ
easat-4163	184	15	provide	provide	VERB
easat-4163	184	16	comprehensive	comprehensive	ADJ
easat-4163	184	17	support	support	NOUN
easat-4163	184	18	for	for	ADP
easat-4163	184	19	covid-19	covid-19	PROPN
easat-4163	184	20	patients	patient	NOUN
easat-4163	184	21	throughout	throughout	ADP
easat-4163	184	22	their	their	PRON
easat-4163	184	23	recovery	recovery	NOUN
easat-4163	184	24	journey	journey	NOUN
easat-4163	184	25	.	.	PUNCT
easat-4163	185	1	transparency	transparency	NOUN
easat-4163	185	2	:	:	PUNCT
easat-4163	185	3	the	the	DET
easat-4163	185	4	authors	author	NOUN
easat-4163	185	5	confirm	confirm	VERB
easat-4163	185	6	that	that	SCONJ
easat-4163	185	7	the	the	DET
easat-4163	185	8	manuscript	manuscript	NOUN
easat-4163	185	9	is	be	AUX
easat-4163	185	10	an	an	DET
easat-4163	185	11	honest	honest	ADJ
easat-4163	185	12	,	,	PUNCT
easat-4163	185	13	accurate	accurate	ADJ
easat-4163	185	14	,	,	PUNCT
easat-4163	185	15	and	and	CCONJ
easat-4163	185	16	transparent	transparent	ADJ
easat-4163	185	17	account	account	NOUN
easat-4163	185	18	of	of	ADP
easat-4163	185	19	the	the	DET
easat-4163	185	20	study	study	NOUN
easat-4163	185	21	;	;	PUNCT
easat-4163	185	22	that	that	SCONJ
easat-4163	185	23	no	no	DET
easat-4163	185	24	vital	vital	ADJ
easat-4163	185	25	features	feature	NOUN
easat-4163	185	26	of	of	ADP
easat-4163	185	27	the	the	DET
easat-4163	185	28	study	study	NOUN
easat-4163	185	29	have	have	AUX
easat-4163	185	30	been	be	AUX
easat-4163	185	31	omitted	omit	VERB
easat-4163	185	32	;	;	PUNCT
easat-4163	185	33	and	and	CCONJ
easat-4163	185	34	that	that	SCONJ
easat-4163	185	35	any	any	DET
easat-4163	185	36	discrepancies	discrepancy	NOUN
easat-4163	185	37	from	from	ADP
easat-4163	185	38	the	the	DET
easat-4163	185	39	study	study	NOUN
easat-4163	185	40	as	as	SCONJ
easat-4163	185	41	planned	plan	VERB
easat-4163	185	42	have	have	AUX
easat-4163	185	43	been	be	AUX
easat-4163	185	44	explained	explain	VERB
easat-4163	185	45	.	.	PUNCT
easat-4163	186	1	this	this	DET
easat-4163	186	2	study	study	NOUN
easat-4163	186	3	followed	follow	VERB
easat-4163	186	4	all	all	DET
easat-4163	186	5	ethical	ethical	ADJ
easat-4163	186	6	practices	practice	NOUN
easat-4163	186	7	during	during	ADP
easat-4163	186	8	writing	writing	NOUN
easat-4163	186	9	.	.	PUNCT
easat-4163	187	1	copyright	copyright	NOUN
easat-4163	187	2	:	:	PUNCT
easat-4163	187	3	©	©	PROPN
easat-4163	187	4	2025	2025	NUM
easat-4163	187	5	by	by	ADP
easat-4163	187	6	the	the	DET
easat-4163	187	7	authors	author	NOUN
easat-4163	187	8	.	.	PUNCT
easat-4163	188	1	this	this	DET
easat-4163	188	2	open	open	ADJ
easat-4163	188	3	-	-	PUNCT
easat-4163	188	4	access	access	NOUN
easat-4163	188	5	article	article	NOUN
easat-4163	188	6	is	be	AUX
easat-4163	188	7	distributed	distribute	VERB
easat-4163	188	8	under	under	ADP
easat-4163	188	9	the	the	DET
easat-4163	188	10	terms	term	NOUN
easat-4163	188	11	and	and	CCONJ
easat-4163	188	12	conditions	condition	NOUN
easat-4163	188	13	of	of	ADP
easat-4163	188	14	the	the	DET
easat-4163	188	15	creative	creative	ADJ
easat-4163	188	16	commons	common	NOUN
easat-4163	188	17	attribution	attribution	NOUN
easat-4163	188	18	(	(	PUNCT
easat-4163	188	19	cc	cc	NOUN
easat-4163	188	20	by	by	ADP
easat-4163	188	21	)	)	PUNCT
easat-4163	188	22	license	license	NOUN
easat-4163	188	23	(	(	PUNCT
easat-4163	188	24	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-4163	188	25	)	)	PUNCT
easat-4163	188	26	.	.	PUNCT
easat-4163	189	1	references	reference	NOUN
easat-4163	189	2	[	[	X
easat-4163	189	3	1	1	NUM
easat-4163	189	4	]	]	PUNCT
easat-4163	189	5	a.	a.	PROPN
easat-4163	189	6	e.	e.	PROPN
easat-4163	189	7	gorbalenya	gorbalenya	PROPN
easat-4163	189	8	et	et	PROPN
easat-4163	189	9	al	al	PROPN
easat-4163	189	10	.	.	PROPN
easat-4163	189	11	,	,	PUNCT
easat-4163	189	12	"	"	PUNCT
easat-4163	189	13	coronaviridae	coronaviridae	NOUN
easat-4163	189	14	study	study	NOUN
easat-4163	189	15	group	group	NOUN
easat-4163	189	16	of	of	ADP
easat-4163	189	17	the	the	DET
easat-4163	189	18	international	international	ADJ
easat-4163	189	19	committee	committee	NOUN
easat-4163	189	20	on	on	ADP
easat-4163	189	21	taxonomy	taxonomy	NOUN
easat-4163	189	22	of	of	ADP
easat-4163	189	23	viruses	virus	NOUN
easat-4163	189	24	.	.	PUNCT
easat-4163	190	1	the	the	DET
easat-4163	190	2	species	specie	NOUN
easat-4163	190	3	severe	severe	ADJ
easat-4163	190	4	acute	acute	ADJ
easat-4163	190	5	respiratory	respiratory	ADJ
easat-4163	190	6	syndrome	syndrome	NOUN
easat-4163	190	7	-	-	PUNCT
easat-4163	190	8	related	relate	VERB
easat-4163	190	9	coronavirus	coronavirus	NOUN
easat-4163	190	10	:	:	PUNCT
easat-4163	190	11	classifying	classify	VERB
easat-4163	190	12	2019	2019	NUM
easat-4163	190	13	-	-	PUNCT
easat-4163	190	14	ncov	ncov	ADV
easat-4163	190	15	and	and	CCONJ
easat-4163	190	16	naming	name	VERB
easat-4163	190	17	it	it	PRON
easat-4163	190	18	sars	sar	NOUN
easat-4163	190	19	-	-	PUNCT
easat-4163	190	20	cov-2	cov-2	NOUN
easat-4163	190	21	,	,	PUNCT
easat-4163	190	22	"	"	PUNCT
easat-4163	190	23	nat	nat	PROPN
easat-4163	190	24	.	.	PUNCT
easat-4163	191	1	microbiol	microbiol	PROPN
easat-4163	191	2	,	,	PUNCT
easat-4163	191	3	vol	vol	NOUN
easat-4163	191	4	.	.	PROPN
easat-4163	192	1	5	5	NUM
easat-4163	192	2	,	,	PUNCT
easat-4163	192	3	no	no	INTJ
easat-4163	192	4	.	.	NOUN
easat-4163	192	5	4	4	NUM
easat-4163	192	6	,	,	PUNCT
easat-4163	192	7	pp	pp	ADJ
easat-4163	192	8	.	.	PUNCT
easat-4163	193	1	536	536	NUM
easat-4163	193	2	-	-	SYM
easat-4163	193	3	544	544	NUM
easat-4163	193	4	,	,	PUNCT
easat-4163	193	5	2020	2020	NUM
easat-4163	193	6	.	.	PUNCT
easat-4163	194	1	[	[	X
easat-4163	194	2	2	2	NUM
easat-4163	194	3	]	]	PUNCT
easat-4163	194	4	c.	c.	PROPN
easat-4163	194	5	huang	huang	PROPN
easat-4163	194	6	et	et	PROPN
easat-4163	194	7	al	al	PROPN
easat-4163	194	8	.	.	PROPN
easat-4163	194	9	,	,	PUNCT
easat-4163	194	10	"	"	PUNCT
easat-4163	194	11	clinical	clinical	ADJ
easat-4163	194	12	features	feature	NOUN
easat-4163	194	13	of	of	ADP
easat-4163	194	14	patients	patient	NOUN
easat-4163	194	15	infected	infect	VERB
easat-4163	194	16	with	with	ADP
easat-4163	194	17	2019	2019	NUM
easat-4163	194	18	novel	novel	ADJ
easat-4163	194	19	coronavirus	coronavirus	NOUN
easat-4163	194	20	in	in	ADP
easat-4163	194	21	wuhan	wuhan	PROPN
easat-4163	194	22	,	,	PUNCT
easat-4163	194	23	china	china	PROPN
easat-4163	194	24	,	,	PUNCT
easat-4163	194	25	"	"	PUNCT
easat-4163	194	26	the	the	DET
easat-4163	194	27	lancet	lancet	NOUN
easat-4163	194	28	,	,	PUNCT
easat-4163	194	29	vol	vol	NOUN
easat-4163	194	30	.	.	PROPN
easat-4163	195	1	395	395	NUM
easat-4163	195	2	,	,	PUNCT
easat-4163	195	3	no	no	NOUN
easat-4163	195	4	.	.	NOUN
easat-4163	195	5	10223	10223	NUM
easat-4163	195	6	,	,	PUNCT
easat-4163	195	7	pp	pp	ADP
easat-4163	195	8	.	.	PUNCT
easat-4163	196	1	497	497	NUM
easat-4163	196	2	-	-	SYM
easat-4163	196	3	506	506	NUM
easat-4163	196	4	,	,	PUNCT
easat-4163	196	5	2020	2020	NUM
easat-4163	196	6	.	.	PUNCT
easat-4163	197	1	[	[	X
easat-4163	197	2	3	3	X
easat-4163	197	3	]	]	X
easat-4163	197	4	j.	j.	PROPN
easat-4163	197	5	e.	e.	PROPN
easat-4163	197	6	gomez	gomez	PROPN
easat-4163	197	7	-	-	PUNCT
easat-4163	197	8	mesa	mesa	PROPN
easat-4163	197	9	,	,	PUNCT
easat-4163	197	10	s.	s.	PROPN
easat-4163	197	11	galindo	galindo	PROPN
easat-4163	197	12	-	-	PUNCT
easat-4163	197	13	coral	coral	PROPN
easat-4163	197	14	,	,	PUNCT
easat-4163	197	15	m.	m.	NOUN
easat-4163	197	16	c.	c.	PROPN
easat-4163	197	17	montes	montes	PROPN
easat-4163	197	18	,	,	PUNCT
easat-4163	197	19	and	and	CCONJ
easat-4163	197	20	a.	a.	PROPN
easat-4163	197	21	j.	j.	PROPN
easat-4163	197	22	m.	m.	PROPN
easat-4163	197	23	martin	martin	PROPN
easat-4163	197	24	,	,	PUNCT
easat-4163	197	25	"	"	PUNCT
easat-4163	197	26	thrombosis	thrombosis	NOUN
easat-4163	197	27	and	and	CCONJ
easat-4163	197	28	coagulopathy	coagulopathy	ADJ
easat-4163	197	29	in	in	ADP
easat-4163	197	30	covid19	covid19	NOUN
easat-4163	197	31	,	,	PUNCT
easat-4163	197	32	"	"	PUNCT
easat-4163	197	33	current	current	ADJ
easat-4163	197	34	problems	problem	NOUN
easat-4163	197	35	in	in	ADP
easat-4163	197	36	cardiology	cardiology	NOUN
easat-4163	197	37	,	,	PUNCT
easat-4163	197	38	vol	vol	NOUN
easat-4163	197	39	.	.	PROPN
easat-4163	197	40	46	46	NUM
easat-4163	197	41	,	,	PUNCT
easat-4163	197	42	no	no	INTJ
easat-4163	197	43	.	.	NOUN
easat-4163	197	44	3	3	NUM
easat-4163	197	45	,	,	PUNCT
easat-4163	197	46	p.	p.	NOUN
easat-4163	197	47	100742	100742	NUM
easat-4163	197	48	,	,	PUNCT
easat-4163	197	49	2021	2021	NUM
easat-4163	197	50	.	.	PUNCT
easat-4163	198	1	[	[	X
easat-4163	198	2	4	4	X
easat-4163	198	3	]	]	PUNCT
easat-4163	198	4	b.	b.	PROPN
easat-4163	198	5	bikdeli	bikdeli	PROPN
easat-4163	198	6	et	et	PROPN
easat-4163	198	7	al	al	PROPN
easat-4163	198	8	.	.	PROPN
easat-4163	198	9	,	,	PUNCT
easat-4163	198	10	"	"	PUNCT
easat-4163	198	11	covid-19	covid-19	PROPN
easat-4163	198	12	and	and	CCONJ
easat-4163	198	13	thrombotic	thrombotic	ADJ
easat-4163	198	14	or	or	CCONJ
easat-4163	198	15	thromboembolic	thromboembolic	ADJ
easat-4163	198	16	disease	disease	NOUN
easat-4163	198	17	:	:	PUNCT
easat-4163	198	18	implications	implication	NOUN
easat-4163	198	19	for	for	ADP
easat-4163	198	20	prevention	prevention	NOUN
easat-4163	198	21	,	,	PUNCT
easat-4163	198	22	antithrombotic	antithrombotic	ADJ
easat-4163	198	23	therapy	therapy	NOUN
easat-4163	198	24	,	,	PUNCT
easat-4163	198	25	and	and	CCONJ
easat-4163	198	26	follow	follow	VERB
easat-4163	198	27	-	-	PUNCT
easat-4163	198	28	up	up	NOUN
easat-4163	198	29	:	:	PUNCT
easat-4163	198	30	jacc	jacc	VERB
easat-4163	198	31	state	state	NOUN
easat-4163	198	32	-	-	PUNCT
easat-4163	198	33	of	of	ADP
easat-4163	198	34	-	-	PUNCT
easat-4163	198	35	the	the	DET
easat-4163	198	36	-	-	PUNCT
easat-4163	198	37	art	art	NOUN
easat-4163	198	38	review	review	NOUN
easat-4163	198	39	,	,	PUNCT
easat-4163	198	40	"	"	PUNCT
easat-4163	198	41	journal	journal	NOUN
easat-4163	198	42	of	of	ADP
easat-4163	198	43	the	the	DET
easat-4163	198	44	american	american	PROPN
easat-4163	198	45	college	college	PROPN
easat-4163	198	46	of	of	ADP
easat-4163	198	47	cardiology	cardiology	NOUN
easat-4163	198	48	,	,	PUNCT
easat-4163	198	49	vol	vol	NOUN
easat-4163	198	50	.	.	PROPN
easat-4163	199	1	75	75	NUM
easat-4163	199	2	,	,	PUNCT
easat-4163	199	3	no	no	INTJ
easat-4163	199	4	.	.	NOUN
easat-4163	199	5	23	23	NUM
easat-4163	199	6	,	,	PUNCT
easat-4163	199	7	pp	pp	ADJ
easat-4163	199	8	.	.	PUNCT
easat-4163	200	1	2950	2950	NUM
easat-4163	200	2	-	-	SYM
easat-4163	200	3	2973	2973	NUM
easat-4163	200	4	,	,	PUNCT
easat-4163	200	5	2020	2020	NUM
easat-4163	200	6	.	.	PUNCT
easat-4163	201	1	[	[	X
easat-4163	201	2	5	5	X
easat-4163	201	3	]	]	PUNCT
easat-4163	201	4	j.	j.	PROPN
easat-4163	201	5	m.	m.	PROPN
easat-4163	201	6	connors	connors	PROPN
easat-4163	201	7	and	and	CCONJ
easat-4163	201	8	j.	j.	PROPN
easat-4163	201	9	h.	h.	PROPN
easat-4163	201	10	levy	levy	PROPN
easat-4163	201	11	,	,	PUNCT
easat-4163	201	12	"	"	PUNCT
easat-4163	201	13	covid-19	covid-19	PROPN
easat-4163	201	14	and	and	CCONJ
easat-4163	201	15	its	its	PRON
easat-4163	201	16	implications	implication	NOUN
easat-4163	201	17	for	for	ADP
easat-4163	201	18	thrombosis	thrombosis	NOUN
easat-4163	201	19	and	and	CCONJ
easat-4163	201	20	anticoagulation	anticoagulation	NOUN
easat-4163	201	21	,	,	PUNCT
easat-4163	201	22	"	"	PUNCT
easat-4163	201	23	blood	blood	NOUN
easat-4163	201	24	,	,	PUNCT
easat-4163	201	25	the	the	DET
easat-4163	201	26	journal	journal	NOUN
easat-4163	201	27	of	of	ADP
easat-4163	201	28	the	the	DET
easat-4163	201	29	american	american	ADJ
easat-4163	201	30	society	society	NOUN
easat-4163	201	31	of	of	ADP
easat-4163	201	32	hematology	hematology	NOUN
easat-4163	201	33	,	,	PUNCT
easat-4163	201	34	vol	vol	NOUN
easat-4163	201	35	.	.	PROPN
easat-4163	201	36	135	135	NUM
easat-4163	201	37	,	,	PUNCT
easat-4163	201	38	no	no	INTJ
easat-4163	201	39	.	.	NOUN
easat-4163	201	40	23	23	NUM
easat-4163	201	41	,	,	PUNCT
easat-4163	201	42	pp	pp	ADJ
easat-4163	201	43	.	.	PUNCT
easat-4163	201	44	2033	2033	NUM
easat-4163	201	45	-	-	SYM
easat-4163	201	46	2040	2040	NUM
easat-4163	201	47	,	,	PUNCT
easat-4163	201	48	2020	2020	NUM
easat-4163	201	49	.	.	PUNCT
easat-4163	202	1	https://doi.org/10.1182/blood.2020006000	https://doi.org/10.1182/blood.2020006000	X
easat-4163	203	1	[	[	X
easat-4163	203	2	6	6	NUM
easat-4163	203	3	]	]	PUNCT
easat-4163	203	4	m.	m.	NOUN
easat-4163	203	5	boccia	boccia	PROPN
easat-4163	203	6	et	et	PROPN
easat-4163	203	7	al	al	PROPN
easat-4163	203	8	.	.	PROPN
easat-4163	203	9	,	,	PUNCT
easat-4163	203	10	"	"	PUNCT
easat-4163	203	11	covid-19	covid-19	PROPN
easat-4163	203	12	and	and	CCONJ
easat-4163	203	13	coagulative	coagulative	ADJ
easat-4163	203	14	axis	axis	NOUN
easat-4163	203	15	:	:	PUNCT
easat-4163	203	16	review	review	NOUN
easat-4163	203	17	of	of	ADP
easat-4163	203	18	emerging	emerge	VERB
easat-4163	203	19	aspects	aspect	NOUN
easat-4163	203	20	in	in	ADP
easat-4163	203	21	a	a	DET
easat-4163	203	22	novel	novel	ADJ
easat-4163	203	23	disease	disease	NOUN
easat-4163	203	24	,	,	PUNCT
easat-4163	203	25	"	"	PUNCT
easat-4163	203	26	monaldi	monaldi	ADJ
easat-4163	203	27	archives	archive	NOUN
easat-4163	203	28	for	for	ADP
easat-4163	203	29	chest	chest	NOUN
easat-4163	203	30	disease	disease	NOUN
easat-4163	203	31	,	,	PUNCT
easat-4163	203	32	vol	vol	NOUN
easat-4163	203	33	.	.	PROPN
easat-4163	204	1	90	90	NUM
easat-4163	204	2	,	,	PUNCT
easat-4163	204	3	no	no	INTJ
easat-4163	204	4	.	.	NOUN
easat-4163	204	5	2	2	NUM
easat-4163	204	6	,	,	PUNCT
easat-4163	204	7	pp	pp	ADJ
easat-4163	204	8	.	.	PUNCT
easat-4163	205	1	271	271	NUM
easat-4163	205	2	-	-	SYM
easat-4163	205	3	277	277	NUM
easat-4163	205	4	,	,	PUNCT
easat-4163	205	5	2020	2020	NUM
easat-4163	205	6	.	.	PUNCT
easat-4163	206	1	https://doi.org/10.4081/monaldi.2020.1300	https://doi.org/10.4081/monaldi.2020.1300	PROPN
easat-4163	207	1	[	[	X
easat-4163	207	2	7	7	NUM
easat-4163	207	3	]	]	PUNCT
easat-4163	207	4	centers	center	NOUN
easat-4163	207	5	,	,	PUNCT
easat-4163	207	6	"	"	PUNCT
easat-4163	207	7	centers	center	NOUN
easat-4163	207	8	for	for	ADP
easat-4163	207	9	disease	disease	NOUN
easat-4163	207	10	control	control	NOUN
easat-4163	207	11	and	and	CCONJ
easat-4163	207	12	prevention	prevention	NOUN
easat-4163	207	13	.	.	PUNCT
easat-4163	208	1	covid-19	covid-19	PROPN
easat-4163	208	2	:	:	PUNCT
easat-4163	208	3	overview	overview	NOUN
easat-4163	208	4	of	of	ADP
easat-4163	208	5	testing	testing	NOUN
easat-4163	208	6	for	for	ADP
easat-4163	208	7	sars	sar	NOUN
easat-4163	208	8	-	-	PUNCT
easat-4163	208	9	cov-2	cov-2	PART
easat-4163	208	10	(	(	PUNCT
easat-4163	208	11	covid-19	covid-19	PROPN
easat-4163	208	12	)	)	PUNCT
easat-4163	208	13	,	,	PUNCT
easat-4163	208	14	"	"	PUNCT
easat-4163	208	15	2022	2022	NUM
easat-4163	208	16	.	.	PUNCT
easat-4163	209	1	[	[	X
easat-4163	209	2	8	8	NUM
easat-4163	209	3	]	]	X
easat-4163	209	4	b.	b.	PROPN
easat-4163	209	5	j.	j.	PROPN
easat-4163	209	6	hunt	hunt	PROPN
easat-4163	209	7	,	,	PUNCT
easat-4163	209	8	"	"	PUNCT
easat-4163	209	9	bleeding	bleed	VERB
easat-4163	209	10	and	and	CCONJ
easat-4163	209	11	coagulopathies	coagulopathie	NOUN
easat-4163	209	12	in	in	ADP
easat-4163	209	13	critical	critical	ADJ
easat-4163	209	14	care	care	NOUN
easat-4163	209	15	,	,	PUNCT
easat-4163	209	16	"	"	PUNCT
easat-4163	209	17	new	new	PROPN
easat-4163	209	18	england	england	PROPN
easat-4163	209	19	journal	journal	PROPN
easat-4163	209	20	of	of	ADP
easat-4163	209	21	medicine	medicine	NOUN
easat-4163	209	22	,	,	PUNCT
easat-4163	209	23	vol	vol	NOUN
easat-4163	209	24	.	.	PROPN
easat-4163	209	25	370	370	NUM
easat-4163	209	26	,	,	PUNCT
easat-4163	209	27	no	no	INTJ
easat-4163	209	28	.	.	NOUN
easat-4163	209	29	9	9	NUM
easat-4163	209	30	,	,	PUNCT
easat-4163	209	31	pp	pp	ADJ
easat-4163	209	32	.	.	PUNCT
easat-4163	209	33	847859	847859	NUM
easat-4163	209	34	,	,	PUNCT
easat-4163	209	35	2014	2014	NUM
easat-4163	209	36	.	.	PUNCT
easat-4163	210	1	https://doi.org/10.1056/nejmra1208626	https://doi.org/10.1056/nejmra1208626	PROPN
easat-4163	211	1	[	[	X
easat-4163	211	2	9	9	NUM
easat-4163	211	3	]	]	X
easat-4163	211	4	b.	b.	PROPN
easat-4163	211	5	s.	s.	PROPN
easat-4163	211	6	joly	joly	PROPN
easat-4163	211	7	,	,	PUNCT
easat-4163	211	8	v.	v.	PROPN
easat-4163	211	9	siguret	siguret	PROPN
easat-4163	211	10	,	,	PUNCT
easat-4163	211	11	and	and	CCONJ
easat-4163	211	12	a.	a.	NOUN
easat-4163	211	13	veyradier	veyradier	NOUN
easat-4163	211	14	,	,	PUNCT
easat-4163	211	15	"	"	PUNCT
easat-4163	211	16	understanding	understand	VERB
easat-4163	211	17	pathophysiology	pathophysiology	NOUN
easat-4163	211	18	of	of	ADP
easat-4163	211	19	hemostasis	hemostasis	NOUN
easat-4163	211	20	disorders	disorder	NOUN
easat-4163	211	21	in	in	ADP
easat-4163	211	22	critically	critically	ADV
easat-4163	211	23	ill	ill	ADJ
easat-4163	211	24	patients	patient	NOUN
easat-4163	211	25	with	with	ADP
easat-4163	211	26	covid-19	covid-19	PROPN
easat-4163	211	27	,	,	PUNCT
easat-4163	211	28	"	"	PUNCT
easat-4163	211	29	intensive	intensive	ADJ
easat-4163	211	30	care	care	NOUN
easat-4163	211	31	medicine	medicine	NOUN
easat-4163	211	32	,	,	PUNCT
easat-4163	211	33	vol	vol	NOUN
easat-4163	211	34	.	.	PROPN
easat-4163	211	35	46	46	NUM
easat-4163	211	36	,	,	PUNCT
easat-4163	211	37	no	no	INTJ
easat-4163	211	38	.	.	NOUN
easat-4163	211	39	8	8	NUM
easat-4163	211	40	,	,	PUNCT
easat-4163	211	41	pp	pp	ADJ
easat-4163	211	42	.	.	PUNCT
easat-4163	211	43	1603	1603	NUM
easat-4163	211	44	-	-	SYM
easat-4163	211	45	1606	1606	NUM
easat-4163	211	46	,	,	PUNCT
easat-4163	211	47	2020	2020	NUM
easat-4163	211	48	.	.	PUNCT
easat-4163	212	1	https://doi.org/10.1007/s00134-020-06088-1	https://doi.org/10.1007/s00134-020-06088-1	PROPN
easat-4163	213	1	[	[	X
easat-4163	213	2	10	10	NUM
easat-4163	213	3	]	]	PUNCT
easat-4163	213	4	m.	m.	NOUN
easat-4163	213	5	ackermann	ackermann	PROPN
easat-4163	213	6	et	et	PROPN
easat-4163	213	7	al	al	PROPN
easat-4163	213	8	.	.	PROPN
easat-4163	213	9	,	,	PUNCT
easat-4163	213	10	"	"	PUNCT
easat-4163	213	11	pulmonary	pulmonary	ADJ
easat-4163	213	12	vascular	vascular	ADJ
easat-4163	213	13	endothelialitis	endothelialitis	NOUN
easat-4163	213	14	,	,	PUNCT
easat-4163	213	15	thrombosis	thrombosis	NOUN
easat-4163	213	16	,	,	PUNCT
easat-4163	213	17	and	and	CCONJ
easat-4163	213	18	angiogenesis	angiogenesis	NOUN
easat-4163	213	19	in	in	ADP
easat-4163	213	20	covid-19	covid-19	PROPN
easat-4163	213	21	,	,	PUNCT
easat-4163	213	22	"	"	PUNCT
easat-4163	213	23	new	new	PROPN
easat-4163	213	24	england	england	PROPN
easat-4163	213	25	journal	journal	PROPN
easat-4163	213	26	of	of	ADP
easat-4163	213	27	medicine	medicine	NOUN
easat-4163	213	28	,	,	PUNCT
easat-4163	213	29	vol	vol	NOUN
easat-4163	213	30	.	.	NOUN
easat-4163	213	31	383	383	NUM
easat-4163	213	32	,	,	PUNCT
easat-4163	213	33	no	no	INTJ
easat-4163	213	34	.	.	NOUN
easat-4163	213	35	2	2	NUM
easat-4163	213	36	,	,	PUNCT
easat-4163	213	37	pp	pp	ADJ
easat-4163	213	38	.	.	PUNCT
easat-4163	214	1	120	120	NUM
easat-4163	214	2	-	-	SYM
easat-4163	214	3	128	128	NUM
easat-4163	214	4	,	,	PUNCT
easat-4163	214	5	2020	2020	NUM
easat-4163	214	6	.	.	PUNCT
easat-4163	215	1	https://doi.org/10.1056/nejmoa2015432	https://doi.org/10.1056/nejmoa2015432	NOUN
easat-4163	216	1	[	[	X
easat-4163	216	2	11	11	NUM
easat-4163	216	3	]	]	X
easat-4163	216	4	f.	f.	PROPN
easat-4163	216	5	klok	klok	PROPN
easat-4163	216	6	et	et	PROPN
easat-4163	216	7	al	al	PROPN
easat-4163	216	8	.	.	PROPN
easat-4163	216	9	,	,	PUNCT
easat-4163	216	10	"	"	PUNCT
easat-4163	216	11	incidence	incidence	NOUN
easat-4163	216	12	of	of	ADP
easat-4163	216	13	thrombotic	thrombotic	ADJ
easat-4163	216	14	complications	complication	NOUN
easat-4163	216	15	in	in	ADP
easat-4163	216	16	critically	critically	ADV
easat-4163	216	17	ill	ill	ADJ
easat-4163	216	18	icu	icu	PROPN
easat-4163	216	19	patients	patient	NOUN
easat-4163	216	20	with	with	ADP
easat-4163	216	21	covid-19	covid-19	PROPN
easat-4163	216	22	,	,	PUNCT
easat-4163	216	23	"	"	PUNCT
easat-4163	216	24	thrombosis	thrombosis	NOUN
easat-4163	216	25	research	research	NOUN
easat-4163	216	26	,	,	PUNCT
easat-4163	216	27	vol	vol	NOUN
easat-4163	216	28	.	.	PROPN
easat-4163	216	29	191	191	NUM
easat-4163	216	30	,	,	PUNCT
easat-4163	216	31	pp	pp	ADJ
easat-4163	216	32	.	.	PUNCT
easat-4163	216	33	145	145	NUM
easat-4163	216	34	-	-	SYM
easat-4163	216	35	147	147	NUM
easat-4163	216	36	,	,	PUNCT
easat-4163	216	37	2020	2020	NUM
easat-4163	216	38	.	.	PUNCT
easat-4163	217	1	https://doi.org/10.1016/j.thromres.2020.04.013	https://doi.org/10.1016/j.thromres.2020.04.013	PROPN
easat-4163	217	2	[	[	X
easat-4163	217	3	12	12	NUM
easat-4163	217	4	]	]	X
easat-4163	217	5	n.	n.	PROPN
easat-4163	217	6	tang	tang	PROPN
easat-4163	217	7	,	,	PUNCT
easat-4163	217	8	h.	h.	PROPN
easat-4163	217	9	bai	bai	PROPN
easat-4163	217	10	,	,	PUNCT
easat-4163	217	11	x.	x.	PROPN
easat-4163	217	12	chen	chen	PROPN
easat-4163	217	13	,	,	PUNCT
easat-4163	217	14	j.	j.	PROPN
easat-4163	217	15	gong	gong	PROPN
easat-4163	217	16	,	,	PUNCT
easat-4163	217	17	d.	d.	PROPN
easat-4163	217	18	li	li	PROPN
easat-4163	217	19	,	,	PUNCT
easat-4163	217	20	and	and	CCONJ
easat-4163	217	21	z.	z.	PROPN
easat-4163	217	22	sun	sun	PROPN
easat-4163	217	23	,	,	PUNCT
easat-4163	217	24	"	"	PUNCT
easat-4163	217	25	anticoagulant	anticoagulant	ADJ
easat-4163	217	26	treatment	treatment	NOUN
easat-4163	217	27	is	be	AUX
easat-4163	217	28	associated	associate	VERB
easat-4163	217	29	with	with	ADP
easat-4163	217	30	decreased	decrease	VERB
easat-4163	217	31	mortality	mortality	NOUN
easat-4163	217	32	in	in	ADP
easat-4163	217	33	severe	severe	ADJ
easat-4163	217	34	coronavirus	coronavirus	NOUN
easat-4163	217	35	disease	disease	NOUN
easat-4163	217	36	2019	2019	NUM
easat-4163	217	37	patients	patient	NOUN
easat-4163	217	38	with	with	ADP
easat-4163	217	39	coagulopathy	coagulopathy	ADJ
easat-4163	217	40	,	,	PUNCT
easat-4163	217	41	"	"	PUNCT
easat-4163	217	42	journal	journal	NOUN
easat-4163	217	43	of	of	ADP
easat-4163	217	44	thrombosis	thrombosis	NOUN
easat-4163	217	45	and	and	CCONJ
easat-4163	217	46	haemostasis	haemostasis	NOUN
easat-4163	217	47	,	,	PUNCT
easat-4163	217	48	vol	vol	NOUN
easat-4163	217	49	.	.	PROPN
easat-4163	217	50	18	18	NUM
easat-4163	217	51	,	,	PUNCT
easat-4163	217	52	no	no	INTJ
easat-4163	217	53	.	.	NOUN
easat-4163	217	54	5	5	NUM
easat-4163	217	55	,	,	PUNCT
easat-4163	217	56	pp	pp	ADJ
easat-4163	217	57	.	.	PUNCT
easat-4163	217	58	1094	1094	NUM
easat-4163	217	59	-	-	SYM
easat-4163	217	60	1099	1099	NUM
easat-4163	217	61	,	,	PUNCT
easat-4163	217	62	2020	2020	NUM
easat-4163	217	63	.	.	PUNCT
easat-4163	218	1	https://doi.org/10.1111/jth.14817	https://doi.org/10.1111/jth.14817	NOUN
easat-4163	219	1	[	[	X
easat-4163	219	2	13	13	NUM
easat-4163	219	3	]	]	PUNCT
easat-4163	219	4	d.	d.	PROPN
easat-4163	219	5	mcgonagle	mcgonagle	PROPN
easat-4163	219	6	,	,	PUNCT
easat-4163	219	7	j.	j.	PROPN
easat-4163	219	8	s.	s.	PROPN
easat-4163	219	9	o'donnell	o'donnell	PROPN
easat-4163	219	10	,	,	PUNCT
easat-4163	219	11	k.	k.	PROPN
easat-4163	219	12	sharif	sharif	PROPN
easat-4163	219	13	,	,	PUNCT
easat-4163	219	14	p.	p.	PROPN
easat-4163	219	15	emery	emery	PROPN
easat-4163	219	16	,	,	PUNCT
easat-4163	219	17	and	and	CCONJ
easat-4163	219	18	c.	c.	PROPN
easat-4163	219	19	bridgewood	bridgewood	PROPN
easat-4163	219	20	,	,	PUNCT
easat-4163	219	21	"	"	PUNCT
easat-4163	219	22	immune	immune	ADJ
easat-4163	219	23	mechanisms	mechanism	NOUN
easat-4163	219	24	of	of	ADP
easat-4163	219	25	pulmonary	pulmonary	ADJ
easat-4163	219	26	intravascular	intravascular	ADJ
easat-4163	219	27	coagulopathy	coagulopathy	ADJ
easat-4163	219	28	in	in	ADP
easat-4163	219	29	covid-19	covid-19	PROPN
easat-4163	219	30	pneumonia	pneumonia	NOUN
easat-4163	219	31	,	,	PUNCT
easat-4163	219	32	"	"	PUNCT
easat-4163	219	33	the	the	DET
easat-4163	219	34	lancet	lancet	PROPN
easat-4163	219	35	rheumatology	rheumatology	NOUN
easat-4163	219	36	,	,	PUNCT
easat-4163	219	37	vol	vol	NOUN
easat-4163	219	38	.	.	PROPN
easat-4163	219	39	2	2	NUM
easat-4163	219	40	,	,	PUNCT
easat-4163	219	41	no	no	INTJ
easat-4163	219	42	.	.	NOUN
easat-4163	219	43	7	7	NUM
easat-4163	219	44	,	,	PUNCT
easat-4163	219	45	pp	pp	ADJ
easat-4163	219	46	.	.	PUNCT
easat-4163	220	1	e437	e437	PROPN
easat-4163	220	2	-	-	SYM
easat-4163	220	3	e445	e445	PROPN
easat-4163	220	4	,	,	PUNCT
easat-4163	220	5	2020	2020	NUM
easat-4163	220	6	.	.	PUNCT
easat-4163	221	1	https://doi.org/10.1016/s2665-9913(20)30121-1	https://doi.org/10.1016/s2665-9913(20)30121-1	PROPN
easat-4163	222	1	[	[	X
easat-4163	222	2	14	14	NUM
easat-4163	222	3	]	]	PUNCT
easat-4163	222	4	t.	t.	PROPN
easat-4163	222	5	zuo	zuo	PROPN
easat-4163	222	6	et	et	PROPN
easat-4163	222	7	al	al	PROPN
easat-4163	222	8	.	.	PROPN
easat-4163	222	9	,	,	PUNCT
easat-4163	222	10	"	"	PUNCT
easat-4163	222	11	alterations	alteration	NOUN
easat-4163	222	12	in	in	ADP
easat-4163	222	13	gut	gut	NOUN
easat-4163	222	14	microbiota	microbiota	NOUN
easat-4163	222	15	of	of	ADP
easat-4163	222	16	patients	patient	NOUN
easat-4163	222	17	with	with	ADP
easat-4163	222	18	covid-19	covid-19	PROPN
easat-4163	222	19	during	during	ADP
easat-4163	222	20	time	time	NOUN
easat-4163	222	21	of	of	ADP
easat-4163	222	22	hospitalization	hospitalization	NOUN
easat-4163	222	23	,	,	PUNCT
easat-4163	222	24	"	"	PUNCT
easat-4163	222	25	gastroenterology	gastroenterology	NOUN
easat-4163	222	26	,	,	PUNCT
easat-4163	222	27	vol	vol	NOUN
easat-4163	222	28	.	.	PROPN
easat-4163	222	29	159	159	NUM
easat-4163	222	30	,	,	PUNCT
easat-4163	222	31	no	no	INTJ
easat-4163	222	32	.	.	NOUN
easat-4163	222	33	3	3	NUM
easat-4163	222	34	,	,	PUNCT
easat-4163	222	35	pp	pp	ADJ
easat-4163	222	36	.	.	PUNCT
easat-4163	223	1	944	944	NUM
easat-4163	223	2	-	-	SYM
easat-4163	223	3	955	955	NUM
easat-4163	223	4	.	.	PUNCT
easat-4163	223	5	e8	e8	PROPN
easat-4163	223	6	,	,	PUNCT
easat-4163	223	7	2020	2020	NUM
easat-4163	223	8	.	.	PUNCT
easat-4163	224	1	https://doi.org/10.1053/j.gastro.2020.05.048	https://doi.org/10.1053/j.gastro.2020.05.048	NOUN
easat-4163	225	1	[	[	X
easat-4163	225	2	15	15	NUM
easat-4163	225	3	]	]	PUNCT
easat-4163	225	4	t.	t.	PROPN
easat-4163	225	5	iba	iba	PROPN
easat-4163	225	6	,	,	PUNCT
easat-4163	225	7	j.	j.	PROPN
easat-4163	225	8	m.	m.	PROPN
easat-4163	225	9	connors	connor	NOUN
easat-4163	225	10	,	,	PUNCT
easat-4163	225	11	and	and	CCONJ
easat-4163	225	12	j.	j.	PROPN
easat-4163	225	13	h.	h.	PROPN
easat-4163	225	14	levy	levy	PROPN
easat-4163	225	15	,	,	PUNCT
easat-4163	225	16	"	"	PUNCT
easat-4163	225	17	the	the	DET
easat-4163	225	18	coagulopathy	coagulopathy	ADJ
easat-4163	225	19	,	,	PUNCT
easat-4163	225	20	endotheliopathy	endotheliopathy	ADJ
easat-4163	225	21	,	,	PUNCT
easat-4163	225	22	and	and	CCONJ
easat-4163	225	23	vasculitis	vasculitis	NOUN
easat-4163	225	24	of	of	ADP
easat-4163	225	25	covid-19	covid-19	PROPN
easat-4163	225	26	,	,	PUNCT
easat-4163	225	27	"	"	PUNCT
easat-4163	225	28	inflammation	inflammation	ADJ
easat-4163	225	29	research	research	NOUN
easat-4163	225	30	,	,	PUNCT
easat-4163	225	31	vol	vol	NOUN
easat-4163	225	32	.	.	PROPN
easat-4163	225	33	69	69	NUM
easat-4163	225	34	,	,	PUNCT
easat-4163	225	35	pp	pp	ADJ
easat-4163	225	36	.	.	PUNCT
easat-4163	226	1	1181	1181	NUM
easat-4163	226	2	-	-	SYM
easat-4163	226	3	1189	1189	NUM
easat-4163	226	4	,	,	PUNCT
easat-4163	226	5	2020	2020	NUM
easat-4163	226	6	.	.	PUNCT
easat-4163	227	1	https://doi.org/10.1007/s00011-020-01401-6	https://doi.org/10.1007/s00011-020-01401-6	NUM
easat-4163	228	1	[	[	X
easat-4163	228	2	16	16	NUM
easat-4163	228	3	]	]	PUNCT
easat-4163	228	4	p.	p.	PROPN
easat-4163	228	5	mehta	mehta	PROPN
easat-4163	228	6	,	,	PUNCT
easat-4163	228	7	d.	d.	PROPN
easat-4163	228	8	f.	f.	PROPN
easat-4163	228	9	mcauley	mcauley	PROPN
easat-4163	228	10	,	,	PUNCT
easat-4163	228	11	m.	m.	NOUN
easat-4163	228	12	brown	brown	PROPN
easat-4163	228	13	,	,	PUNCT
easat-4163	228	14	e.	e.	PROPN
easat-4163	228	15	sanchez	sanchez	PROPN
easat-4163	228	16	,	,	PUNCT
easat-4163	228	17	r.	r.	PROPN
easat-4163	228	18	s.	s.	PROPN
easat-4163	228	19	tattersall	tattersall	PROPN
easat-4163	228	20	,	,	PUNCT
easat-4163	228	21	and	and	CCONJ
easat-4163	228	22	j.	j.	PROPN
easat-4163	228	23	j.	j.	PROPN
easat-4163	228	24	manson	manson	PROPN
easat-4163	228	25	,	,	PUNCT
easat-4163	228	26	"	"	PUNCT
easat-4163	228	27	covid-19	covid-19	PROPN
easat-4163	228	28	:	:	PUNCT
easat-4163	228	29	consider	consider	VERB
easat-4163	228	30	cytokine	cytokine	ADJ
easat-4163	228	31	storm	storm	NOUN
easat-4163	228	32	syndromes	syndrome	NOUN
easat-4163	228	33	and	and	CCONJ
easat-4163	228	34	immunosuppression	immunosuppression	NOUN
easat-4163	228	35	,	,	PUNCT
easat-4163	228	36	"	"	PUNCT
easat-4163	228	37	the	the	DET
easat-4163	228	38	lancet	lancet	NOUN
easat-4163	228	39	,	,	PUNCT
easat-4163	228	40	vol	vol	NOUN
easat-4163	228	41	.	.	PROPN
easat-4163	229	1	395	395	NUM
easat-4163	229	2	,	,	PUNCT
easat-4163	229	3	no	no	INTJ
easat-4163	229	4	.	.	NOUN
easat-4163	229	5	10229	10229	NUM
easat-4163	229	6	,	,	PUNCT
easat-4163	229	7	pp	pp	ADP
easat-4163	229	8	.	.	PUNCT
easat-4163	230	1	1033	1033	NUM
easat-4163	230	2	-	-	SYM
easat-4163	230	3	1034	1034	NUM
easat-4163	230	4	,	,	PUNCT
easat-4163	230	5	2020	2020	NUM
easat-4163	230	6	.	.	PUNCT
easat-4163	231	1	https://doi.org/10.1016/s0140-6736(20)30628-0	https://doi.org/10.1016/s0140-6736(20)30628-0	PROPN
easat-4163	232	1	[	[	X
easat-4163	232	2	17	17	NUM
easat-4163	232	3	]	]	PUNCT
easat-4163	232	4	z.	z.	PROPN
easat-4163	232	5	varga	varga	PROPN
easat-4163	232	6	et	et	PROPN
easat-4163	232	7	al	al	PROPN
easat-4163	232	8	.	.	PROPN
easat-4163	232	9	,	,	PUNCT
easat-4163	232	10	"	"	PUNCT
easat-4163	232	11	endothelial	endothelial	ADJ
easat-4163	232	12	cell	cell	NOUN
easat-4163	232	13	infection	infection	NOUN
easat-4163	232	14	and	and	CCONJ
easat-4163	232	15	endotheliitis	endotheliitis	PRON
easat-4163	232	16	in	in	ADP
easat-4163	232	17	covid-19	covid-19	PROPN
easat-4163	232	18	,	,	PUNCT
easat-4163	232	19	"	"	PUNCT
easat-4163	232	20	the	the	DET
easat-4163	232	21	lancet	lancet	NOUN
easat-4163	232	22	,	,	PUNCT
easat-4163	232	23	vol	vol	NOUN
easat-4163	232	24	.	.	PROPN
easat-4163	233	1	395	395	NUM
easat-4163	233	2	,	,	PUNCT
easat-4163	233	3	no	no	INTJ
easat-4163	233	4	.	.	NOUN
easat-4163	233	5	10234	10234	NUM
easat-4163	233	6	,	,	PUNCT
easat-4163	233	7	pp	pp	ADJ
easat-4163	233	8	.	.	PUNCT
easat-4163	234	1	14171418	14171418	NUM
easat-4163	234	2	,	,	PUNCT
easat-4163	234	3	2020	2020	NUM
easat-4163	234	4	.	.	PUNCT
easat-4163	235	1	https://doi.org/10.1016/s0140-6736(20)30937-5	https://doi.org/10.1016/s0140-6736(20)30937-5	PROPN
easat-4163	235	2	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-4163	235	3	https://doi.org/10.1182/blood.2020006000	https://doi.org/10.1182/blood.2020006000	PROPN
easat-4163	236	1	https://doi.org/10.4081/monaldi.2020.1300	https://doi.org/10.4081/monaldi.2020.1300	PROPN
easat-4163	236	2	https://doi.org/10.1056/nejmra1208626	https://doi.org/10.1056/nejmra1208626	PROPN
easat-4163	236	3	https://doi.org/10.1007/s00134-020-06088-1	https://doi.org/10.1007/s00134-020-06088-1	NUM
easat-4163	236	4	https://doi.org/10.1056/nejmoa2015432	https://doi.org/10.1056/nejmoa2015432	NOUN
easat-4163	236	5	https://doi.org/10.1016/j.thromres.2020.04.013	https://doi.org/10.1016/j.thromres.2020.04.013	PROPN
easat-4163	236	6	https://doi.org/10.1111/jth.14817	https://doi.org/10.1111/jth.14817	PROPN
easat-4163	236	7	https://doi.org/10.1016/s2665-9913(20)30121-1	https://doi.org/10.1016/s2665-9913(20)30121-1	PROPN
easat-4163	236	8	https://doi.org/10.1053/j.gastro.2020.05.048	https://doi.org/10.1053/j.gastro.2020.05.048	PROPN
easat-4163	236	9	https://doi.org/10.1007/s00011-020-01401-6	https://doi.org/10.1007/s00011-020-01401-6	NUM
easat-4163	236	10	https://doi.org/10.1016/s0140-6736(20)30628-0	https://doi.org/10.1016/s0140-6736(20)30628-0	PROPN
easat-4163	236	11	https://doi.org/10.1016/s0140-6736(20)30937-5	https://doi.org/10.1016/s0140-6736(20)30937-5	PROPN
easat-4163	236	12	514	514	NUM
easat-4163	236	13	edelweiss	edelweiss	PROPN
easat-4163	236	14	applied	apply	VERB
easat-4163	236	15	science	science	NOUN
easat-4163	236	16	and	and	CCONJ
easat-4163	236	17	technology	technology	NOUN
easat-4163	236	18	issn	issn	PROPN
easat-4163	236	19	:	:	PUNCT
easat-4163	236	20	2576	2576	NUM
easat-4163	236	21	-	-	SYM
easat-4163	236	22	8484	8484	NUM
easat-4163	236	23	vol	vol	NOUN
easat-4163	236	24	.	.	PROPN
easat-4163	237	1	9	9	NUM
easat-4163	237	2	,	,	PUNCT
easat-4163	237	3	no	no	INTJ
easat-4163	237	4	.	.	NOUN
easat-4163	237	5	1	1	NUM
easat-4163	237	6	:	:	PUNCT
easat-4163	237	7	505	505	NUM
easat-4163	237	8	-	-	SYM
easat-4163	237	9	514	514	NUM
easat-4163	237	10	,	,	PUNCT
easat-4163	237	11	2025	2025	NUM
easat-4163	237	12	doi	doi	NOUN
easat-4163	237	13	:	:	PUNCT
easat-4163	237	14	10.55214/25768484.v9i1.4163	10.55214/25768484.v9i1.4163	NUM
easat-4163	237	15	©	©	PROPN
easat-4163	237	16	2025	2025	NUM
easat-4163	237	17	by	by	ADP
easat-4163	237	18	the	the	DET
easat-4163	237	19	authors	author	NOUN
easat-4163	237	20	;	;	PUNCT
easat-4163	237	21	licensee	licensee	PROPN
easat-4163	237	22	learning	learning	NOUN
easat-4163	237	23	gate	gate	NOUN
easat-4163	238	1	[	[	X
easat-4163	238	2	18	18	NUM
easat-4163	238	3	]	]	PUNCT
easat-4163	238	4	m.	m.	NOUN
easat-4163	238	5	levi	levi	PROPN
easat-4163	238	6	,	,	PUNCT
easat-4163	238	7	j.	j.	PROPN
easat-4163	238	8	thachil	thachil	PROPN
easat-4163	238	9	,	,	PUNCT
easat-4163	238	10	t.	t.	PROPN
easat-4163	238	11	iba	iba	PROPN
easat-4163	238	12	,	,	PUNCT
easat-4163	238	13	and	and	CCONJ
easat-4163	238	14	j.	j.	PROPN
easat-4163	238	15	h.	h.	PROPN
easat-4163	238	16	levy	levy	PROPN
easat-4163	238	17	,	,	PUNCT
easat-4163	238	18	"	"	PUNCT
easat-4163	238	19	coagulation	coagulation	NOUN
easat-4163	238	20	abnormalities	abnormality	NOUN
easat-4163	238	21	and	and	CCONJ
easat-4163	238	22	thrombosis	thrombosis	NOUN
easat-4163	238	23	in	in	ADP
easat-4163	238	24	patients	patient	NOUN
easat-4163	238	25	with	with	ADP
easat-4163	238	26	covid-19	covid-19	PROPN
easat-4163	238	27	,	,	PUNCT
easat-4163	238	28	"	"	PUNCT
easat-4163	238	29	the	the	DET
easat-4163	238	30	lancet	lancet	PROPN
easat-4163	238	31	haematology	haematology	NOUN
easat-4163	238	32	,	,	PUNCT
easat-4163	238	33	vol	vol	NOUN
easat-4163	238	34	.	.	PROPN
easat-4163	238	35	7	7	NUM
easat-4163	238	36	,	,	PUNCT
easat-4163	238	37	no	no	INTJ
easat-4163	238	38	.	.	NOUN
easat-4163	238	39	6	6	NUM
easat-4163	238	40	,	,	PUNCT
easat-4163	238	41	pp	pp	ADJ
easat-4163	238	42	.	.	PUNCT
easat-4163	239	1	e438	e438	NUM
easat-4163	239	2	-	-	SYM
easat-4163	239	3	e440	e440	PROPN
easat-4163	239	4	,	,	PUNCT
easat-4163	239	5	2020	2020	NUM
easat-4163	239	6	.	.	PUNCT
easat-4163	240	1	https://doi.org/10.1016/s2352-3026(20)30145-9	https://doi.org/10.1016/s2352-3026(20)30145-9	PRON
easat-4163	240	2	[	[	X
easat-4163	240	3	19	19	NUM
easat-4163	240	4	]	]	PUNCT
easat-4163	240	5	b.	b.	PROPN
easat-4163	241	1	k.	k.	PROPN
easat-4163	241	2	manne	manne	PROPN
easat-4163	241	3	et	et	PROPN
easat-4163	241	4	al	al	PROPN
easat-4163	241	5	.	.	PROPN
easat-4163	241	6	,	,	PUNCT
easat-4163	241	7	"	"	PUNCT
easat-4163	241	8	platelet	platelet	NOUN
easat-4163	241	9	gene	gene	NOUN
easat-4163	241	10	expression	expression	NOUN
easat-4163	241	11	and	and	CCONJ
easat-4163	241	12	function	function	NOUN
easat-4163	241	13	in	in	ADP
easat-4163	241	14	patients	patient	NOUN
easat-4163	241	15	with	with	ADP
easat-4163	241	16	covid-19	covid-19	PROPN
easat-4163	241	17	,	,	PUNCT
easat-4163	241	18	"	"	PUNCT
easat-4163	241	19	blood	blood	NOUN
easat-4163	241	20	,	,	PUNCT
easat-4163	241	21	the	the	DET
easat-4163	241	22	journal	journal	NOUN
easat-4163	241	23	of	of	ADP
easat-4163	241	24	the	the	DET
easat-4163	241	25	american	american	ADJ
easat-4163	241	26	society	society	NOUN
easat-4163	241	27	of	of	ADP
easat-4163	241	28	hematology	hematology	NOUN
easat-4163	241	29	,	,	PUNCT
easat-4163	241	30	vol	vol	NOUN
easat-4163	241	31	.	.	PROPN
easat-4163	241	32	136	136	NUM
easat-4163	241	33	,	,	PUNCT
easat-4163	241	34	no	no	INTJ
easat-4163	241	35	.	.	NOUN
easat-4163	241	36	11	11	NUM
easat-4163	241	37	,	,	PUNCT
easat-4163	241	38	pp	pp	ADJ
easat-4163	241	39	.	.	PUNCT
easat-4163	242	1	1317	1317	NUM
easat-4163	242	2	-	-	SYM
easat-4163	242	3	1329	1329	NUM
easat-4163	242	4	,	,	PUNCT
easat-4163	242	5	2020	2020	NUM
easat-4163	242	6	.	.	PUNCT
easat-4163	243	1	https://doi.org/10.1182/blood.2020007214	https://doi.org/10.1182/blood.2020007214	ADJ
easat-4163	243	2	[	[	X
easat-4163	243	3	20	20	NUM
easat-4163	243	4	]	]	PUNCT
easat-4163	243	5	t.	t.	PROPN
easat-4163	243	6	iba	iba	PROPN
easat-4163	243	7	,	,	PUNCT
easat-4163	243	8	j.	j.	PROPN
easat-4163	243	9	h.	h.	PROPN
easat-4163	243	10	levy	levy	PROPN
easat-4163	243	11	,	,	PUNCT
easat-4163	243	12	m.	m.	NOUN
easat-4163	243	13	levi	levi	PROPN
easat-4163	243	14	,	,	PUNCT
easat-4163	243	15	and	and	CCONJ
easat-4163	243	16	j.	j.	PROPN
easat-4163	243	17	thachil	thachil	PROPN
easat-4163	243	18	,	,	PUNCT
easat-4163	243	19	"	"	PUNCT
easat-4163	243	20	coagulopathy	coagulopathy	ADJ
easat-4163	243	21	in	in	ADP
easat-4163	243	22	covid‐19	covid‐19	PROPN
easat-4163	243	23	,	,	PUNCT
easat-4163	243	24	"	"	PUNCT
easat-4163	243	25	journal	journal	NOUN
easat-4163	243	26	of	of	ADP
easat-4163	243	27	thrombosis	thrombosis	NOUN
easat-4163	243	28	and	and	CCONJ
easat-4163	243	29	haemostasis	haemostasis	NOUN
easat-4163	243	30	,	,	PUNCT
easat-4163	243	31	vol	vol	NOUN
easat-4163	243	32	.	.	PROPN
easat-4163	243	33	18	18	NUM
easat-4163	243	34	,	,	PUNCT
easat-4163	243	35	no	no	INTJ
easat-4163	243	36	.	.	NOUN
easat-4163	243	37	9	9	NUM
easat-4163	243	38	,	,	PUNCT
easat-4163	243	39	pp	pp	ADJ
easat-4163	243	40	.	.	PUNCT
easat-4163	243	41	2103	2103	NUM
easat-4163	243	42	-	-	SYM
easat-4163	243	43	2109	2109	NUM
easat-4163	243	44	,	,	PUNCT
easat-4163	243	45	2020	2020	NUM
easat-4163	243	46	.	.	PUNCT
easat-4163	244	1	[	[	X
easat-4163	244	2	21	21	NUM
easat-4163	244	3	]	]	X
easat-4163	244	4	j.	j.	PROPN
easat-4163	244	5	gollamudi	gollamudi	PROPN
easat-4163	244	6	et	et	PROPN
easat-4163	244	7	al	al	PROPN
easat-4163	244	8	.	.	PROPN
easat-4163	244	9	,	,	PUNCT
easat-4163	244	10	"	"	PUNCT
easat-4163	244	11	thrombosis	thrombosis	NOUN
easat-4163	244	12	and	and	CCONJ
easat-4163	244	13	thromboembolism	thromboembolism	NOUN
easat-4163	244	14	:	:	PUNCT
easat-4163	244	15	brighton	brighton	PROPN
easat-4163	244	16	collaboration	collaboration	NOUN
easat-4163	244	17	case	case	NOUN
easat-4163	244	18	definition	definition	NOUN
easat-4163	244	19	and	and	CCONJ
easat-4163	244	20	guidelines	guideline	NOUN
easat-4163	244	21	for	for	ADP
easat-4163	244	22	data	data	NOUN
easat-4163	244	23	collection	collection	NOUN
easat-4163	244	24	,	,	PUNCT
easat-4163	244	25	analysis	analysis	NOUN
easat-4163	244	26	,	,	PUNCT
easat-4163	244	27	and	and	CCONJ
easat-4163	244	28	presentation	presentation	NOUN
easat-4163	244	29	of	of	ADP
easat-4163	244	30	immunization	immunization	NOUN
easat-4163	244	31	safety	safety	NOUN
easat-4163	244	32	data	datum	NOUN
easat-4163	244	33	,	,	PUNCT
easat-4163	244	34	"	"	PUNCT
easat-4163	244	35	vaccine	vaccine	NOUN
easat-4163	244	36	,	,	PUNCT
easat-4163	244	37	vol	vol	NOUN
easat-4163	244	38	.	.	PROPN
easat-4163	244	39	40	40	NUM
easat-4163	244	40	,	,	PUNCT
easat-4163	244	41	no	no	INTJ
easat-4163	244	42	.	.	NOUN
easat-4163	244	43	44	44	NUM
easat-4163	244	44	,	,	PUNCT
easat-4163	244	45	pp	pp	ADJ
easat-4163	244	46	.	.	PUNCT
easat-4163	244	47	6431	6431	NUM
easat-4163	244	48	-	-	SYM
easat-4163	244	49	6444	6444	NUM
easat-4163	244	50	,	,	PUNCT
easat-4163	244	51	2022	2022	NUM
easat-4163	244	52	.	.	PUNCT
easat-4163	245	1	https://doi.org/10.1016/j.vaccine.2022.09.001	https://doi.org/10.1016/j.vaccine.2022.09.001	VERB
easat-4163	246	1	[	[	X
easat-4163	246	2	22	22	NUM
easat-4163	246	3	]	]	PUNCT
easat-4163	246	4	j.	j.	PROPN
easat-4163	246	5	poissy	poissy	PROPN
easat-4163	246	6	et	et	PROPN
easat-4163	246	7	al	al	PROPN
easat-4163	246	8	.	.	PROPN
easat-4163	246	9	,	,	PUNCT
easat-4163	246	10	"	"	PUNCT
easat-4163	246	11	pulmonary	pulmonary	ADJ
easat-4163	246	12	embolism	embolism	NOUN
easat-4163	246	13	in	in	ADP
easat-4163	246	14	patients	patient	NOUN
easat-4163	246	15	with	with	ADP
easat-4163	246	16	covid-19	covid-19	PROPN
easat-4163	246	17	:	:	PUNCT
easat-4163	246	18	awareness	awareness	NOUN
easat-4163	246	19	of	of	ADP
easat-4163	246	20	an	an	DET
easat-4163	246	21	increased	increase	VERB
easat-4163	246	22	prevalence	prevalence	NOUN
easat-4163	246	23	,	,	PUNCT
easat-4163	246	24	"	"	PUNCT
easat-4163	246	25	circulation	circulation	NOUN
easat-4163	246	26	,	,	PUNCT
easat-4163	246	27	vol	vol	NOUN
easat-4163	246	28	.	.	PROPN
easat-4163	246	29	142	142	NUM
easat-4163	246	30	,	,	PUNCT
easat-4163	246	31	no	no	INTJ
easat-4163	246	32	.	.	NOUN
easat-4163	246	33	2	2	NUM
easat-4163	246	34	,	,	PUNCT
easat-4163	246	35	pp	pp	ADJ
easat-4163	246	36	.	.	PUNCT
easat-4163	247	1	184	184	NUM
easat-4163	247	2	-	-	SYM
easat-4163	247	3	186	186	NUM
easat-4163	247	4	,	,	PUNCT
easat-4163	247	5	2020	2020	NUM
easat-4163	247	6	.	.	PUNCT
easat-4163	248	1	[	[	X
easat-4163	248	2	23	23	NUM
easat-4163	248	3	]	]	PUNCT
easat-4163	248	4	a.	a.	PROPN
easat-4163	248	5	e.	e.	PROPN
easat-4163	248	6	merkler	merkler	PROPN
easat-4163	248	7	et	et	PROPN
easat-4163	248	8	al	al	PROPN
easat-4163	248	9	.	.	PROPN
easat-4163	248	10	,	,	PUNCT
easat-4163	248	11	"	"	PUNCT
easat-4163	248	12	risk	risk	NOUN
easat-4163	248	13	of	of	ADP
easat-4163	248	14	ischemic	ischemic	ADJ
easat-4163	248	15	stroke	stroke	NOUN
easat-4163	248	16	in	in	ADP
easat-4163	248	17	patients	patient	NOUN
easat-4163	248	18	with	with	ADP
easat-4163	248	19	coronavirus	coronavirus	NOUN
easat-4163	248	20	disease	disease	NOUN
easat-4163	248	21	2019	2019	NUM
easat-4163	248	22	(	(	PUNCT
easat-4163	248	23	covid-19	covid-19	PROPN
easat-4163	248	24	)	)	PUNCT
easat-4163	248	25	vs	vs	ADP
easat-4163	248	26	patients	patient	NOUN
easat-4163	248	27	with	with	ADP
easat-4163	248	28	influenza	influenza	NOUN
easat-4163	248	29	,	,	PUNCT
easat-4163	248	30	"	"	PUNCT
easat-4163	248	31	jama	jama	PROPN
easat-4163	248	32	neurology	neurology	NOUN
easat-4163	248	33	,	,	PUNCT
easat-4163	248	34	vol	vol	NOUN
easat-4163	248	35	.	.	PROPN
easat-4163	249	1	77	77	NUM
easat-4163	249	2	,	,	PUNCT
easat-4163	249	3	no	no	INTJ
easat-4163	249	4	.	.	NOUN
easat-4163	249	5	11	11	NUM
easat-4163	249	6	,	,	PUNCT
easat-4163	249	7	pp	pp	ADJ
easat-4163	249	8	.	.	PUNCT
easat-4163	250	1	1366	1366	NUM
easat-4163	250	2	-	-	SYM
easat-4163	250	3	1372	1372	NUM
easat-4163	250	4	,	,	PUNCT
easat-4163	250	5	2020	2020	NUM
easat-4163	250	6	.	.	PUNCT
easat-4163	251	1	https://doi.org/10.1001/jamaneurol.2020.2730	https://doi.org/10.1001/jamaneurol.2020.2730	PROPN
easat-4163	252	1	[	[	X
easat-4163	252	2	24	24	NUM
easat-4163	252	3	]	]	PUNCT
easat-4163	252	4	c.	c.	PROPN
easat-4163	252	5	magro	magro	PROPN
easat-4163	252	6	et	et	PROPN
easat-4163	252	7	al	al	PROPN
easat-4163	252	8	.	.	PROPN
easat-4163	252	9	,	,	PUNCT
easat-4163	252	10	"	"	PUNCT
easat-4163	252	11	complement	complement	VERB
easat-4163	252	12	associated	associate	VERB
easat-4163	252	13	microvascular	microvascular	NOUN
easat-4163	252	14	injury	injury	NOUN
easat-4163	252	15	and	and	CCONJ
easat-4163	252	16	thrombosis	thrombosis	NOUN
easat-4163	252	17	in	in	ADP
easat-4163	252	18	the	the	DET
easat-4163	252	19	pathogenesis	pathogenesis	NOUN
easat-4163	252	20	of	of	ADP
easat-4163	252	21	severe	severe	ADJ
easat-4163	252	22	covid19	covid19	NOUN
easat-4163	252	23	infection	infection	NOUN
easat-4163	252	24	:	:	PUNCT
easat-4163	252	25	a	a	DET
easat-4163	252	26	report	report	NOUN
easat-4163	252	27	of	of	ADP
easat-4163	252	28	five	five	NUM
easat-4163	252	29	cases	case	NOUN
easat-4163	252	30	,	,	PUNCT
easat-4163	252	31	"	"	PUNCT
easat-4163	252	32	translational	translational	ADJ
easat-4163	252	33	research	research	NOUN
easat-4163	252	34	,	,	PUNCT
easat-4163	252	35	vol	vol	NOUN
easat-4163	252	36	.	.	NOUN
easat-4163	252	37	220	220	NUM
easat-4163	252	38	,	,	PUNCT
easat-4163	252	39	pp	pp	ADJ
easat-4163	252	40	.	.	PUNCT
easat-4163	253	1	1	1	NUM
easat-4163	253	2	-	-	SYM
easat-4163	253	3	13	13	NUM
easat-4163	253	4	,	,	PUNCT
easat-4163	253	5	2020	2020	NUM
easat-4163	253	6	.	.	PUNCT
easat-4163	254	1	https://doi.org/10.1016/j.trsl.2020.04.007	https://doi.org/10.1016/j.trsl.2020.04.007	PROPN
easat-4163	254	2	[	[	X
easat-4163	254	3	25	25	NUM
easat-4163	254	4	]	]	PUNCT
easat-4163	254	5	x.-h	x.-h	PROPN
easat-4163	254	6	.	.	PUNCT
easat-4163	255	1	yang	yang	PROPN
easat-4163	255	2	,	,	PUNCT
easat-4163	255	3	r.-r	r.-r	PROPN
easat-4163	255	4	.	.	PUNCT
easat-4163	256	1	li	li	PROPN
easat-4163	256	2	,	,	PUNCT
easat-4163	256	3	r.-h	r.-h	NOUN
easat-4163	256	4	.	.	PUNCT
easat-4163	257	1	sun	sun	PROPN
easat-4163	257	2	,	,	PUNCT
easat-4163	257	3	j.	j.	PROPN
easat-4163	257	4	liu	liu	PROPN
easat-4163	257	5	,	,	PUNCT
easat-4163	257	6	and	and	CCONJ
easat-4163	257	7	d.-c	d.-c	PROPN
easat-4163	257	8	.	.	PUNCT
easat-4163	258	1	chen	chen	PROPN
easat-4163	258	2	,	,	PUNCT
easat-4163	258	3	"	"	PUNCT
easat-4163	258	4	focus	focus	VERB
easat-4163	258	5	on	on	ADP
easat-4163	258	6	coronavirus	coronavirus	NOUN
easat-4163	258	7	disease	disease	NOUN
easat-4163	258	8	2019	2019	NUM
easat-4163	258	9	associated	associate	VERB
easat-4163	258	10	coagulopathy	coagulopathy	ADJ
easat-4163	258	11	,	,	PUNCT
easat-4163	258	12	"	"	PUNCT
easat-4163	258	13	chinese	chinese	ADJ
easat-4163	258	14	medical	medical	ADJ
easat-4163	258	15	journal	journal	PROPN
easat-4163	258	16	,	,	PUNCT
easat-4163	258	17	vol	vol	NOUN
easat-4163	258	18	.	.	PROPN
easat-4163	258	19	133	133	NUM
easat-4163	258	20	,	,	PUNCT
easat-4163	258	21	no	no	INTJ
easat-4163	258	22	.	.	NOUN
easat-4163	258	23	18	18	NUM
easat-4163	258	24	,	,	PUNCT
easat-4163	258	25	pp	pp	ADJ
easat-4163	258	26	.	.	PUNCT
easat-4163	259	1	2239	2239	NUM
easat-4163	259	2	-	-	SYM
easat-4163	259	3	2241	2241	NUM
easat-4163	259	4	,	,	PUNCT
easat-4163	259	5	2020	2020	NUM
easat-4163	259	6	.	.	PUNCT
easat-4163	260	1	[	[	X
easat-4163	260	2	26	26	NUM
easat-4163	260	3	]	]	PUNCT
easat-4163	260	4	s.	s.	PROPN
easat-4163	260	5	testa	testa	PROPN
easat-4163	260	6	et	et	PROPN
easat-4163	260	7	al	al	PROPN
easat-4163	260	8	.	.	PROPN
easat-4163	260	9	,	,	PUNCT
easat-4163	260	10	"	"	PUNCT
easat-4163	260	11	direct	direct	ADJ
easat-4163	260	12	oral	oral	ADJ
easat-4163	260	13	anticoagulant	anticoagulant	ADJ
easat-4163	260	14	plasma	plasma	NOUN
easat-4163	260	15	levels	level	NOUN
easat-4163	260	16	’	'	PUNCT
easat-4163	260	17	striking	strike	VERB
easat-4163	260	18	increase	increase	NOUN
easat-4163	260	19	in	in	ADP
easat-4163	260	20	severe	severe	ADJ
easat-4163	260	21	covid‐19	covid‐19	PROPN
easat-4163	260	22	respiratory	respiratory	ADJ
easat-4163	260	23	syndrome	syndrome	NOUN
easat-4163	260	24	patients	patient	NOUN
easat-4163	260	25	treated	treat	VERB
easat-4163	260	26	with	with	ADP
easat-4163	260	27	antiviral	antiviral	ADJ
easat-4163	260	28	agents	agent	NOUN
easat-4163	260	29	:	:	PUNCT
easat-4163	260	30	the	the	DET
easat-4163	260	31	cremona	cremona	PROPN
easat-4163	260	32	experience	experience	NOUN
easat-4163	260	33	,	,	PUNCT
easat-4163	260	34	"	"	PUNCT
easat-4163	260	35	journal	journal	NOUN
easat-4163	260	36	of	of	ADP
easat-4163	260	37	thrombosis	thrombosis	NOUN
easat-4163	260	38	and	and	CCONJ
easat-4163	260	39	haemostasis	haemostasis	NOUN
easat-4163	260	40	,	,	PUNCT
easat-4163	260	41	vol	vol	NOUN
easat-4163	260	42	.	.	PROPN
easat-4163	260	43	18	18	NUM
easat-4163	260	44	,	,	PUNCT
easat-4163	260	45	no	no	INTJ
easat-4163	260	46	.	.	NOUN
easat-4163	260	47	6	6	NUM
easat-4163	260	48	,	,	PUNCT
easat-4163	260	49	pp	pp	ADJ
easat-4163	260	50	.	.	PUNCT
easat-4163	260	51	1320	1320	NUM
easat-4163	260	52	-	-	SYM
easat-4163	260	53	1323	1323	NUM
easat-4163	260	54	,	,	PUNCT
easat-4163	260	55	2020	2020	NUM
easat-4163	260	56	.	.	PUNCT
easat-4163	261	1	https://doi.org/10.1111/jth.14871	https://doi.org/10.1111/jth.14871	PROPN
easat-4163	262	1	[	[	X
easat-4163	262	2	27	27	NUM
easat-4163	262	3	]	]	X
easat-4163	262	4	r.	r.	PROPN
easat-4163	262	5	beun	beun	PROPN
easat-4163	262	6	,	,	PUNCT
easat-4163	262	7	n.	n.	PROPN
easat-4163	262	8	kusadasi	kusadasi	PROPN
easat-4163	262	9	,	,	PUNCT
easat-4163	262	10	m.	m.	NOUN
easat-4163	262	11	sikma	sikma	PROPN
easat-4163	262	12	,	,	PUNCT
easat-4163	262	13	j.	j.	PROPN
easat-4163	262	14	westerink	westerink	PROPN
easat-4163	262	15	,	,	PUNCT
easat-4163	262	16	and	and	CCONJ
easat-4163	262	17	a.	a.	NOUN
easat-4163	262	18	huisman	huisman	PROPN
easat-4163	262	19	,	,	PUNCT
easat-4163	262	20	"	"	PUNCT
easat-4163	262	21	thromboembolic	thromboembolic	ADJ
easat-4163	262	22	events	event	NOUN
easat-4163	262	23	and	and	CCONJ
easat-4163	262	24	apparent	apparent	ADJ
easat-4163	262	25	heparin	heparin	ADJ
easat-4163	262	26	resistance	resistance	NOUN
easat-4163	262	27	in	in	ADP
easat-4163	262	28	patients	patient	NOUN
easat-4163	262	29	infected	infect	VERB
easat-4163	262	30	with	with	ADP
easat-4163	262	31	sars‐cov‐2	sars‐cov‐2	PROPN
easat-4163	262	32	,	,	PUNCT
easat-4163	262	33	"	"	PUNCT
easat-4163	262	34	international	international	ADJ
easat-4163	262	35	journal	journal	NOUN
easat-4163	262	36	of	of	ADP
easat-4163	262	37	laboratory	laboratory	NOUN
easat-4163	262	38	hematology	hematology	NOUN
easat-4163	262	39	,	,	PUNCT
easat-4163	262	40	vol	vol	NOUN
easat-4163	262	41	.	.	PROPN
easat-4163	262	42	42	42	NUM
easat-4163	262	43	,	,	PUNCT
easat-4163	263	1	no	no	INTJ
easat-4163	263	2	.	.	PUNCT
easat-4163	264	1	suppl	suppl	PROPN
easat-4163	264	2	1	1	NUM
easat-4163	264	3	,	,	PUNCT
easat-4163	264	4	p.	p.	NOUN
easat-4163	264	5	19	19	NUM
easat-4163	264	6	,	,	PUNCT
easat-4163	264	7	2020	2020	NUM
easat-4163	264	8	.	.	PUNCT
easat-4163	265	1	https://doi.org/10.1111/ijlh.13230	https://doi.org/10.1111/ijlh.13230	VERB
easat-4163	266	1	[	[	X
easat-4163	266	2	28	28	NUM
easat-4163	266	3	]	]	X
easat-4163	266	4	m.	m.	NOUN
easat-4163	266	5	m.	m.	PROPN
easat-4163	266	6	chlebowski	chlebowski	PROPN
easat-4163	266	7	,	,	PUNCT
easat-4163	266	8	s.	s.	PROPN
easat-4163	266	9	baltagi	baltagi	PROPN
easat-4163	266	10	,	,	PUNCT
easat-4163	266	11	m.	m.	NOUN
easat-4163	266	12	carlson	carlson	PROPN
easat-4163	266	13	,	,	PUNCT
easat-4163	266	14	j.	j.	PROPN
easat-4163	266	15	h.	h.	PROPN
easat-4163	266	16	levy	levy	PROPN
easat-4163	266	17	,	,	PUNCT
easat-4163	266	18	and	and	CCONJ
easat-4163	266	19	p.	p.	NOUN
easat-4163	266	20	c.	c.	NOUN
easat-4163	266	21	spinella	spinella	NOUN
easat-4163	266	22	,	,	PUNCT
easat-4163	266	23	"	"	PUNCT
easat-4163	266	24	clinical	clinical	ADJ
easat-4163	266	25	controversies	controversy	NOUN
easat-4163	266	26	in	in	ADP
easat-4163	266	27	anticoagulation	anticoagulation	NOUN
easat-4163	266	28	monitoring	monitoring	NOUN
easat-4163	266	29	and	and	CCONJ
easat-4163	266	30	antithrombin	antithrombin	ADJ
easat-4163	266	31	supplementation	supplementation	NOUN
easat-4163	266	32	for	for	ADP
easat-4163	266	33	ecmo	ecmo	NOUN
easat-4163	266	34	,	,	PUNCT
easat-4163	266	35	"	"	PUNCT
easat-4163	266	36	critical	critical	ADJ
easat-4163	266	37	care	care	NOUN
easat-4163	266	38	,	,	PUNCT
easat-4163	266	39	vol	vol	NOUN
easat-4163	266	40	.	.	PROPN
easat-4163	267	1	24	24	NUM
easat-4163	267	2	,	,	PUNCT
easat-4163	267	3	pp	pp	ADJ
easat-4163	267	4	.	.	PUNCT
easat-4163	268	1	1	1	NUM
easat-4163	268	2	-	-	SYM
easat-4163	268	3	12	12	NUM
easat-4163	268	4	,	,	PUNCT
easat-4163	268	5	2020	2020	NUM
easat-4163	268	6	.	.	PUNCT
easat-4163	269	1	https://doi.org/10.1186/s13054-020-2726-9	https://doi.org/10.1186/s13054-020-2726-9	PRON
easat-4163	269	2	[	[	X
easat-4163	269	3	29	29	NUM
easat-4163	269	4	]	]	PUNCT
easat-4163	269	5	m.	m.	NOUN
easat-4163	269	6	a.	a.	PROPN
easat-4163	269	7	mazzeffi	mazzeffi	PROPN
easat-4163	269	8	,	,	PUNCT
easat-4163	269	9	j.	j.	PROPN
easat-4163	269	10	h.	h.	PROPN
easat-4163	269	11	chow	chow	PROPN
easat-4163	269	12	,	,	PUNCT
easat-4163	269	13	and	and	CCONJ
easat-4163	269	14	k.	k.	PROPN
easat-4163	269	15	tanaka	tanaka	PROPN
easat-4163	269	16	,	,	PUNCT
easat-4163	269	17	"	"	PUNCT
easat-4163	269	18	covid-19	covid-19	PROPN
easat-4163	269	19	associated	associated	ADJ
easat-4163	269	20	hypercoagulability	hypercoagulability	NOUN
easat-4163	269	21	:	:	PUNCT
easat-4163	269	22	manifestations	manifestation	NOUN
easat-4163	269	23	,	,	PUNCT
easat-4163	269	24	mechanisms	mechanism	NOUN
easat-4163	269	25	,	,	PUNCT
easat-4163	269	26	and	and	CCONJ
easat-4163	269	27	management	management	NOUN
easat-4163	269	28	,	,	PUNCT
easat-4163	269	29	"	"	PUNCT
easat-4163	269	30	shock	shock	NOUN
easat-4163	269	31	,	,	PUNCT
easat-4163	269	32	vol	vol	NOUN
easat-4163	269	33	.	.	PROPN
easat-4163	270	1	55	55	NUM
easat-4163	270	2	,	,	PUNCT
easat-4163	270	3	no	no	INTJ
easat-4163	270	4	.	.	NOUN
easat-4163	270	5	4	4	NUM
easat-4163	270	6	,	,	PUNCT
easat-4163	270	7	pp	pp	ADJ
easat-4163	270	8	.	.	PUNCT
easat-4163	271	1	465	465	NUM
easat-4163	271	2	-	-	SYM
easat-4163	271	3	471	471	NUM
easat-4163	271	4	,	,	PUNCT
easat-4163	271	5	2021	2021	NUM
easat-4163	271	6	.	.	PUNCT
easat-4163	272	1	https://doi.org/10.1097/shk.0000000000001660	https://doi.org/10.1097/shk.0000000000001660	NOUN
easat-4163	272	2	[	[	X
easat-4163	272	3	30	30	NUM
easat-4163	272	4	]	]	X
easat-4163	272	5	a.	a.	NOUN
easat-4163	272	6	c.	c.	PROPN
easat-4163	272	7	spyropoulos	spyropoulo	VERB
easat-4163	272	8	et	et	PROPN
easat-4163	272	9	al	al	PROPN
easat-4163	272	10	.	.	PROPN
easat-4163	272	11	,	,	PUNCT
easat-4163	272	12	"	"	PUNCT
easat-4163	272	13	modified	modify	VERB
easat-4163	272	14	improve	improve	VERB
easat-4163	272	15	vte	vte	NOUN
easat-4163	272	16	risk	risk	NOUN
easat-4163	272	17	score	score	NOUN
easat-4163	272	18	and	and	CCONJ
easat-4163	272	19	elevated	elevate	VERB
easat-4163	272	20	d	d	X
easat-4163	272	21	-	-	PUNCT
easat-4163	272	22	dimer	dimer	NOUN
easat-4163	272	23	identify	identify	VERB
easat-4163	272	24	a	a	DET
easat-4163	272	25	high	high	ADJ
easat-4163	272	26	venous	venous	ADJ
easat-4163	272	27	thromboembolism	thromboembolism	NOUN
easat-4163	272	28	risk	risk	NOUN
easat-4163	272	29	in	in	ADP
easat-4163	272	30	acutely	acutely	ADV
easat-4163	272	31	ill	ill	ADJ
easat-4163	272	32	medical	medical	ADJ
easat-4163	272	33	population	population	NOUN
easat-4163	272	34	for	for	ADP
easat-4163	272	35	extended	extended	ADJ
easat-4163	272	36	thromboprophylaxis	thromboprophylaxis	NOUN
easat-4163	272	37	,	,	PUNCT
easat-4163	272	38	"	"	PUNCT
easat-4163	272	39	th	th	X
easat-4163	272	40	open	open	ADJ
easat-4163	272	41	,	,	PUNCT
easat-4163	272	42	vol	vol	NOUN
easat-4163	272	43	.	.	PROPN
easat-4163	273	1	4	4	NUM
easat-4163	273	2	,	,	PUNCT
easat-4163	273	3	no	no	INTJ
easat-4163	273	4	.	.	NOUN
easat-4163	273	5	01	01	NUM
easat-4163	273	6	,	,	PUNCT
easat-4163	273	7	pp	pp	PROPN
easat-4163	273	8	.	.	PUNCT
easat-4163	273	9	e59	e59	NOUN
easat-4163	273	10	-	-	PUNCT
easat-4163	273	11	e65	e65	NOUN
easat-4163	273	12	,	,	PUNCT
easat-4163	273	13	2020	2020	NUM
easat-4163	273	14	.	.	PUNCT
easat-4163	274	1	https://doi.org/10.1055/s-0040-1705137	https://doi.org/10.1055/s-0040-1705137	PROPN
easat-4163	274	2	https://doi.org/10.1016/s2352-3026(20)30145-9	https://doi.org/10.1016/s2352-3026(20)30145-9	VERB
easat-4163	274	3	https://doi.org/10.1182/blood.2020007214	https://doi.org/10.1182/blood.2020007214	ADJ
easat-4163	274	4	https://doi.org/10.1016/j.vaccine.2022.09.001	https://doi.org/10.1016/j.vaccine.2022.09.001	PROPN
easat-4163	274	5	https://doi.org/10.1001/jamaneurol.2020.2730	https://doi.org/10.1001/jamaneurol.2020.2730	PROPN
easat-4163	274	6	https://doi.org/10.1016/j.trsl.2020.04.007	https://doi.org/10.1016/j.trsl.2020.04.007	PROPN
easat-4163	274	7	https://doi.org/10.1111/jth.14871	https://doi.org/10.1111/jth.14871	PROPN
easat-4163	274	8	https://doi.org/10.1111/ijlh.13230	https://doi.org/10.1111/ijlh.13230	PROPN
easat-4163	274	9	https://doi.org/10.1186/s13054-020-2726-9	https://doi.org/10.1186/s13054-020-2726-9	PROPN
easat-4163	274	10	https://doi.org/10.1097/shk.0000000000001660	https://doi.org/10.1097/shk.0000000000001660	NOUN
easat-4163	274	11	https://doi.org/10.1055/s-0040-1705137	https://doi.org/10.1055/s-0040-1705137	NOUN